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ABSTRACT 
 
 Progress in the field of magic-angle-spinning (MAS) solid-state nuclear magnetic 
resonance (NMR) has enabled, for the first time, the investigation of amyloid fibrils at an atomic 
level. Amyloid fibrils are not soluble and do not form crystals. Therefore, they are not accessible 
by traditional structural techniques (solution NMR and X-ray diffraction). Since 2004, five 
different 3D structures of amyloid fibrils have been solved and deposited in the protein data bank 
(pdb) using MAS solid-state NMR. These include structured regions ranging from 11 to 40 
residues. 
 Parkinson’s disease (PD) is the most common movement disorder that is characterized by 
the presence of Lewy bodies (LBs) in dopaminergic neurons. LBs are intracytoplasmic 
aggregates composed largely of fibrillar α-synuclein (AS). AS is a 140 residues protein that 
binds to anionic phospholipids with an α-helical secondary structure and promotes AS 
fibrillation at certain lipid-to-protein ratios. While most cases of PD are sporadic, three distinct 
mutations (A30P, E46K, A53T) in the AS gene and multiplication of the wild-type (WT) AS 
allele have been identified in familial early-onset PD. Together, these findings implicate AS 
misfolding in both sporadic and familial PD, but why and how these structural changes occur in 
the protein are not yet understood.  
 In my thesis, I have focused on new methodology development combined with state-of-the-
art solid-state NMR experiments with scanning transmission electron microscopy (STEM) to 
obtain atomic level structural information of the AS fibrils and the mechanism of their formation. 
We first investigated the effect of protein deuteration and 1H decoupling optimization to 
maximize the resolution and sensitivity of biomolecular solid-state NMR. We then applied state-
of-the-art solid-state NMR experiments to do a detailed structural characterization and 
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conformational dynamics of AS fibrils using improved sample preparation and labeling schemes. 
These results show that the core of the fibrils extends for about 70 residues with a repeated 
secondary structure motif. Additionally, it demonstrates that the three mutation sites (A30P, 
E46K, A53T) are located in structured regions of the fibrils. Upon mutation, we have shown that 
the structure suffers major and minor perturbations by E46K and A53T, respectively; while the 
structure is unaltered by A30P. The fibril formation has also been investigated by capturing the 
transition from α-helical to β-sheet at the atomic level using solid-state NMR. Additionally, to 
investigate the AS fold, the mass-per-length (MPL) measurement of the fibrils has been obtained 
using STEM that together with solid-state NMR restraints have been used to propose possible 
models of how the fibrils arrange. Finally, initial results for solving 3D high-resolution structures 
of large proteins with new computational methods have been investigated.    
 Taken together, these investigations will serve as basis for the understanding of how AS 
fibrils lead to the formation of LBs, the pathological hallmark of PD, and the transmission of 
aggregates from neuron-to-neuron involved in the propagation of the disease. Additionally, our 
results also demonstrate the feasibility and potential of solid-state NMR for the investigation of 
large amyloids and their misfolding pathways.  
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CHAPTER 1 
Introduction:  
Protein structure determination by magic-angle spinning solid-state NMR, 
and its application for understanding the formation, structure and stability of 
amyloid fibrils 
1.1 Notes and Acknowledgements 
 This chapter is adapted from an invited review article in preparation for the Annual 
Review in Biophysics, Protein structure determination by magic-angle spinning solid-state NMR, 
and its application for understanding the formation, structure and stability of amyloid fibrils, 
volume 42, 2013, authors: Gemma Comellas and Chad M. Rienstra. Funding support from the 
National Institutes of Health (R01-GM073770) is gratefully acknowledged. Gemma Comellas 
was a Caja Madrid Foundation and an Agusti Pedro Pons Graduate Fellow. All 3D structure 
figures were made using the VMD-Xplor visualization package. The authors also thank to 
Kristin Nuzzio and Dr. Anna Nesbitt for insightful discussions. License permissions have been 
obtained from the corresponding journals from which figures have been used for the review 
article. Permission is granted for the use of Figure 1B from Diane Sullenberger, PNAS Executive 
Editor and is cited accordingly. Figures 3A, 3B, 3C and 4B were adapted with kind permissions 
from Nature Publishing Group and Elsevier.  
1.2 Abstract 
 Protein structure determination methods using magic-angle spinning (MAS) solid-state 
nuclear magnetic resonance (NMR) have experienced a remarkable development in the last 
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decade. Significant advances in instrumentation, spectroscopic techniques and computational 
methods, as well as in sample preparation made the determination of the first high-resolution 
structures of a peptide and a protein structure possible in 2002. Subsequent developments 
enabled the investigation of larger proteins, the initial application of automatic routines and the 
improvement of structural resolution. The application of these methods has made possible the 
investigation of amyloid fibril structures, conformational dynamics and their formation at an 
atomic level for the first time, as these are systems not accessible by other common techniques. 
Recent advances and future trends for protein structure determination using MAS solid-state 
NMR, as well as their application to the study of amyloid fibrils, are reviewed. 
1.3 Introduction 
 Amyloid fibrils are well-known for their relationship in protein misfolding and the 
formation of deposits present in many diseases ranging from Alzheimer’s, Parkinson’s, 
dementia, Huntington’s, type II diabetes to prion diseases. Recent discoveries have also 
correlated amyloids to a large variety of non-disease amyloids and functional activity ranging 
from the storage of peptide hormones to the curli protein in E. coli, among many other systems. 
As a result, amyloid fibrils have become the center of many investigations, as evidenced by the 
citations of articles on amyloid fibrils per year (Figure 1.1A).  
 Structural studies of amyloid fibrils were initiated by fiber diffraction3 and  demonstrated 
the presence of a “cross-β” pattern, as shown for α-synuclein (AS) fibrils in Figure 1.1B. This 
pattern supports the arrangement of the backbone chains in parallel or anti-parallel register 
relative to each other in the perpendicular direction of the fibril axis (Figure 1.1C). Electron 
microscopy studies also demonstrated that amyloids are long, unbranched fibrils (Figure 1.1D). 
Due to their common structural properties, biochemical assays have commonly been used for the 
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identification of amyloids; the most common ones include the binding of Congo red or 
Thioflavin T. However, in order to evaluate the structural features that differentiate one amyloid 
to another, such as structural changes by mutation, structural changes between infectious and 
non-infections prions, or site-specific differences in the water accessibility or conformational 
dynamics, one needs higher resolution structural information. Amyloid fibrils, in their native 
form, are insoluble and non-crystalline. Therefore, atomic-level structures of these systems 
cannot be obtained using common techniques, such as solution NMR or X-ray diffraction. MAS 
solid-state NMR can be applied to non-soluble proteins of any size and do not require sample 
orientation. Consequently, it is uniquely positioned to obtain high-resolution structural and 
dynamic information of amyloid fibrils, their precursors or relevant states associated with 
physiological lipids, as well as their stability.  
 
Figure 1.1. Advances in the investigation of amyloid fibrils and common structural features 
 
(A) Number of citations per year of investigations associated to amyloid fibrils. Data from the web of 
science with the keywords: “amyloid fibrils”. Common structural features of amyloid fibrils: (B) “Cross-
β” pattern, as evidenced by the fiber diffraction pattern for wild-type (WT) α-synuclein (AS) fibrils1 - 
Copyright 2001 National Academy of Science, U.S.A, (C) Representation of the parallel and anti-parallel 
arrangement of amyloid fibrils and (D) Electron micrograph of AS fibrils showing the typical amyloid 
fibril morphology2 with copyright permissions. 
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1.4 Protein structure determination by magic-angle spinning solid-state NMR 
1.4.1 The evolution of magic-angle spinning solid-state NMR 
 Since the discovery of NMR in 1946, extensive work was conducted in the development 
of NMR for both liquids and solids. In 1984 the first “de novo” structure of a protein was solved 
by solution NMR by the group of the Nobel Laureate Kurt Wüthrich4. Although solid-state NMR 
would allow to access systems not approachable by other techniques, the complexity caused by 
the additional anisotropic interactions made its development for solving protein structures slower 
than that of solution NMR. While MAS was already described in 1958 (Ref. 5), assignable high-
resolution spectra of proteins were only obtained around the year 2000 (Ref. 6,7), following 
progress in magnetic-field strength, decoupling and recoupling pulse sequences and sample 
preparation techniques to solve, in 2002, the first high-resolution structures of a peptide8 and a 
protein9 by solid-state NMR. In 2004, an atomic resolution structure of a peptide monomer in an 
amyloid fibril was published10, in 2005 high-resolution spectra of the amyloid form of the HET-s 
prion domain were observed for the first time11 and the atomic resolution structure of the fibril 
was published in 200812. MAS solid-state NMR has experienced a tremendous development in 
the last decade. Additional protein structures have been determined13-22, and MAS solid-state 
NMR is becoming a powerful technique for the mechanistic and structural investigation of 
biological solids. Today, these results have already resulted in 3D structures of 5 different 
amyloid fibrils by MAS solid-state NMR that have been deposited in the protein data bank 
(PDB)10,12,23-25.  
1.4.2 Progress in structural determination methods 
 Approximately 10 years ago, the 3D structures of a peptide and a protein were solved for 
the first time using MAS solid-state NMR. These structures were based on the determination of 
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unambiguous distance restraints, resulting from the reintroduction of the dipolar couplings 
through rotor synchronized radio-frequencies (RF) pulses, and the use of simulated annealing 
programs for the structure calculations8,9. The peptide structure of MLF was achieved by 
combining heteronuclear 13C-15N distance restraints with torsion angle restraints (Figure 1.2A) 
on uniform (U)-13C, 15N isotopically labeled samples (Figure 1.2C).  
Table 1.1 RMSD measurements for the 3D structures solved by using solid-state NMR restraints 
and deposited in the protein data bank (pdb) 
* Conformers alignment and RMSD measurement was done using the VMD-xplor function that uses the 
method of Kabsch (Acta Cryst. (1978) A34, 827-828).  
** These measurements include residues 226 to 242 and 262 to 278 and in parenthesis all atoms from the 
PDB that include a large disordered loop. 
*** These measurements include residues 226 to 246 and 262 to 287 and in parenthesis all atoms from 
the PDB that include a large disordered loop. 
 
MEASURED 
RMSD* 
 
Publication 
year 
 
PDB 
number 
 
Peptide or 
protein Backbone All 
atoms 
 
# residues (# 
monomers) 
 
# confor-
mers  
 
All atom 
RMSD/total 
number of 
residues 
2002 1Q7O MLF 0.012 0.635 3 20 0.212 
2002 1M8M Spectrin 
SH3  
2.089 3.108 56 12 0.055 
2004 1RVS TTR 0.728 1.486 11 20 0.135 
2005 1XSW Kaliotoxin 0.846 2.031 38 10 0.053 
2006 1ZY6 Protegrin-1 - - 19 (x2) 1 - 
2006 2CZP Mastoparan 0.444 1.594 15 10 0.106 
2006 2NNT WW CA 
150 
0.331 0.671 30 (x4) 10 0.022 (0.006) 
2006 2E8D β2m 1.681 2.579 22 (x4) 10 0.117 (0.029) 
2007 2JU6 GB1 0.825 1.700 56 10 0.030 
2008 2RLZ Crh domain 1.011 1.607 85 (x2) 10 0.019 (0.009) 
2008 2RNM Het-S (218-
289) 
0.731 
(3.724)** 
1.342 
(4.478)*
* 
34 (x5) 
79 (x5) 
20 0.039 (0.008) 
0.057 (0.011) 
2008 2JSV GB1 0.355 1.099 56 10 0.020 
2008 2JZZ UBQ 1.712 2.259 76 20 0.030 
2008 2K0P GB1 - - 56 1 - 
2008 2K9C MMP-12 3.106 3.781 153 20 0.025 
2009 2KAD Influenza 
M2 channel 
- - 25 (x4) 1 - 
2009 2KIB hIAPP 0.412 0.962 7 (x8) 10 0.137 (0.017) 
2009 2KQ4 GB1 0.234 0.684 56 10 0.012 
2010 2KRJ MMP-12 1.309 2.097 153 20 0.014 
2010 2KQT Influenza 
M2 channel 
0.092 0.115 25 (x 4) 17 0.005 (0.001) 
2010 2KHT HNP-1 1.682 2.831 30 10 0.094 
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Table 1.1 (cont.) 
2010 2KLR αβ-
crystalline 
1.423 2.260 82 (x2) 10 0.028 (0.014) 
2010 2KJ3 Het-S (218-
289) 
1.097 
(3.700)**
* 
1.645 
(4.446)*
** 
47 (x3) 
79 (x3) 
20 0.023 (0.008) 
0.056 (0.019) 
2011 2L3Z UBQ 1.398 2.078 76 20 0.027 
2011 2LGI GB1 0.162 0.612 56 10 0.011 
 
 
 In the same year, the first structure of a 62 residue protein was obtained by combining 
dihedral angles (predicted from the chemical shift assignments) and unambiguous homonuclear 
distance restraints from experiments with proton-driven spin diffusion (PDSD) recoupling 
(Figure 1.2A). In this case, 13C-sparse labeled samples were used (Figure 1.2C). Since these 
initial studies, substantial progress has been made in the field towards measuring new structural 
restraints, improving the resolution and complexity of the structures and developing new 
software and hardware to facilitate the data collection and analysis for protein structure 
determination methodology. This progress is evidenced by the number of citations per year 
(Figure 1.2B) and the improvement in the all atoms RMSD (root-mean-square deviation)/total 
number of residues, as shown in Figure 1.2C and Table 1.1. In 2003, a higher resolution structure 
of the α-spectrin SH3 domain was obtained following a similar approach, as the previous 
structure, but with the application of 3D solid-state NMR experiments (no coordinates were 
deposited in the PDB) 26.  
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Figure 1.2. Advances in the structure determination methods by solid-state NMR 
 
(A) Representation of the different kinds of restraints that have been used for 3D structure determination 
with solid-state NMR using the pdb 2QMT structure of the protein GB1. (B) Number of citations per year 
involving solid-state NMR structural studies of proteins. Data from the web of science with the keywords: 
“solid-state NMR”, “structure” and “proteins”. (C) Timeline for the 3D structures of peptides and proteins 
solved by magic-angle spinning solid-state NMR and deposited in the pdb databank: using new 
methodology development and their application for solving amyloid fibrils structures. RSMD calculations 
are described in Table 1.1.  
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 In 2005, short unambiguous 1H-1H distances were measured for a 38 residue U-13C, 15N 
labeled protein using indirect detection on 13C-13C 2D spectra. In combination with the dihedral 
angles predicted from the chemical shifts, its 3D structure was solved (Figure 1.2)13. Further 
significant advancements in the field included the development of 1H detection methods for 
solid-state NMR, which required significant instrumental improvement to design fast MAS triple 
resonance probes together with the development of new pulse sequences and proton diluted 
labeling methods to obtain narrow proton linewidths27-33. In 2007, these techniques resulted in 
the first protein structure solved with 1H detected experiments14 and to recently solve a protein 
structure with 4D solid-state NMR experiments (Figure 1.2)34. Recent publications have also 
demonstrated their application to amyloid fibrils35. In the same year, the structure of human 
microcrystalline ubiquitin (UBQ) was also solved using unambiguous distance restraints from 
13C-13C 2D spectra with DARR mixing on uniform (U)-13C isotopically labeled samples 36 (no 
coordinates were deposited in the pdb). 
 After these early studies, several new solid-state NMR structures have been deposited 
based on the development of new computational methods, as well as the use of novel structural 
restraints (Figure 1.2A). Computational advances included the application of automated iterative 
assignment algorithm in the program ARIA to solve the 3D structure of a protein in a swapped 
dimer (Figure 1.2C), using highly ambiguous homonuclear distance restraints15. Further 
improvements included the application of automatic analysis of 2D spectra with the 
ATNOS/CANDID program to solve the structure of UBQ17, as well as the application of the 
Cheshire program for de novo determination of the β1 immunoglobulin binding domain of 
protein G (GB1) structure with only the solid-state NMR chemical shifts19 (Figure 1.2C). New 
methods for protein structure determination in the solid-state included the use of pseudocontact 
   9 
shifts (PCS) (Figure 1.2A) in paramagnetic proteins18,21, which combined with several 
recoupling pulse sequences permitted to solve the structure of a 153 residues protein. Subsequent 
studies demonstrated the possibility to extend the paramagnetic relaxation enhancement (PRE) 
experiments to other proteins via the introduction of paramagnetic spin labels, which have 
recently enabled the rapid determination of the protein GB1 fold without the use of conventional 
internuclear distance restraints 37. Several other homonuclear recoupling pulse sequences have 
also been developed and are summarized in Table 1.2. Although they have not yet been used to 
solve 3D protein structures, they might have the potential to do so.  
 Despite the frequent use of homonuclear distance restraints, quantitative heteronuclear 
distance restraints have also been used as structure determination methods (Figure 1.2A and 
Table 1.2). High precision heteronuclear restraints can be obtained through the fitting of dipolar 
dephasing curves with the rotational echo double resonance (REDOR)38 experiment, as 
demonstrated for the MLF structure, or buildup curves for the transferred echo double resonance 
(TEDOR)39 experiment. Several modifications of the original pulse sequences enabled their 
application for 3D protein structure determination, as demonstrated by the application of the 3D 
ZF TEDOR for the protein GB1 using 13C-15N distances20.  
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Table 1.2. Structural restraints used by MAS solid-state NMR for the determination of 3D protein 
structures 
 
aIn several cases more than one kind of restraint was used, and proteins were classified within the type of 
restraints with the largest number of restraints that were used.  
bBasic pulse sequences used to measure such restraints (with corresponding citations). 
cExamples of proteins solved with such restraints, disotopic labeling schemes used to do so and eprotein 
sizes.   
 
Restraint typea Basic pulse sequenceb Protein or peptide structurec Isotopic labeling schemed Size (kDa)e 
Dihedral angles based 
on the chemical shift  
 Specific CP 40 
15N13C13C 41 
 13C15N13C 42 
GB1 19 U-13C, 15N 6.0 
Spectrin SH3 domain 9 Sparse 13C, U-15N 7.0 
Kaliotoxin 13 U-13C, 15N 4.0 
GB1 14 U-2H, 13C, 15N-back exchange 6.0 
 
Crh domain, dimer 15 U-13C, 15N 9.5 (x2) 
Ubiquitin (UBQ) 17 U-13C, 15N 9.0 
Macrophase metalloelastase 
(MPP-12) 18,21 
U-13C, 15N: U- 12C, 14N 17.6 
 
Human α-defensin (HNP-1) 63 U-13C, 15N 3.0 
 
UBQ 34 U-2H, 15N, VL-13CHD2 9.0 
αβ-crystalline 64 U-13C,15N 
Sparse 13C,14N: U- 12C, 15N 
 U-13C, 15N: U- 12C, 14N 
20.0 (x2) 
 
β2-microglobulin (β2m) 23 U-13C, 15N 2.5 (x4) 
WW domain of CA 150 24 Sparse 13C, U-15N 
U-13C,15N 
4.5 (x4) 
 
HET-s (218-289) Prion form 
12,65 
 
U-13C,15N 
U-13C,14N: U- 12C,15N 
 U-13C,15N: U- 12C,14N 
8.6 (x 5; 
x3) 
 
Fragment of the human islet 
amyloid polypeptide (hIAPP) 25 
U-13C, 15N 
 
0.75 (x8) 
 
Amantadine-bound M2 
transmembrane peptide of 
influenza A (M2TMP) 66 
U-13C, 15N-VSL 2.75 (x4) 
Distances restraints 
from homonuclear 
dipolar recoupling 
experiments 
 
PDSD 43 
DARR 44 
CHHC 45 
PAIN 46 
PAR 47 
R2 48,49 
R2TR 50 
R2T 51 
RFDR 52 and variations  
DRAMA 53 
HORROR 54 
MELODRAMA 55 
C7 56 
Post-C7 57 
CMR7 58 
DRAWS 59 
DREAM 60 
PARIS 61 and variations 
SHANGAI 62 
HNP-1  U-13C, 15N 3.0 
MLF 8 U-13C, 15N 0.4 
TTR 10 
 
U-13C, 15N-YTIA 
U-13C, 15N-AALL 
U-13C, 15N-LSPY 
1.0 
GB1 20 Sparse 13C, U-15N 6.0 
Amantadine-bound M2 
transmembrane peptide of 
influenza A (M2TMP) 68 
U-13C, 15N-LVAG 
U-13C, 15N-SID 
2.75 (x4) 
Mastoparan 69 U-13C, 15N 2.0 
Distances restraints 
from heteronuclear 
dipolar recoupling 
experiments 
REDOR 38 and variations  
TEDOR 39 and variations 
FRESH 67 
Protegin-1 70 U-15N-C15: U-13C‘-C15 
4-19F-F12, 13C‘-V16 
4.0 (x2) 
MLF 8 U-13C, 15N 0.4 
TTR 10 U-13C, 15N 1.0 
Human α-defensin (HNP-1) 63 U-13C,15N 
Sparse 13C, U-15N 
3.0 
Torsion angles/Vector 
angles (ϕ[i], χ1[i] ψ[i-
1], based on the dipolar 
and/or chemical shift 
anisotropy (CSA) 
orientations) 
T-MREV 71 
R1817 72 
ROCSA 73 
GB1 16,22 U-13C, 15N 6.0 
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 Further applications also demonstrated their potential for the determination of the GB1 
supramolecular structure, using mixed labeled samples74, or the recent application using 13C{2H} 
REDOR dephasing curves to solve a very high-resolution structure of amantadine drug in the M2 
channel (See Table 1.1)66,68.  
 Very high-resolution structures can also be obtained upon the combination of distance 
restraints with relative orientations of the molecular fragments. Examples of their application 
include the use of torsion angles for MLF (8) or human α-defensin (HNP-1)63, as well as, vector 
angles (VEANS)16 or chemical shift tensors (CST)22,75 for the determination of the GB1 structure 
(Figures 1.2A and 1.2C). These studies have provided the foundation for a new class of restraints 
for protein structure determination and refinement in the solid-state. Although these have been 
applied for relatively small systems, they have the potential to be applied to larger systems in 
combination with the use of larger magnetic fields and labeling schemes. 
1.4.3 Future trends  
 The technological and spectroscopic advances that MAS solid-state NMR has 
experienced in the last decade has significantly contributed to the development of the technique. 
The design of new probes to reduce RF-induced sample heating has been crucial for the study of 
biomolecular systems76. Fast MAS techniques for both 13C and 1H detection have enhanced the 
sensitivity and spectral resolution of solid-state NMR, allowing the application of 3D and 4D 1H 
detection methods in solids for the first time. Dynamic nuclear polarization (DNP) enhanced 
solid-state NMR was already introduced in the 1950’s, but it is was not until the recent 
development of high-power sources that this technique has been put into practice for 
biomolecular NMR77. The signal enhancement resulting from the transfer of magnetic 
polarization from unpaired electron spins to the nuclear spins will help to overcome the current 
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sensitivity problems in solid-state NMR. Several applications of the technique using polarizing 
agents have demonstrated its application to proteins78,79, including amyloid fibrils80. Although 
significant progress has been made with DNP solid-state NMR, further instrumental and 
technical advances, such as the application of DNP at higher magnetic fields or the introduction 
of paramagnetic labels as polarizing agents, are expected to provide significant potential for 
future applications81. 
 Several new computational methods have also been described for protein structure 
determination and several 3D protein structures have already been solved, as summarized in 
Table 1.2. Additional computational advances have included the development of automated 
chemical shift assignment protocols for multidimensional solid-state NMR spectra. Initial 
automated analysis routines have been developed and demonstrated their applicability82,83. 
However, additional advances for their implementation will be necessary to overcome problems 
due to (i) the presence of larger spectral linewidths and (ii) the lack of a significant number of 
resonances compared to solution NMR. Considering the current state-of-the-art methods of the 
field, further advances in MAS solid-state NMR combined with additional progress in the 
computational routines are expected to overcome some of the existing obstacles that will make 
automatic routines and analysis methods feasible in the solid-state.  
 The combination of different kind of restraints has demonstrated the possibility of 
obtaining extremely high-resolution structures in the solid-state (all atom RMSD/total number of 
residues < 0.005, as shown in the Table 1.1)16,22,75. Several protein structures in the range of 22 
to 82 residues have already been solved, as described above, and initial results have also 
demonstrated the ability for solving larger structures than these18,21. Although MAS solid-state 
NMR is attaining the stage of a prominent technique for biomolecular structural investigations, 
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continued technological and computational advancement, together with improvements in the 
sample preparation will ensure its position to significantly contribute to the state-of-the-art of 
protein structure determination. Such advances will ensure their application for solving structures 
of large proteins, including membrane proteins embedded in physiological relevant lipids, as 
well as, amyloid fibrils in their native forms.  
1.5 High-resolution structural studies of amyloids 
1.5.1 Previous structural studies of amyloid fibrils 
 Structural studies of amyloid fibrils by MAS solid-state NMR began with the 
examination of the β-amyloid (Aβ) peptide associated with Alzheimer’s disease, including the 
description of its secondary structure and the first structural model of an amyloid peptide84-86. 
Further examinations included the investigation of several other Aβ constructs and the full length 
peptide for the exploration of the β-sheet arrangement87-89, structural model 90 and the 
phenomena of polymorphism91, as summarized in Table 1.3. At the same time, other amyloid 
fibrils were also investigated, including the first prion studied by solid-state NMR, the mouse 
prion protein MoPrP (89-143) and its mutant P101L92, the human calcitonin fibrils93 and the 
Transthyretin (TTR) (105-115) amyloid peptide94 associated to amyloidosis, as well as the 
investigation of engineered amyloids95. These studies also demonstrated the presence of anti-
parallel arrangements in amyloid fibrils, as shown for Aβ96 and calcitonin93. 
 After 2005, the number of investigations of amyloid fibrils continued to increase with 
almost an exponential trend, as evidenced by Figure 1.1A. Many new systems were investigated 
in the following years by solid-state NMR, as summarized in Table 1.3. These systems included 
many diseases, such as diabetes mellitus, Parkinson’s, Huntington’s, medullary carcinoma, aortic 
medial or amyloidosis, as well as, several mammalian and fungal Prions. In addition to the 
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disease-associated amyloid fibrils, functional amyloids have also been investigated by using 
MAS solid-state NMR and ranged from the investigation of the curli protein, associated with the 
bacteria Escherichia coli (E. Coli), to the recent study of hormone storage as amyloids or 
engineered amyloids. 
Table 1.3. Amyloid fibrils studied by MAS solid-state NMR 
 Diseases or associated 
systems 
Aggregating protein or 
peptide 
Number 
of 
residues 
Structural information obtained by solid-state NMR 
Alzheimer's disease, 
Cerebral Amyloid 
angiopathy 
Aβ (39-43) 
Aβ (1-40) 
 
Aβ (16-22) 
Aβ (34-42) 
Aβ (10-35) 
Aβ (26-40) 
Aβ (1-42) 
Aβ (11-25) 
Aβ (14-23) 
D23N aβ40 
Inclusion bodies derived aβ  
Aβ (1-40) intermediate 
tau 
5 
39 
 
7 
9 
26 
15 
41 
15 
10 
40 
 
39 
β-Sheet Arrangement 87 
β-Sheet Arrangement 88, Structural model 90,97, molecular 
polymorphism 91 
β-Sheet Arrangement 89 
Secondary structure 84, structural model 86 
β-Sheet Arrangement 98-100 
Polymorphism 85 
Structural model 101 
pH effect on the β-Sheet Arrangement 96 
β-Sheet Arrangement 102 
β-Sheet Arrangement 103 
Structures comparison 104,105 
Structural model 106 
Secondary structure; structural model 107 
Type 2 diabetes mellitus IAPP 
IAPP (20-29) 
37 Structural model 108 
3D structure 25, polymorphism 109 
Parkinson's disease AS 
 
A30P, E46K, A53T AS 
140 
 
140 
Secondary structure and dynamics 2,110-112, β-Sheet Arrangement 113, 
fibril formation mechanism 114 
Secondary structure comparison to wild-type 2,115,116 
Huntington’s disease; 
transcriptional activator 
WW domain of CA150 
Huntingin  
40 
17 
3D structure 24, Structures comparison 117 
Secondary structure 118 
Medullary carcinoma  Calcitonin 32 Structural model 93 
Aortic medial amyloid Medin (AMed) (42-49) 8 Structural model 119 
Familial amyloid 
polyneuropathy, senile 
systemic amyloidosis 
TTR (105-115) 11 Secondary structure and structural model 94, 3D structure 10 
Dialysis related 
amyloidosis 
β2m (20-41) 
β2m 
22 
99 
3D structure 23 
Structural changes by pH 120, β-Sheet Arrangement 121 
Mammalian prions, 
diseases caused by 
misfolding and 
aggregation 
MoPrP (89-143), P101L 
MoPrP (89-143) 
SyrianHamster (H1) PrP 
(109-122) 
huPrP (23-144) Y145Stop 
55 
 
14 
 
122 
Secondary structures 92, β-Sheet Arrangement 122 
 
Structural model 123 
 
Secondary structure 124, dynamics 125  and β-sheet arrangement 126 
Fungal prions, naturally 
occurring proteins that 
can undergo structural 
conversion and become 
infections 
Sup35 (1-253) 
Sup35 (7-13) 
Ure2p (10-39) 
Ure2p (1-89) 
Ure2p, Ure2p (1-93) 
Rnq1p (153-405) 
HET-s (218-298) 
 
HET-s 
Inclusion derived HET-s 
253 
7 
 
30 
89 
93 
253 
80 
298 
80 
β-Sheet Arrangement 127 
Structural comparison 128 
β-Sheet Arrangement 129 
β-Sheet Arrangement 130 
Structural comparison 131 
β-Sheet Arrangement 132 
Secondary structure 133, 3D structure 12,65, conformational 
dynamics134,135, water accessibility 136, Structural changes by pH137 
Structural comparison138 
Structural comparison 139 
Other functional 
amyloids  
Curli fibrils from E coli. 
Somastotastine hormone 
storage 
22 Secondary structure; β-Sheet Arrangement 140  
Secondary structure 141 
Engineered amyloid 
peptides; fundamental 
studies in biophysics 
Cc-β 
 
T2Q-GB1 
17 
 
56 
β-Sheet Arrangement 95, structural changes by pH 142 
Secondary structure and β-Sheet Arrangement 143 
   15 
1.5.2 Practical aspects for the investigation of amyloid fibrils 
 The first step toward investigating amyloid fibrils by MAS solid-state NMR is the 
preparation of significant quantities (~5-30 mg) of isotopically labeled peptide or protein. This is 
usually accomplished by using solid-phase peptide-synthesis (SPPS), for peptides or proteins of 
a relatively small number of amino acids, or bacterial expression for peptides or proteins of any 
size and followed by purification. Different labeling schemes have been used in the past. These 
range from U-13C, 15N and 13C-sparse labeling schemes to residue or atom specific labels. Once 
sufficient isotopically labeled peptide or protein has been obtained, in vitro fibrils are prepared 
by incubating at specific conditions (concentration, temperature, pH, buffer), usually trying to 
mimick the physiological ones. To do so, it is extremely important to ensure reproducible sample 
preparation conditions, as shown for AS fibrils in Figure 1.3A. This is essential for the 
determination of 3D structures, as one needs to unambiguously distinguish between 
intermolecular and intramolecular restraints by using different labeling schemes. Additionally, it 
is also essential for the investigation of structural changes, for example by protein mutation. 
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Figure 1.3. Practical aspects of solid-state NMR studies of amyloid fibrils 
 
(A) Chemical shift comparison to demonstrate reproducible sample preparation, (B) selection of the 
optional hydration conditions (C) representation of the sequential chemical shift assignments using 
multidimensional experiments and (D) conformational dynamics, (E) representation of the necessary 
labeling schemes (homogeneous, diluted and mixed samples) for unambiguous determination of 
intramolecular and intermolecular restraints and (F) Mass-per-length measurement as a restraint for the 
structure calculations. Figures were adapted from references2 with copyright permissions.   
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 Amyloid fibril formation is a nucleation-based process. Once the initial nucleus is 
formed, the fibril formation is accelerated towards the formation of mature fibrils. As a result, 
one can use such property for the preparation of fibrils by seeding with previous generations. Not 
only does this methodology accelerate the fibril formation and ensure the reproducibility sample 
preparation in order to use different labeling schemes, but it can also be used to seed isotopically 
labeled samples with physiological samples, as previously demonstrated for the Aβ protein 
seeded with inclusion bodies from Alzheimer’s disease patients104 or HET-s seeded with 
inclusion bodies138.  
 In order to obtain high-resolution structural and conformational dynamics information 
about amyloid fibrils, it is necessary to maximize the spectral quality (both in terms of sensitivity 
and resolution). Our investigations with AS fibrils have demonstrated significant effect of the 
hydration level on the spectral quality. Initial studies were conducted with the fibrils prepared by 
ultracentrifugation after fibrillation, removal of the supernatant and then centrifugation of the 
fibrils into the MAS rotor. Spectra on these initial samples presented less peaks than expected for 
a 140-residue protein111. Substantial increase in sensitivity was observed by lowering the sample 
temperature, which at the same time compromised the spectral resolution. A similar effect was 
observed by drying the fibrils144. Our recent results have demonstrated that optimizing the 
sample hydration conditions can maximize resolution and sensitivity2, as shown in Figure 1.3B. 
Comparison of our results with other amyloid fibrils studies suggest that the optimal hydration 
level for resolution and sensitivity of amyloid fibrils might be system dependent.  
 Different approaches have been used for the investigation of amyloid fibrils. When high-
resolution spectra have been obtained or when relatively small systems are being studied, the 
most common methodology for solid-state NMR studies includes the use of U-13C, 15N 
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isotopically samples from SPPS or bacterial expression. Chemical shift assignments in these 
cases have usually been obtained by performing a sequential backbone walk with 3D 
experiments, as shown in Figure 1.3C and 1.3D for AS fibrils. For small peptides, only 2D 
experiments may be necessary. These methodology has been applied to several amyloid 
systems2,23,94,97,110,112 ,116,120,124,128,131,133,143, as summarized in Table 1.3. In cases where lower 
spectral resolution was obtained or only site-specific information for certain positions were 
desired, other approaches have been typically used to obtain information of the chemical shift 
assignments with site-specific labeling methods using SPPS or bacterial expression25,84,86-
93,95,96,98-103,108,109,119,123,127,129,132,140,142.  
 In order to solve a 3D structure of an amyloid fibril, it is important to be able to obtain 
and distinguish between intramolecular and intermolecular restraints. Intramolecular restraints 
will provide information of the monomer fold, while intermolecular restraints will be essential 
for understanding the supramolecular structure of the monomer present in the fibrils. Although 
initial efforts have been made towards developing computational methods to distinguish between 
these two types of restraints15, the most common current approach is the use of different 
isotopically labeled samples. These samples are usually prepared by mixing isotopically labeled 
monomers with unlabeled monomers or by mixing different labeling schemes. As shown in 
Figure 1.3E, these labeling schemes include diluted samples, which will provide information of 
the intramolecular restraints, and mixed samples to obtain information of intermolecular 
restraints. These restraints can also complement structural information obtained by other 
experimental techniques, as described in the following section, which might be incorporated into 
the structure calculation protocols. 
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 Amyloid fibrils are structurally characterized for having a relatively rigid β-sheet core, 
together with additional flexible regions in most of the cases. Cross-polarization (CP) dipolar-
based experiments usually fail in detecting the more dynamic parts of the fibrils. However, these 
regions have been previously investigated for some amyloids, such as HET-s134,138, tau 
fibrils107,145, AS fibrils2,110 or huPrP Y145Stop125 by using INEPT (insensitive nuclei enhanced 
by polarization transfer) and/or J-based spectroscopy. Significant conformational dynamics have 
also been detected within the relatively rigid core of the fibrils, as shown by the changes in 
intensity of multidimensional experiments displayed in Figure 1.3D. Qualitative analysis has also 
been performed for some cases, such as huPrP Y145Stop125 or AS fibrils2, which demonstrate 
agreement between the intensity change in the CP-dipolar-based experiments and the change in 
the 15N T1ρ measurements. However, a detailed quantitative analysis of the conformational 
dynamics has not yet been described. These conformational dynamics can difficult the structural 
studies by solid-state NMR, as signal intensities in the CP-dipolar-based experiment will be 
substantially decreased in the more dynamic regions. Therefore, methodology improvements for 
maximizing the sensitivity of MAS solid-state NMR spectra, not only from a sample preparation 
point of view, will be essential for the detection of weak peaks in the spectra. For example, one 
of our recent investigations demonstrated a significant enhancement of sensitivity and resolution 
of AS fibrils spectra by a straightforward optimization of SPINAL-64 1H decoupling 146. 
1.5.3 Contributions from other techniques 
 MAS solid-state NMR is uniquely positioned to obtain 3D high-resolution structures for 
systems not accessible by other techniques. However, it can greatly benefit by using 
complementary information from other techniques for the investigation of amyloid fibrils. 
Electron microscopy can provide structural information of amyloid fibrils in their native state 
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without requiring the use of isotopic labeling schemes. Measurement of the fibril diameter can be 
done using Transmission Electron Microscopy (TEM) or Cryo-TEM and can be used as a 
restraint for 3D structure determination. The mass-per-unit-length (MPL), which can be 
measured with Scanning TEM (STEM) or Title beam-TEM (TB-TEM), reports on the axial 
stacking of the monomer perpendicular to the fibril axis, as shown in Figure 1.3F. This 
measurement has been previously used to obtain information about the amyloid fibril fold for 
many systems (Figure 1.4A) and used as a restraint for the structure calculations, as recently 
demonstrated for HET-s65,147.  
 
Figure 1.4. Contributions to structural MAS solid-state NMR studies by other techniques and 
applications from the structural studies 
 
(A) MPL measurement of HET-s fibrils using STEM for the determination a 3D structure of HET-s. (B) 
Model of the αβ-crystalline oligomer using the solid-state NMR 3D structure and the average volumetric 
map generated from SAXS data. (C) 3D structure of Congo red docked to HET-s Prion (218-289). 
Figures were adapted from references147,64,148 with copyright permissions.  
  
 Further information regarding the morphology of the fibrils can be obtained from Cryo-
TEM or atomic force microscopy (AFM). Qualitative analysis of the fibrils’ morphology has 
already been done for many amyloid fibrils, but one might envision a possible future scenario 
where such information could be included in the structure calculations to obtain the 
supramolecular structure of the fibril.  
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 Further contributions have been obtained from small-angle X-ray scattering (SAXS), for 
which crystalline samples are not needed, and structural information on the order of microscale 
to nanoscale can be obtained. Together with the MAS solid-state NMR data, SAXS data could be 
used for the determination of the supramolecular structure, as demonstrated for the structure of 
αβ-crystalline (Figure 1.4B). Additional contributions from X-ray on the study of amyloids can 
be found for very specific cases. Although X-ray crystallography cannot be used for the structure 
determination of amyloid fibrils in their native form, some structural information has been 
obtained for short segments of amyloids that can be microcrystallized149. However, comparison 
of the MAS solid-state NMR and X-ray crystallography approaches have revealed differences in 
the packing details of the side-chains150.  
 Once a 3D structure of the amyloid fibril is obtained, information regarding its 
conformational dynamics and stability could also be complemented with molecular dynamics 
simulations. For example, in the case of the HET-s(218-289) prion, solid-state NMR data was 
obtained for the order and dynamics of the rigid and flexible parts of the fibrils and was 
combined with molecular dynamic simulations to investigate the stability of the fibrillar core135.  
1.5.4 Structures of amyloids solved and deposited in the pdb 
 The remarkable advancement that MAS solid-state NMR has experienced in the last 
decade has permitted the structure determination of the 3D structures of five different amyloid 
fibrils that have been deposited in the pdb (Figure 1.2C). The first structure of an amyloid 
peptide, TTR(105-115), was solved by combining the dihedral angles (obtained with chemical 
shift assignments) with 13C-15N distance restraints and torsion angles using simulated annealing 
(Figure 1.2C). This 3D structure demonstrated that TTR(105-115) adopts an extended β-sheet 
strand with long-range order that helped to explain the unusual stability of this assembly. Further 
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investigations of amyloid structures on the size of 22 to 30 amino acids were obtained by 
combining chemical shift assignments and homonuclear distance restraints23,24.  
 Significant advancements were made when the structure of the HET-s (218-298) prion 
protein was solved, which demonstrated the presence of a triangular β-selenoid fibrillar core12. 
To do so, chemical shift assignments were combined with the mass-per-length measurement and 
solid-state NMR restraints from different isotopically labeled samples65 (Figure 1.3E). Simulated 
annealing approaches were used for the structure calculations and the final structure was 
supported with further analysis of the distance restraints. An improved structured for the HET-s 
(281-298) with further β-strand regions was also recently published12,65. Additional new 
advances also included the combination of ambiguous homonuclear distance restraints and 
symmetry information to solve the structure of the 11 residue human islet amyloid polypeptide 
hIAPP(20-29)25. 
1.5.5 Applications resulting from structural studies of amyloids  
 The application of MAS solid-state NMR to amyloid fibrils has enabled the atomic-level 
investigation of these relevant systems for the first time. The HET-s (281-298) 3D structure, for 
example, has recently been used as basis for the determination of the binding site of the molecule 
Congo red148 using docking techniques. The structure of this complex was used to evaluate the 
binding site and design a point mutant where Congo red does not bind. These results demonstrate 
the specificity of such binding and corroborate the importance of having high-resolution 
structural information of amyloids. Therefore, further developments in solid-state NMR for 
might help in the design of molecules that selectively bind to amyloids as possible biomarkers 
for the early diagnostic of diseases or possible inhibitors of the amyloid fibril formation. Future 
structural studies might also assist in the future design of new-engineered amyloids. 
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1.6 Conclusions and future trends 
 The work reviewed here illustrates the substantial advancement of MAS solid-state NMR 
and its application for the investigation of amyloid fibrils at the atomic-level. Although only the 
structures of five different amyloids have yet been solved and deposited into the pdb, substantial 
differences in the 3D structures of the fibrils have been observed. Future improvement of the 
structure determination methods, including new pulse sequences, hardware advances and new 
computational resources will contribute to the advancement of structure determination methods 
by solid-state NMR. Taking together these advances in combination with other techniques, we 
expect that solid-state NMR will enable the investigation of larger amyloids, more structural 
diversity than for small systems can be expected. Additionally, the possibility of not only 
investigating the amyloid fibril structure, but also of different states found in the folding pathway 
and their conformation dynamics, will permit a better understanding of the amyloid fibril 
formation at an atomic-level. 
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CHAPTER 2 
High-resolution 13C-detected magic-angle spinning solid-state NMR 
spectroscopy of deuterated proteins 
2.1 Notes and Acknowledgements 
This chapter is adapted with kind permission from Springer Science and Business Media: 
Journal of Biomolecular NMR, High-resolution 13C-detected solid-state NMR spectroscopy of 
deuterated proteins, volume 48, 2010, pages 103-111, authors: Ming Tang*, Gemma Comellas*, 
Leonard J. Mueller, Chad M. Rienstra. *These authors contributed equally to this work. This 
work was supported by National Institute of Health (NIGMS GM075937 and GM073770, 
S10RR023677) and the National Science Foundation (CHE-0848607). Gemma Comellas was a 
Caja Madrid Foundation and Agusti Pedro Pons Graduate Fellow. The authors thank to John J. 
Shea and John M. Boettcher for the sample preparation. 
2.2 Abstract 
High-resolution magic-angle spinning (MAS) solid-state nuclear magnetic resonance 
(NMR) spectroscopy is a novel technique that has substantially advanced in the last decade, but 
it is still challenged by the relatively low resolution in comparison to solution NMR. Here, we 
present high resolution 13C-detected solid-state NMR spectra of the deuterated β-1 
immunoglobulin binding domain of the protein G (GB1) to show that all 15N, 13C’, 13Cα and 
13Cβ sites are resolved in 13C-13C and 15N-13C spectra, with significant improvement in T2 
relaxation times and resolution at high magnetic field (750 MHz). The comparison of echo T2 
values between deuterated and protonated GB1 at various spinning rates and under different 
decoupling schemes indicates that 13Cα T2‘ times increase by almost a factor of two upon 
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deuteration at all spinning rates and under moderate decoupling strength, and thus the deuteration 
enables application of scalar-based correlation experiments that are challenging from the 
standpoint of transverse relaxation, with moderate proton decoupling. Additionally, deuteration 
in large proteins is a useful strategy to selectively detect polar residues that are often important 
for protein function and protein-protein interactions. 
2.3 Introduction 
 Deuteration is a common strategy employed in protein solution NMR to improve the 
spectral resolution and sensitivity by increasing the transverse relaxation times (T2) and 
suppressing the 1H-1H scalar couplings1. The combination of triple resonance experiments with 
2H, 13C, 15N labeled samples is essential for the solution structure determination of large proteins, 
but the substitution of deuterons for protons depletes the number of protons available for distance 
restraints. As a result, several deuterium-labeling schemes that produce molecules with different 
patterns of incorporation have been employed1. 
  Initial applications of deuteration to solid-state NMR have been reported in the literature, 
including both the study of protein dynamics and 1H-1H distance measurements, based on the 
detection of the deuterium and proton nucleus, respectively2,3. The relaxation and lines shape of 
the deuterium quadrupole, which are sensitive to the local dynamics, have also been used to 
obtain information on different motional behaviors2. The large gyromagnetic ratio of the 1H 
nucleus provides high sensitivity to measure 1H-1H distances that are very useful for structure 
calculations, where deuteration has been used to eliminate the strong 1H homonuclear dipolar 
couplings4. Recently, NMR samples with paramagnetic ion doping under fast MAS have shown 
enhanced sensitivity with fast data acquisition5. A set of low power 1H decoupling also showed 
high-resolution spectra of several proteins under fast MAS6,7. Proton dilution from deuteration 
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and back-exchange, combined with fast MAS and low power 1H decoupling, made it possible to 
obtain enough 1H-1H distance constraints to calculate a full protein structure8. 
 The application of deuterated samples for 13C detection in typical solid-state NMR 
experiments, such as 13C-13C or 15N-13C correlations, has been investigated in the case of 
membrane proteins such as bacteriorhodopsin9. Although some difficulties might be expected for 
1H-13C cross-polarization (CP) with deuterated samples due to the dilution of the 1H bath, 
Morcombe et al. demonstrated that CP efficiency is still reasonably efficient, the effect on the 1H 
and 13C T1 relaxation times is surprisingly little, and no statistically significant broadening of the 
13C line widths was observed in the case of ubiquitin10. 
  Here we present the effect of deuteration on chemical shifts, T2 relaxations times, spin 
diffusion rates, and 1H decoupling requirements for a deuterated protein, the beta-1 
immunoglobulin binding domain of protein G (GB1), in high resolution 13C-detected solid-state 
NMR spectra. Our results show significant improvement in T2 relaxation times even with low 
proton-decoupling power that will make possible to perform J-based solid-state NMR 
experiments11,12 to improve resolution of non-crystalline samples. The improvement in the T2 
relaxation times and resolution will facilitate the sequential backbone assignments of large 
systems in which peak separation represents a big challenge, and exchangeable protons or water 
protons will enhance the selective detection of polar residues or residues that are close to water 
molecules. Therefore, the application of deuteration to solid-state NMR shows great potential in 
the structure determination of large protein systems that are of high interest and also in the 
evaluation of water accessibility on protein complexes and aggregates. 
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2.4 Materials and Methods 
2.4.1 Sample preparation 
1H, 13C, 15N-labeled GB1 (U-CN-GB1) and 2H, 13C, 15N-labeled GB1 (U-CDN-GB1) 
were prepared according to previously published procedures13,14. The deuterated protein was 
purified in H2O, so the exchangeable deuterons were replaced by protons. Nanocrystalline 
samples were precipitated with 2-methyl-pentane-2,4-diol (MPD) and isopropanol (IPA)13. A 
total of 18 mg material with 6 mg (1.0 µmol) U-CDN-GB1 was packed into a standard wall 3.2 
mm MAS rotor with rubber disks for maintaining hydration. About 5 mg (0.9 µmol) U-CDN-
GB1 and 4 mg solvents were packed into a 1.6 mm MAS rotor, and around 5 mg (0.9 µmol) U-
CN-GB1 and 4 mg solvents were packed into another 1.6 mm MAS rotor.  
2.4.2 Solid-state NMR spectroscopy 
NMR experiments were carried out on a 750 MHz Varian INOVA spectrometer with a 
3.2 mm BioMAS probe15 and a 1.6 mm BioFastMAS probe (Varian, Inc.). For the BioMAS 
probe, the π/2 pulse widths for 1H, 13C, 15N were 2.7, 4.5, 7.0 µs, respectively. For the 
BioFastMAS probe, the π/2 pulse widths for 1H, 13C were 1.7, 2.8 µs, respectively. The MAS 
rates were 12.5 kHz on the BioMAS probe and 18 to 40 kHz on the BioFastMAS probe. For 2D 
13C-13C and 15N-13C experiments, the dipolar assisted rotational resonance (DARR) scheme16 
was used for 13C-13C mixing. For 2D NcaCX experiments, a selective SPECIFIC CP17 was used 
for polarization transfer from 15N to 13C. Typical 1H decoupling at 70 kHz was used for both t1 
and t2 evolutions in 2D experiments at 12.5 kHz MAS. For 2D J-MAS CACO IPAP experiments 
(based on the CTUC COSY experiment)11,12 acquired at 32 kHz MAS, 110 kHz SPINAL-64 
(Ref. 18) decoupling was used during the constant-time intervals and acquisition. Average echo 
T2s (typically referred to as T2')18 values for CO and Cα at different decoupling conditions were 
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measured using a 1D CP Hahn-echo19 experiment with a 180° soft pulse on CO or Cα resonance 
to remove the effect of 13C-13C J-couplings20 (the pulse sequence is shown in Figure 2.1). It has 
been reported that the linewidths of deuterated methyl groups can be improved by 2H 
decoupling21, so we measured T2 values of C’, Cα and methyl groups of U-CDN-GB1 with low 
power 2H WALTZ-16 decoupling22 (~1.2 kHz) with a 1.6 mm 1H-13C-15N-2H magic-angle 
spinning probe on 500 MHz (1H frequency) at 32 kHz MAS and found significant T2 
improvement in methyl groups as expected. Chemical shifts were referenced externally with 
adamantane with the downfield 13C resonance of 40.48 ppm on the DSS scale23. 
 
Figure 2.1. Pulse sequence for the 13C’ and 13Cα  T2 measurements of U-CDN-GB1 and U-CN-GB1. 
 
2.4.3 Data processing  
2D spectra were processed with NMRPipe24 and were analyzed with Sparky program (T. 
D. Goddard and D. G. Kneller, University of San Francisco). Back linear prediction and 
polynomial baseline correction were applied to the direct dimension. Zero filling and Lorentzian-
to-Gaussian apodization were used for each dimensions before Fourier transformation. Detailed 
acquisition and processing parameters are included in figure captions.  
2.5 Results and discussion 
 To evaluate the effect of deuteration on 13C relaxation properties, 13C CP Hahn-echo 
experiments were carried out for deuterated and protonated GB1 under different spinning rates 
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and different 1H decoupling sequences with various radio-frequency (RF) field strengths. The 
field strengths were selected to avoid rotary resonance conditions at high MAS rates by picking 
the local maximums of signal intensities while arraying the CW decoupling strengths25. Table 
2.1 summarizes the 13C T2' values of U-CDN-GB1 and U-CN-GB1. At the moderate spinning 
rates (12.5 and 18 kHz), the 13Cα T2' of U-CDN-GB1 is almost twice the U-CN-GB1 with 
optimized SPINAL-64 decoupling (26 ms vs. 13 ms). Even at the high spinning rate of 40 kHz, 
both the 13Cα and 13C’ T2' of U-CDN-GB1 are much longer than for U-CN-GB1. Therefore, the 
removal of 13C-1H dipolar couplings by deuteration indeed improves the 13C T2' significantly. In 
terms of J-coupling effect from 2H, we compared T2 values of C’, Cα and methyl groups of U-
CDN-GB1 under low power 2H WALTZ-16 decoupling (~1.2 kHz) at 32 kHz MAS, and found 
no improvement in C’ (50 ms) and Cα (25 ms), but great enhancement in methyl groups from 21 
ms to 50 ms. In addition to the echo T2 values, the directly observed 13C linewidths are greatly 
narrowed. Figure 2.2 and 2.3 show well-resolved 13C-13C 2D and NcaCX 2D spectra of U-CDN-
GB1. Typical 13C linewidths in the 2D spectra are 0.2~0.4 ppm, to which 13C-13C J-couplings, 
present in uniformly labeled samples, contribute 35~55 Hz (0.2~0.3 ppm). Especially apparent in 
the carbonyl region of the NcaCX 2D spectra (Figure 2.3b) where 13C’ linewidths are less than 
0.2 ppm, so that some N-C’ crosspeaks actually show the splitting of ~ 50 Hz corresponding to 
JCOCA (such as Y3, K4, D26, V39, F52, T55).  
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Table 2.1. Summary of T2 values of 13C’ and 13Cα  of U-CDN-GB1 and U-CN-GB1.  
T2’ values were measured at three power levels (low, medium and high) with each decoupling scheme 
(XiX 26, TPPM 27 and SPINAL-64 (Ref. 28)) under each MAS rate.  
 
Sample MAS rates (kHz) 
1H 
Decoupling 
Scheme  
1H Decoupling 
Power (kHz) 
13C’ 
(ms) 
13Cα  
(ms) 
none 0 8 9 
TPPM 70 18 13 
25 5 4 
50 25 24 
12.5 
SPINAL-64 
70 27 26 
7 10 11 
62 19 17 XiX 
120 34 25 
7 10 11 
62 8 9 TPPM 
120 20 18 
7 12 11 
62 11 12 
18.0 
SPINAL-64 
120 28 22 
7 12 12 
50 16 14 XiX 
120 35 23 
7 12 14 
50 9 8 TPPM 
120 35 21 
7 12 13 
50 8 8 
26.0 
SPINAL-64 
120 40 23 
7 25 19 
65 31 21 XiX 
120 50 26 
7 25 19 
65 14 14 TPPM 
120 30 21 
7 26 19 
65 23 20 
U-CDN-GB1 
36.0 
SPINAL-64 
120 50 25 
12.5 TPPM 70 - 13 
XiX 43 22 12 18.0 SPINAL-64 130 35 13 
XiX 43 22 12 
U-CN-GB1 
40.0 SPINAL-64 130 14 10 
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Figure 2.2. 13C-13C 2D correlation spectra of U-CDN-GB1. 
Spectra were acquired at 12.5 kHz MAS with DARR mixing (BioMAS probe, 1.2 s pulse delay, 8 scans 
per row, maximum t1 = 15.36 ms, maximum t2 = 20.48 ms, 1H carrier frequency set to 4.5 ppm, total 
4.3~5.1 h). (A) 2D spectrum with 50 ms DARR mixing. Dashed rectangle indicates the expanded region. 
Solid rectangles indicate the well-resolved peaks from Gly, Ala and Thr. (B) Expanded spectrum of 
intraresidual Cα-Cβ correlations with 50 ms DARR mixing (labels include only the residue numbers). (C) 
2D spectrum with 300 ms DARR mixing. Dashed rectangle indicates the expanded region. (D) Expanded 
spectrum of interresidual Cα-Cα and Cα-Cβ correlations with 300 ms DARR mixing (Cα-Cα 
correlations labels only include the residue numbers). Both data were processed with 20 and 20 Hz net 
line broadening in each dimension.  
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Figure 2.3. NcaCX 2D spectra of U-CDN-GB1. 
Spectra were acquired at 12.5 kHz with 13C-13C DARR mixing (BioMAS probe, 1.2 s pulse delay, 64 
scans per row, 4.8 ms NC SPECIFIC CP, maximum t1 = 16 ms, maximum t2 = 20.48 ms, 1H carrier 
frequency set to 8.3 ppm, total 3~3.5 h). (A) NcaCX 2D spectrum with 50 ms DARR mixing. (B) 
Expanded region in the dashed rectangle in (A) shows intraresidual N-C’ correlations. (C) NcaCX 2D 
spectrum with 300 ms DARR mixing. (D) Expanded region in the dashed rectangle in (C) shows 
interresidual N-C’ correlations. Both data were processed with 20 and 10 Hz net line broadening in 15N 
and 13C dimension, respectively. 
 
The assignments of U-CDN-GB1 were completed by comparing the 2D spectra with the 
ones of U-CN-GB1, using the published chemical shift of U-CN-GB1 and assuming that the 
upfield shift of 13C chemical shift caused by deuterium is around 0.5~1.0 ppm. The 13C’, 13Cα, 
13Cβ, 15N of all the residues have been assigned. As shown in 13C-13C 2D spectrum with short 50 
ms mixing time (Figure 2.2A), there are clearly resolved Ala Cα-Cβ, Gly Cα-C’, Thr Cα-Cβ 
and Cβ-Cγ2 crosspeaks. An expansion of the Cα-Cβ crosspeaks of all other residues is shown in 
Figure 2.2B. The residues that are in β-strand have stronger Cα-Cβ peaks than those in helix, 
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and the peaks from polar and aromatic residues have higher intensities than those from nonpolar 
residues. At long 300 ms mixing time (Figure 2.2C,D), the spectrum showed more correlations 
between the sidechains and backbone carbons of polar residues, and also some inter-residual 
correlations in which at least one residue is polar or aromatic. Similar crosspeak patterns 
occurred in NcaCX 2D spectra (Figure 2.3D). Almost all the N-C’, N-Cα, N-Cβ peaks are well 
resolved in the spectrum at short mixing time, with some N-Cγ (Asn, Asp), N-Cδ (Gln, Glu) and 
N-Cε (Lys) peaks for the residues with exchangeable-proton sidechains. At the long mixing time, 
inter-residue N-C peaks show up and mainly involved with polar residues. In the expanded 
region of NcaCX 2D spectrum with 300 ms mixing (Figure 2.3d), crosspeaks between Leu and 
other residues are clearly weaker than those between polar residues. Furthermore, some 
crosspeaks appear in the region of 110~140 ppm of 13C chemical shift, corresponding to the 
correlations between amide nitrogens and sidechain carbons of Y3, Y33, Y45 and W43, which 
also have exchangeable protons on the side chains. Overall, most sidechain 13C of polar residues 
and some of the nonpolar and aromatic residues were assigned, and the deviations of these 
assignments were within 0.1 ppm. Therefore, the deuterated protein samples not only maintain 
the capability of assigning all the backbone resonances that are important for determining the 
secondary structures, but also strengthen the selection of sidechains of polar residues that are 
closely related to protein functions or interactions between proteins. Particularly in solid-state 
NMR, this feature would be valuable for assigning loop regions or channel lining interfaces of 
membrane proteins, since those regions are usually abundant of polar residues.  
 To confirm our assumptions and characterize in more detail the upfield isotope shifts 
from deuterium, we compared the chemical shifts of U-CDN-GB1 and U-CN-GB1, as 
summarized in Table 2.2.  Δδ(D)calc are calculated by the equation29: 
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  (1) 
where nΔδ(D) represents the n-bond isotope effect per deuteron and dnb is the number of 
deuterons n bonds away from the detected nucleus. The average deuterium effects are ~0.1 ppm 
for 13C’, ~0.3 ppm for 13Cα and ~0.9 ppm for 13Cβ. Generally, the deuterium effects in solid-
state NMR are slightly smaller (0.1~0.2 ppm) than the values in solution NMR. For each site, the 
deuterium effects are mostly consistent (deviations within 0.1 ppm), except a few outliers with 
deviations larger than 0.4 ppm (Thr, Trp, Tyr 13Cβ, Lys 13Cδ and 13Cε). Such deviations were 
also observed in solution NMR29, which could result from subtle environmental changes around 
these sites that are next to either hydroxyl groups, amine groups or aromatic rings.   
 
Figure 2.4. J-MAS CACO IPAP spectrum of U-CDN-GB1. 
Spectra were acquired at 32 kHz MAS (BioFastMAS probe, 1.5 s pulse delay, 16 scans per row, 
constant time interval τ1 = τ2 = 4.5 ms, maximum t1 = 8.5 ms, maximum t2 = 20.48 ms, 1H carrier 
frequency set to 4.5 ppm, total 7.5 h). It was the added spectrum of IP and AP spectra. The data 
were processed with 5 Hz net line broadening in both dimensions.  
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Table 2.2. Summary of chemical shift differences (Δδ(D) = δ(D) – δ(H)) between U-CN-GB1 and 
UCDN-GB1.  
Δδ(D)calc are calculated with equation (1), where 1Δδ(D) = –0.29 ppm, 2Δδ(D) = –0.13 ppm and 3Δδ(D) = 
–0.07 ppm29. a 15N and 13CαGly chemical shifts were separately measured.  
 
Residues Site Environment Δδ(D) (ppm) {d1b, d2b, d3b } 
Δδ(D)calc 
(ppm) 
  No deuteron    
All C’ CO(CD,NH) –0.103 ± 0.180   
Asp, Asn Cγ CO(CD2,NH2) –0.026 ± 0.177   
Glu, Gln Cδ CO(CD2, NH2) 0.012 ± 0.115   
All N NH(CD) –0.299 ± 0.128  –0.3a 
  C with one deuteron    
Thr Cα CD(CDOH,NH) –0.276 ± 0.048 {1 ,1 ,3} –0.63 
Ala Cα CD(CD3,NH) –0.336 ± 0.082 {1 ,3 ,0} –0.68 
Val, Ile Cα CD(CD,NH) –0.344 ± 0.065 {1 ,1 ,6} –0.84 
Asp, Asn, Phe, Tyr, 
Trp Cα CD(CD2,NH) –0.282 ± 0.117 {1 ,2 ,0} –0.55 
Leu Cα CD(CD2,NH) –0.285 ± 0.056 {1 ,2 ,1} –0.69 
Glu, Gln, Lys, Met Cα CD(CD2,NH) –0.366 ± 0.045 {1 ,2 ,2} –0.76 
Thr Cβ CD(CD,CD3,OH) –0.620 ± 0.482 {1 ,4 ,0} –0.81 
Val Cβ CD(CD3,CD3) –0.951 ± 0.049 {1 ,7 ,0} –1.20 
  C with two deuterons    
Gly Cα CD2(NH) –0.277 ± 0.117 {2 ,0 ,0} –0.39a 
Asp, Asn, Phe, Tyr, 
Trp Cβ CD2(CD,C) –0.620 ± 0.482 {2 ,1 ,0} –0.71 
Glu, Gln, Met Cβ CD2(CD,CD2) –0.892 ± 0.074 {2 ,3 ,0} –0.97 
Leu Cβ CD2(CD,CD2) –0.946 ± 0.051 {2 ,2 ,6} –1.26 
Lys Cβ CD2(CD,CD2) –0.971 ± 0.064 {2 ,3 ,2} –1.11 
Glu, Gln Cγ CD2(CD2,C) –0.694 ± 0.113 {2 ,2 ,1} –0.91 
Lys Cγ CD2(CD2,CD2) –1.137 ± 0.067 {2 ,4 ,3} –1.31 
Lys Cδ CD2(CD2,CD2) –1.258 ± 0.480 {2 ,4 ,2} –1.1 
Lys Cε CD2(CD2,NH3) –0.621 ± 0.346 {2 ,2 ,2} –0.98 
  C with three deuterons    
Ala Cβ CD3(CD) –0.776 ± 0.063 {3 ,1 ,0} –1.00 
Thr Cγ CD3(CD–CD) –0.886 ± 0.075 {3 ,1 ,1} –1.07 
Val Cγ CD3(CD–CD3) –0.937 ± 0.093 {3 ,1 ,4} –1.28 
Leu Cδ CD3(CD) –1.181 ± 0.130 {3 ,1 ,5} –1.35 
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While all multidimensional experiments gain from the increase in signal power 
associated with longer T2 values, scalar-coupling-driven correlation experiments will additionally 
benefit from the slower decoherence rates during the relatively long echo periods necessary for 
coherence transfer through the J coupling. Indeed, during the last decade a growing number of 
2D and 3D correlation experiments have emerged that make use of the indirect spin-spin 
coupling to map out through-bond connectivity in solid-state proteins.3,11,12,30,31 The vast majority 
of these experiments have been implemented under conditions of high-power proton decoupling 
(> 150 kHz), where the value of the echo T2’ is maximized (De Paepe et al., 2003).  Deuteration 
will allow the use of lower power decouplings while maintaining longer T2’ values 21, as we 
exploit in the implementation of the J-MAS CACO IPAP correlation experiment11,12 shown in 
Figure 2.4. This J-based correlation spectrum was acquired at 32 kHz MAS with only moderate 
(110 kHz, 75% of the full power - 150 kHz) proton decoupling. The combination of the constant-
time evolution in the indirect dimension11,12 and the in-phase anti-phase selection in the direct 
dimension32 leads to a highly resolved 2D spectrum and deuteration paired with low power 
proton decoupling that is clearly compatible even with challenging J-based transfer experiments.  
 One significant practical aspect of these studies is that the 1H-13C CP conditions for the 
U-CDN-GB1 sample are much more sensitive than those for U-CN-GB1. This is the case even 
with a large tangent amplitude ramp applied, and thus the CP amplitudes need careful 
optimization under the condition where 2D experiments would be performed.  Moreover, the 
overall instrumental stability is critical, in addition to the optimization of 1H decoupling to 
achieve optimal T2’ values. Figure 2.5 shows that U-CDN-GB1 Cα signal intensities had less 
variation with different pulse widths and phase angles of SPINAL-64 decoupling that those of 
TPPM decoupling. Therefore, SPINAL-64 decoupling is much less sensitive to pulse width and 
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phase angle than TPPM decoupling. We also found that SPINAL-64 decoupling is less sensitive 
to 1H carrier frequency than TPPM decoupling (data not shown). Figure 2.6 compares the 
NcaCX 2D spectra of U-CDN-GB1 at 12.5 kHz MAS with SPINAL-64 and TPPM decouplings. 
The 15N linewidths are significantly better using SPINAL-64 decoupling than using TPPM 
decoupling (0.5 ppm vs. 1.2 ppm for D40 15N). Therefore, SPINAL-64 decoupling is a better 
choice for deuterated protein samples. In addition, low-power XiX decoupling provides 
reasonable T2’ values at fast MAS (Table 2.1), and thus it is also a viable choice in fast spinning 
regime. 
 
Figure 2.5. 13C CP Hahn-echo spectra (Cα  region shown) of U-CDN-GB1 at 18 kHz MAS with 
TPPM and SPINAL-64 decoupling schemes. 
 
(A) TPPM decoupling as a function of the pulse width (pw in µs); (B) SPINAL-64 decoupling as a 
function of the pulse width (pw in µs); (C) TPPM decoupling as a function of the phase; (D) SPINAL-64  
decoupling as a function of the phase (ph); The 1H carrier frequency was set to 8.3 ppm. The decoupling 
strength was 95 kHz for both schemes. The Hahn-echo time was 8.89 ms.  
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Figure 2.6. NcaCX 2D spectra of U-CDN-GB1 with 100 ms DARR mixing under SPINAL-64 and 
TPPM 1H decouplings. 
 
Spectra were acquired witth the BioMAS probe, 1.2 s pulse delay, 64 scans per row, 4.8 ms NC 
SPECIFIC CP, maximum t1 = 16 ms, maximum t2 = 20.48 ms, total 3~3.5 h. (A) N-Cα region of NcaCX 
2D spectrum using 70 kHz SPINAL-64 decoupling in both t1 and t2 evolutions (τp = 7.2 µs, φ = 6°, α = 
10°, β = 20°). 1H carrier frequency was set to amide 1H frequency (8.3 ppm). (B) N-Cα region of NcaCX 
2D spectrum using 70 kHz TPPM decoupling in both t1 and t2 evolutions (τp = 6.6 µs, φ = 12°). 1H carrier 
frequency was set to amide 1H frequency (8.3 ppm). 
 
2.6 Conclusions 
We have demonstrated 13C-detected solid-state NMR spectroscopy of deuterated GB1. 
Deuteration provides a significant improvement in 13Cα T2’ by eliminating the 13C-1H dipolar 
coupling. T2’ enhancement makes experiments that require long T2’ values feasible, such as J-
based experiments, especially for large proteins in high magnetic field. Unique crosspeak 
patterns that result from exchangeable protons on sidechains of polar residues reduce the overlap 
in the methylene and methyl regions and provides easier identification of polar residues in large 
proteins, which usually play important roles in protein functions and/or in the interactions with 
other proteins. 
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CHAPTER 3 
Straightforward, effective calibration of SPINAL-64 decoupling results in the 
enhancement of sensitivity and resolution of biomolecular solid-state NMR 
3.1 Notes and Acknowledgements 
This chapter is adapted with kind permission from Elsevier: Journal of Magnetic 
Resonance, Straightforward, effective calibration of SPINAL-64 decoupling results in 
enhancement of sensitivity and resolution of biomolecular solid-state NMR, volume 209, issue 2, 
2011, pages 131-135, authors: Gemma Comellas, Jakob J. Lopez, Andrew J. Nieuwkoop, Luisel 
R. Lemkau and Chad M. Rienstra. This work was supported by the National Institutes of Health 
(R01-GM073770 and R01-GM073770 ARRA supplement to C.M.R.). The authors would like to 
thank Dr. Ming Tang for carefully reading the manuscript. 
3.2 Abstract 
Biomolecular Magic-angle spinning (MAS) solid-state NMR spectroscopy provides 
insight into atomic-resolution conformational dynamics and structural details of biological 
systems, such as amyloids, that are not approachable by common techniques like solution NMR 
or X-ray diffraction. Although the state-of-the-art of solid-state NMR has substantially advanced 
in the last decade; the study of many of these systems is still challenged by the spectral 
resolution and sensitivity. Here, we describe a simple yet highly effective optimization strategy 
for SPINAL-64 1H decoupling conditions for MAS solid-state NMR. With adjustment of the 
phase angles in a coupled manner, the optimal conditions resulting from three parameter 
optimizations can be determined with adjustment of a single phase. Notably, echo T2 relaxation 
times for 13C and 15N show significant enhancement (up to 64%), relative to the previous 
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described SPINAL-64 conditions, under the moderate 1H decoupling levels (60 - 100 kHz) and 
MAS rate (13.3 kHz) commonly employed for high-resolution solid-state NMR spectroscopy of 
proteins. Additionally, we also investigated the effect at higher spinning rate (33.3 kHz) and 
compared the results with other 1H decoupling schemes (TPPM, XiX), as well as SPINAL-64 
with the originally reported optimal values. 
3.3 Introduction 
High-resolution spectra are essential for the study of large biological systems by MAS 
solid-state NMR spectroscopy. One of the main limitations for such studies are imposed by the 
lifetimes of transverse magnetization (T2)1 for the observed nuclei, due to the strong dipolar 
coupling interactions between 1H and X (usually 13C or 15N)2. As a result, considerable research 
effort has resulted in a plethora of 1H decoupling sequences3-6.  
Continuous-wave (CW)7 decoupling was for many years the only effective heteronuclear 
1H decoupling method for rigid solids, but for most applications has been supplanted by two 
pulse phase-modulation (TPPM)8, which consists of a series of near π pulses with alternating 
phases (see Fig. 1b). A variety of 1H decoupling methods with phase and/or frequency 
modulations extending upon the TPPM approach were subsequently developed3-6. Among these, 
we have observed that SPINAL-64 (small phase incremental alternation with 64 steps, Fig. 1b)9, 
is particularly robust with respect to radio-frequency (RF) inhomogeneity and/or pulse width 
imperfection and has better compensation for resonance offsets, arising from the compensatory 
super cycles of the basic SPINAL element. SPINAL-64 has also been described to be superior in 
performance under some regimes of decoupling power than TPPM10. The benefits of SPINAL 
are particularly evident, in comparison with CW decoupling, for magnetically aligned samples11.  
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In the original publication describing SPINAL-64, Fung et al. note the optimal values for 
the flip angle θ, phase angle φ, and phase increments α and β to be, 11/12 π, 10°, 5° and 10° (Ref. 
9), respectively. Thakur et al. reported improvements in performance and efficiency upon 
modification of the phase (from 1 to 5°) and angle increments (from 3-16°) on crystalline 
glycine12. In the course of utilizing the SPINAL-64 sequence for studies of biomolecular samples 
including nanocrystalline, fibrillar and membrane proteins, at different moderate MAS rates (10-
16.7 kHz), we found that different phase angles from the ones previously reported were 
consistently preferred. Although we arrived at these values by empirical, experimental 
optimization in three dimensions, we have also identified trends that enable the global optimum 
solution to be found in a small fraction of the total optimization time. The results yield an 
improved decoupling performance, as shown in Figure 3.1 for N-acetyl valine (NAV). The 
changes in phase parameters are modest, but yield substantial benefits in relaxation times and 
resolution for 2D MAS NMR spectra.  
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Figure 3.1. Comparison of the 1H decoupling parameters arrays. 
Part of the arrays of the variable parameters for 13C detection with (a) SPINAL-64 and (b) TPPM and 15N 
detection with  (c) SPINAL-64 and (d) TPPM 1H decoupling for NAV. All arrays were acquired with 85 
kHz of decoupling power at 750 MHz 1H frequency and 13.3 kHz MAS. A soft pulse was used to select 
the 13CA. Spectra labeled with (*) correspond to the closed conditions to the optimal reported values 
(θ=(11/12)π, ϕ= 10°, α=5° and β=10°) 9. Horizontal dashed lines correspond to the highest peak height 
level obtained from the optimized conditions. 
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Figure 3.2. Comparison of the TPPM and SPINAL-64 pulse sequences and transverse relaxation 
times (T2). 
 
Schematic representation of (a) the pulse sequence used for the determination of the T2 values with (b) 
TPPM and SPINAL-64 1H decoupling (flip angle (θ), phase angle (φ) and phase increments α and β for 
the phase angle). Comparison of T2 values between TPPM, SPINAL-64 with the optimal reported values 
(θ =(11/12)π, ϕ= 10°, α=5° and β=10°) 9 and the optimized parameters (opt.) and XiX for NAV at 
different 1H decoupling powers (70, 85, 100 kHz) for (c) 13C detection and (d) 15N detection. All arrays 
were acquired at 13.3 kHz MAS and 750 MHz 1H frequency. Comparison of T2 values between SPINAL-
64 with the optimal reported values (θ =(11/12)π, ϕ= 10°, α=5° and β=10°) 9 and the optimized 
parameters for A30P AS fibrils at different 1H decoupling powers (67, 72, 80, 85 kHz) for (e) 13C 
detection and (f) 15N detection at 13.3 kHz and 600 MHz. Error bars correspond to the error associated 
with the fitting of the experimental data. 
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3.4 Materials and methods 
3.4.1 Sample Preparation 
U-13C,15N-labeled A30P AS was prepared as described in Kloepper et al.13 and fibrils 
were prepared for solid-state NMR as recent studies for the wild-type AS fibrils described 
elsewhere. Samples were packed into 1.6 and 3.2 mm MAS NMR rotors (Varian, Inc., Palo Alto, 
CA) and confined to the active sample region of the rotor and kept hydrated by Kel-F and rubber 
spacers.14  
3.4.2 Solid-state NMR spectroscopy 
All experiments were carried out with the variable temperature gas at 10 °C, which 
corresponded to an actual sample temperature of ~14 °C, as determined by ethylene glycol 
calibration. Experiments were carried out on a 600 MHz Infinity Plus spectrometer (Varian 
NMR) equipped with a HXY (T3) probe tuned to 1H-13C-15N triple mode at 13.333 kHz MAS 
rate and on a 750 MHz Wide Bore VNMRS spectrometer (Varian NMR) equipped with a HFXY 
probe tuned to 1H-13C-15N triple mode at 13.333 and 33.333 kHz MAS rates. For the 600 MHz 
spectrometer, the NAV π/2 pulse widths for 1H and 13C were 1.90 and 2.70 µs, respectively, and 
for A30P AS fibrils, the π/2 pulse widths for 1H, 13C, 15N were 2.25, 2.62 and 3.75 µs, 
respectively. For the 750 MHz spectrometer, the NAV π/2 pulse widths for 1H, 13C and 15N were 
1.90, 2.20 and 3.90 µs, respectively. All experiments utilized tangent ramped cross 
polarization15. TPPM,8 SPINAL-64 (Ref. 9) and XiX4 1H decoupling were applied during 
acquisition and evolution periods. For the 2D 13C-13C spectra, the dipolar assisted rotational 
resonance (DARR) scheme16 was used for 13C-13C mixing. For the 2D NCA experiments, a 
selective SPECIFIC CP17 was used for polarization transfer from 15N to 13C. Average echo T2s 
(typically referred to as T2')1 values for 13CA and 15N at different decoupling conditions and 
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optimization conditions were measured using a 1D CP Hahn-echo18 experiment with a 180° soft 
pulse on 15CA resonance to remove the effect of 13C-13C J-couplings19 (no soft pulse was used for 
the 15N  measurement). Chemical shifts were referenced externally with adamantane (assuming 
the downfield peak to resonate at 40.48 ppm)20. 
Plotting and data analysis were carried out with scripts written in house, using Python 
2.5, specifically with the python modules ‘scipy’ and ‘matplotlib’. 2D spectra were processed 
with NMRPipe21 and were analyzed with Sparky program22. Back linear prediction and 
polynomial baseline correction were applied to the direct dimension. Zero filling and Lorentzian-
to-Gaussian apodization were used for each dimensions before Fourier transformation.  
3.5 Results and discussion 
A comparison of the 13C and 15N transverse magnetization lifetimes (T2) for the originally 
reported optimal values9 and the values we obtain on our samples following optimization is 
depicted in Figure 3.2. An increase for the T2 values up to 64% (15N) and 25% (13C) were noted 
for uniformly 13C-15N enriched A30P alpha-synuclein (AS) in fibrillar form (Figure 3.2). A 
comparison of two frequently used 2D correlation experiments is depicted in Figure 3.3, using 
the originally reported optimal values9 (left) and the optimized values (right), with a 1H 
decoupling power of 80 kHz. These spectra (13C-13C with 50 ms DARR mixing and 15N-13C with 
specific CP) demonstrate an improved sensitivity (up to 80% enhancement of the S/N or 125% 
of the peak height for Ala CA-CB cross-peaks and 63% of the S/N or 100% of the peak height 
for Thr CA-CB cross-peaks) and linewidths (up to 67% for the 15N and 44% for 13C in the 
15N13CA 2D), as shown in expanded regions in Figure 3.3. 
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Figure 3.3.  Comparison of A30P AS fibrils spectral expansions acquired with (left) optimal 
reported values 9 and (right) optimized values of the SPINAL-64. 
 
Left spectra used optimal reported values (θ =(11/12)π, ϕ= 10°, α=5° and β=10°)  and (right) optimized 
values of the SPINAL-64 1H decoupling (80 kHz) for a 13C13C spectrum with 50 ms DARR mixing time: 
(a) methyl region  (b) Thr and Ser CA-CB, (c) Gly CA-C and (d) Ala CA-CB correlations and (e) 
15N13CA spectrum with some Gly correlations. Both spectra were acquired under identical conditions at 
600 MHz (1H frequency) and 13.333 kHz MAS rate. Contour levels were draw at 7 σ.  
 
We optimized SPINAL-64 1H decoupling with respect to the flip angle (θ), the phase 
angle (φ) and the phase increments α and β (see arrays in Figure 3.4 for A30P AS fibrils). 
During optimization, θ was varied from 150° to 210°, φ from 0° to 10°, and α from 0° to 10°. 
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These optimizations, conducted on a variety of biological samples, demonstrated that the best 
values, under the moderate 1H decoupling levels and MAS rate commonly employed for high-
resolution solid-state NMR, occur when the parameters ϕ and α add up to 10° (as shown for 
A30P AS fibrils and NAV in Tables 3.1 and 3.2, respectively), which corresponds to arrays 
located in the diagonal of the plots (indicated with darker background in Figure 3.1 and 3.4). 
Thus, the most efficient optimization of SPINAL-64 would include a 3D array of θ, φ from 0° to 
10° and α from 10° to 0°, where φ and α add to 10° in each step in a single dimension of the 
array. In all these experiments the variable parameter β was set to two times α, which 
corresponds to the optimum or very close to the optimum, as shown in Figure 3.4. 
Table 3.1. Optimized parameters for SPINAL-64 1H decoupling for A30P AS fibrils at different 1H 
decoupling power levels with 13C and 15N detection acquired at 13.3 kHz MAS and 600 MHz 1H 
frequency. 
 
SPINAL-64 parameters 
13C detection 15N detection 
Power 
(kHz) 
θ (°) ϕ (°) α (°) β (°) θ (°) ϕ(°) α(°) β(°) 
67 178 6 4 8 180 2 8 16 
73 188 8 2 4 188 4 6 12 
80 184 6 4 8 179 4 6 12 
86 174 4 6 12 174 8 2 4	  
 
Table 3.2. Optimized parameters for SPINAL-64 1H decoupling for NAV at different 1H 
decoupling power levels (70-100 kHz) and MAS rates (13.3-33.3 kHz) for 13C and 15N detection at 
750 MHz 1H frequency. 
 
SPINAL-64 parameters  
13C detection 15N detection 
MAS 
(Hz) 
Power 
(kHz) 
θ (°) ϕ (°) α (°) β (°) θ (°) ϕ (°) α (°) β (°) 
70 195 8 2 4 198 6 4 8 
85 192 6 4 8 199 6 4 8 
13333 
100 195 6 4 8 190 8 2 4 
70 169 6 2 4 169 6 2 4 33333 
85 186 6 2 4 186 6 4 8 
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Figure 3.4. Array of the SPINAL-64 parameters for A30P AS fibrils 
 (a) Array of the SPINAL-64 parameters (θ,	  ϕ	  and	  α;	  β=2α) for A30P AS fibrils at 80 kHz 1H decoupling 
for 13C detection. Soft pulses were used to select the 13CA. Spectra labeled with (*) correspond to the 
closed conditions to the optimal reported values (θ =(11/12)π, ϕ= 10°, α=5° and β=10°)9. Horizontal 
dashed lines correspond to the highest peak height level obtained from the optimized conditions. (b) 
Array of the SPINAL-64 parameter β (from 0 to 20, in steps of 1) for A30P AS fibrils at 80 kHz 
(θ =184°, ϕ= 6°, α=4°) with 13C detection and soft pulse to select the 13CA). 
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The improvement of transversal magnetization lifetimes of 13C and 15N is clearly shown 
using NAV (Figure 3.2), but also demonstrates an improvement of SPINAL-64 versus TPPM or 
XiX, when the variable parameters are optimized at a moderate MAS rate (13.3 kHz) and 
commonly employed power levels (70-100 kHz) for high-resolution solid-state NMR10 (see 
Figure 3.1). In the optimization arrays, θ was varied from 150° to 210° for SPINAL-64 and 
TPPM, φ from 0° to 10° and α from 0° to 10° for SPINAL-64 and φ from 0° to 30° for TPPM. 
These arrays also demonstrate a smaller dependence of the signal intensity on the decoupling 
pulse duration for SPINAL-64 and thus more experimental stability with respect to changes in 
pulse widths for a selected conditions than TPPM over the same range of θ and φ, which is an 
important requirement for conducting long multidimensional experiments in biomolecular solid-
state NMR.  
Finally, we also explored the effect of the optimization at a higher MAS rate (33.333 
kHz), as reported on Tables 3.2-3.4. Our results demonstrate a considerable improvement in the 
performance of SPINAL-64 over the originally optimal reported9 variable parameters and shows 
that SPINAL-64 with the optimized parameters behaves similarly or better than TPPM or XiX 
for 1H decoupling powers between 70-100 kHz. At high MAS rate (33.333 kHz), the 
optimization arrays showed slightly different preferred values for the variable parameters than 
observed for moderate spinning rates. The best values occur when the parameters ϕ and α add up 
to 8° and/or 10°, depending on the power level.  
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Table 3.3. 13C T2 values for N-acetylvaline (NAV) at different 1H decoupling power levels (70-100 
kHz) and schemes (TPPM, SPINAL-64 with originally reported optimal9 and optimized variable 
parameters and XiX) at 750 MHz 1H frequency. 
 
1H carrier was set at the frequency of the 1HA peak. Error bars correspond to the error associated with the 
fitting. 
 
13CA T2 (ms)  
MAS 
(Hz) 
 
Power 
(kHz) 
 
TPPM 
SPINAL-64  
(original variable 
parameters) 
SPINAL-64 
(optimized variable 
parameters) 
 
 XiX 
70 11.1 ± 0.2 8.2 ± 0.1 10.4 ± 0.2 7.4 ± 0.1 
85 12.4  ± 0.2 10.4 ± 0.2 13.6 ± 0.6 10.2 ± 0.3 
13333 
100 12.4 ± 0.2 11.5 ± 0.2 14.5 ± 0.7 11.7 ± 0.4 
70 3.0  ± 0.1 1.2 ± 0.1 5.8 ± 0.1 3.7 ± 0.1 33333 
85 8.8  ± 0.1 2.1 ± 0.1 9.6 ± 0.1 10.5 ± 0.1 
 
Table 3.4. 15N T2 measurements for N-acetylvaline (NAV) at different 1H decoupling power 
levels (70-100 kHz) and schemes (TPPM, SPINAL-64 with originally reported optimal9 and 
optimized variable parameters and XiX) at 750 MHz 1H frequency.  
 
1H carrier was set at the frequency of the 1HN peak. Error bars correspond to the error associated 
with the fitting. 
 
15N T2 (ms)  
MAS 
(Hz) 
 
Power 
(kHz) 
 
TPPM 
 
 
SPINAL-64  
(original 
variable 
parameters) 
SPINAL-64 
(optimized 
variable 
parameters) 
 
    XiX 
70 38 ± 2 28 ± 1 37 ± 2 26 ± 1 
85 26 ± 1 40 ± 2 47 ± 3 38 ± 2 
13333 
100 46 ± 3 45 ± 3 54 ± 4 44 ± 3 
70 8.0 ± 0.4 2.5 ± 0.2 7.3 ± 0.5 3.7 ± 0.1 33333 
85 20.2 ± 0.6 7.1 ± 0.4 20.0 ± 0.9 12.8 ± 0.1 
 
3.6 Conclusions 
By optimizing the variable parameters for SPINAL-64 1H decoupling for a variety of 
biological samples, we observed a considerable improvement in the performance of SPINAL-64 
versus the originally reported parameters (θ=(11/12)π, ϕ= 10°, α=5° and β=10°)9. Here, we have 
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reported a series of experiments to demonstrate the effect on the T2s for A30P AS fibrils and 
NAV at different power levels, a comparison with the originally reported values, TPPM and XiX 
decoupling, as well as the effect in multidimensional solid-state NMR experiments. Our results 
show an improvement up to 64 % in the T2s and a sensitivity enhancement up to 80% of S/N of 
individual peaks in multidimensional experiments of A30P AS fibrils that lead to significant 
improvement in the spectra resolution. 
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CHAPTER 4 
Structured regions of α-synuclein fibrils include the early-onset Parkinson’s 
disease mutation sites 
4.1 Notes and Acknowledgements 
This chapter is adapted with kind permission from Elsevier: Journal of Molecular 
Biology, Structured regions of α-synuclein fibrils include the early-onset Parkinson’s disease 
mutation sites, volume 411, 2011, pages 881-895, authors: Gemma Comellas, Luisel R. Lemkau, 
Andrew J. Nieuwkoop, Kathryn D. Kloepper, Daniel T. Ladror, Reika Ebisu, Wendy S. Woods, 
Andrew S. Lipton, Julia M. George and Chad M. Rienstra. This work was supported by the 
National Institutes of Health (R01-GM073770, R01-GM073770 ARRA supplement and NCRR 
Instruments Grant S10 RR025037-01). Gemma Comellas was a Caja Madrid Foundation 
Graduate Fellow. A portion of the research was performed in the Environmental Molecular 
Sciences Laboratory, a national scientific user facility sponsored by the Department of Energy's 
Office of Biological and Environmental Research and located at Pacific Northwest National 
Laboratory. Electron micrographs (EMs) were carried out in the Frederick Seitz Materials 
Research Laboratory Central Facilities, University of Illinois, which are partially supported by 
the U.S. Department of Energy under grants DE-FG02-07ER46453 and DE-FG02-07ER46471. 
The authors thank to Dr. Robert Tycko for advice regarding fibril re-hydration, Dr. Lou A. 
Miller for help and advice regarding EM, Dr. Benjamin J. Wylie for help and advice with the 
data fitting, Lindsay J. Sperling for discussion about the NMR experiments, and Dr. Anna E. 
Nesbitt for careful reading and discussions of the manuscript. 
	   	   	  
   65 
4.2 Abstract 
α-Synuclein (AS) fibrils are the major component of Lewy bodies, the pathological 
hallmark of Parkinson’s disease (PD). Here, we use results from an extensive investigation 
employing solid-state NMR to present a detailed structural characterization and conformational 
dynamics quantification of full-length AS fibrils. Our results show that the core extends with a 
repeated structural motif. This result disagrees with the previously proposed fold of AS fibrils 
obtained with limited solid-state NMR data. Additionally, our results demonstrate that the three 
single point mutations associated with early-onset PD—A30P, E46K and A53T—are located in 
structured regions. We find that E46K and A53T mutations, located in rigid β-strands of the 
wild-type fibrils, are associated with major and minor structural perturbations, respectively. 
4.3 Introduction 
Parkinson’s disease (PD) is the most common movement disorder, affecting 
approximately 1-2% of the population over age 651. PD is characterized by the presence of Lewy 
bodies (LBs)2, which are intracytoplasmic aggregates composed largely of fibrillar α-synuclein 
(AS)3. AS is a “natively unfolded” protein in solution4, whose function is not well understood. 
AS forms α-helices throughout the N-terminal domain when exposed to phospholipids, 
detergents or membrane vesicles5 and can convert to insoluble fibrils with β–sheet secondary 
structure in vitro6; these fibrils have been shown to have a similar morphology to that found in 
LBs6,7. Additionally, three single missense mutations (A30P, E46K, A53T) in the AS gene8-10 and 
multiplication of the wild-type (WT) AS allele11,12 have been identified in early-onset PD. More 
recent studies have demonstrated that exogenous fibrils can seed LB-like inclusions in cell 
culture13. It was also recently proposed that AS pathology can be propagated by direct neuron-to-
neuron transmission of AS aggregates in vivo14. Together, these findings implicate AS 
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misfolding in both sporadic and familial PD. However, why and how these structural changes 
occur in the protein is not yet understood.  
 Early structural studies of AS fibrils supported the existence of a central β-sheet core, but 
did not provide detailed information on the extent of the structured regions and the topology6,15. 
High-resolution magic-angle spinning (MAS) solid-state nuclear magnetic resonance (NMR) 
spectroscopy provides site-specific structural information on amyloidogenic peptides and 
proteins16-26. These molecules are inaccessible to other structural determination techniques, such 
as solution NMR, because they are not soluble, or X-ray diffraction, because they do not form 
diffraction quality crystals. Previous solid-state NMR studies of AS fibrils—from our laboratory 
and others—reported substantial numbers of resonance assignments, but were lacking key 
stretches of amino acid residues such as the region between residues 43 to 49 where the single 
point mutation E46K is located27-31. Some of these previous studies attributed the missing signals 
to their potential localization within dynamic loops31, and proposed a possible fold of AS fibrils 
on the basis of these assumptions. None reported the overall high-resolution fold of the protein, 
detailed side chain conformations, hydrogen bonding patterns or packing arrangements. 
 Here we show that state-of-the-art solid-state NMR experiments, combined with 
improved sample preparation and labeling schemes, have enabled us to detect many of the 
previously unobserved residues and to perform detailed analysis of the sidechains, as well as the 
backbone. Although some of these newly-assigned residues previously were identified, but not 
assigned, at low temperature with fully hydrated, frozen fibrils28, they were not detected in 
previous solid-state NMR studies at ambient conditions due to conformational dynamics of prior 
sample preparations. To understand the origin of the missing peaks in previous studies, here we 
present comprehensive studies, including high sensitivity dipolar correlation experiments, scalar-
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coupling mediated correlation spectroscopy, site-specific measurements of the dipolar order 
parameters and relaxation rates and a systematic comparison of signal intensities. These results 
reveal that many of these critical signals, which previously escaped detection, are located in β-
sheet strands that impact the fibril quaternary structure, in disagreement with the previously 
proposed fold of the fibrils31. Additionally, our results demonstrate that the three early-onset PD 
mutation sites are located in structured regions of the fibrils, with E46 and A53 located in rigid 
β-strands of the WT fibrils, and A30 in a random coil region. These results are in agreement with 
the major and minor perturbations observed upon E46K and A53T mutation, respectively, and 
the relative lack of perturbation for A30P. 
4.4 Materials and methods 
4.4.1 Protein expression and purification 
U-13C, 15N-labeled WT, A30P, E46K and A53T AS were expressed and purified as 
previously described32. U-15N WT AS with 2-[13C] glycerol and U-15N WT AS with 1,3-[13C] 
glycerol AS were prepared with the same protocol, but [15N] ammonium chloride was used as the 
sole nitrogen source and either 2-[13C]-glycerol and calcium 13C-carbonate, or 1,3-[13C]-glycerol 
and natural abundance carbonate as the sole carbon sources, respectively.  
4.4.2 Preparation of the fibrils 
Dry (WT, A30P, E46K and A53T) AS fibrils were prepared as previously described29. 
For washed samples, the pellet was washed with Milli-Q water, subjected to ultracentrifugation 
and dried. The dried pellets were packed into 3.2 mm MAS NMR rotors (Varian, Inc., Palo Alto 
and Walnut Creek, CA, and Fort Collins, CO; now part of Agilent Technologies, Santa Clara, 
CA and Loveland, CO), rehydrated to 36% water by mass and kept hydrated by Kel-F and rubber 
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spacers. Non-seeded AS fibrils were formed in the same conditions but incubated for a total of 4 
weeks.  
4.4.3 Sample hydration 
Previous studies from our group have demonstrated an important effect of the hydration 
to the resolution and sensitivity of the solid-state NMR spectra of the full-length AS fibrils29. 
Here, we optimized the hydration level of AS fibrils to maximize the resolution and sensitivity of 
the solid-state NMR multidimensional experiments, which was essential to complete the 
chemical shift assignments. To optimize the hydration level, we dried fibrils by N2 gas until no 
changes in mass were observed, and a 1H 1D and a 13C-13C 2D spectra were acquired (Figure 
4.1). The hydration of the sample was gradually increased and a 1H 1D and a 13C-13C 2D spectra 
were acquired at each hydration level up to 50 % (mass of water/total mass), as shown in Figure 
4.2.  
As reported in Table 4.1, the pulse width for both for 1H and 13C become longer upon 
hydration and the overall cross-polarization (CP) decreases its efficiency. However, we observe a 
significant improvement in the 13C linewidths (LWs) and signal-to-noise ratios of individual 
peaks (see Table 4.1) that we attributed to changes in the timescale dynamics of certain regions 
of the full-length protein. Average linewidths (LW) ± standard deviation and normalized signal 
to noise were obtained by measuring the LW and signal-to-noise ratio for a total of 20 resolved 
peaks in 13C-13C 2D experiments. Conditions marked in bold correspond to the optimal 
conditions selected for the multidimensional NMR experiments. 
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Figure 4.1. Optimizing hydration of AS samples for the solid-state NMR experiments (mass of 
water/total mass).  
(A) 1H 1D spectra of U-13C,15N AS fibrils at different hydration levels (dry, 16%, 26%, 36% 44% and 
50%) and (B) 13C-13C 2D spectra with 50 ms DARR mixing. All spectra were acquired under identical 
conditions at 600 MHz (1H frequency) and 13.3 kHz MAS rate. (*) Dry fibrils correspond to fibrils dried 
by N2 gas until no changes in mass were observed, as previously described29. Spectra marked in blue 
correspond to the optimal conditions selected for the multidimensional NMR experiments. 
 
Table 4.1. Comparison of 1H and 13C pulse widths (PW), CP enhancement and 13C linewidths (Hz) 
at different percentages of hydration (mass of water/total mass) for U-15N,13C WT AS fibrils.  
(*) Dry fibrils correspond to fibrils dried by N2 gas until no changes in mass were observed, as previously 
described.29 Average linewidths (LW) ± standard deviation were obtained by measuring the LWs for a 
total of 20 resolved peaks in 13C-13C 2D experiments at 600 MHz (1H frequency) and 13.3 kHz MAS. 
Conditions marked in bold correspond to the optimal conditions selected for the multidimensional NMR 
experiments. 
 
Hydration 
(water by 
mass) 
13C PW 
(µs) 
1H PW 
(µs) 
CP 
enhancement 
Average 
13C LW 
(Hz) 
Normalized 
signal to 
noise 
Dry fibrils (*) 1.90±0.05 2.00±0.05 1.91±0.07 141±44 0.76±0.06 
16%  1.90±0.05 2.05±0.05 1.73±0.06 125±45 0.82±0.05 
28%  1.90±0.05 2.05±0.05 1.70±0.06 104±45 0.84±0.05 
36%  1.95±0.05 2.15±0.05 1.57±0.06 88±44 0.90±0.05 
44%  1.95±0.05 2.15±0.05 1.40±0.06 95±42 1.00±0.04 
50%  1.95±0.05 2.20±0.05 1.31±0.07 93±45 0.94±0.04 
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4.4.4 Solid-state NMR spectroscopy 
MAS solid-state NMR experiments were performed using an 11.7 Tesla (500 MHz) 
Varian Infinity Plus spectrometer with a 3.2 mm Varian BalunTM probe, a 14.1 Tesla (600 MHz) 
Varian Infinity Plus spectrometer with a 3.2 mm T3 Varian 1H-13C-15N probe, a 17.6 Tesla (750 
MHz) Varian Unity Inova spectrometer with a Varian 3.2 mm BalunTM 1H-13C-15N probe and a 
21.1 Tesla (900 MHz) Varian Unity Inova spectrometer equipped with a 3.2 mm Varian 
BioMASTM 1H-13C-15N probe. All experiments (unless indicated) were performed with the 
variable-temperature (VT) gas adjusted to 10 °C, which corresponded to a sample temperature of 
~12-17 °C determined by ethylene glycol calibration. All experiments (unless indicated) utilized 
tangent ramped CP.33 TPPM34 or SPINAL 64 (Refs. 35,36) 1H decoupling was applied during 
acquisition and evolution periods with a field strength of ~80 kHz (unless indicated). For 3D 15N-
13C-13C and 13C-15N-13C correlation experiments, band-selective SPECIFIC CP37 was used for 
polarization transfer between 15N and 13C and DARR38 or SPC53 (Ref. 35,36) mixing was used 
for 13C-13C polarization transfer. Chemical shifts were referenced externally with adamantane 
(assuming the downfield peak of 40.48 ppm)39. 
4.4.5 Electron Microscopy 
AS fibrils were applied to formvar carbon coated grids (300 mesh), fixated with 
Karnovsky’s fixative, negatively stained with 2 % (w/v) ammonium molybdate, and viewed in a 
Hitachie H600 Transmission Electron Microscope (TEM), operating at 75 kV.  
4.4.6 Data processing and simulations 
All spectra were processed with nmrPipe40 with back linear prediction and polynomial 
baseline correction in the direct dimension. Zero filling and Lorentzian-to-Gaussian apodization 
and/or cosine bells were applied for each dimension before Fourier transformation. Peak picking, 
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assignments and peak height measurements were performed in Sparky41. Extraction of the 
evolution curves (t2) from the 3D MAS solid-state NMR experiments was conducted by using 
the autoFit.tcl package in nmrPipe40, after having picked the peaks in the first 15N-13C (F1-F3) 
plane. Dipolar coupling trajectories were fit to exact spin simulations by using in-house 
FORTRAN-77 code that called both external MINUIT42 minimization libraries and the 
SPINEVOLUTION43 simulation package.   
4.5 Results  
4.5.1 Comprehensive chemical shift assignments demonstrate secondary structure details of the 
AS fibrillar core  
AS fibrils were prepared as previously described29 and identical spectra (Figure 4.2) were 
obtained from several independent sample batches (|Δδ|avg< 0.2 ppm). Previous solid-state NMR 
studies27 reported differences in the fibril morphology that were attributed to minor variations in 
the fibrillation conditions44. Our results indicate high reproducibility of the sample preparation, 
with or without seeding with prior fibril generations (Figure 4.2C), an essential requirement for 
using different labeling schemes and performing structural comparisons between the WT and 
mutants. As previously demonstrated, regardless of sample hydration, portions of the core 
chemical shift assignments were conserved, with the exception of residues located in loops such 
as S87 and I88.29 We subsequently determined the level of optimal hydration to maximize overall 
spectral sensitivity and resolution to 36% water by mass (Figure 4.2; see Materials and 
Methods). 
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Figure 4.2. Microscopically ordered AS fibrils.  
 
(A) 13C-13C 2D spectrum of U-13C,15N AS fibrils with 36% water by mass (50 ms DARR mixing, 750 
MHz 1H frequency and 16.7 kHz MAS rate). (B) Transmission electron micrographs of AS fibrils. (C) 
Correlations of 13CA,13CB and 13C’ AS chemical shifts (CS) from independent sample preparation batches 
(above) seeded with unlabeled fibrils and (below) unseeded.  
 
The resulting two-dimensional (2D) spectra are well resolved (<0.2 ppm inhomogeneous 
broadening); however, due to the highly repetitive AS sequence, 3D spectra are essential to 
perform de novo chemical shift assignments. Thus, we collected extensive sets of spectra to 
assign the 13C and 15N chemical shifts unambiguously. Figure 4.3A illustrates a strip plot of the 
3D NCACX, NCOCX and CAN(CO)CX with 50 ms and CON(CA)CX with 10 ms dipolar 
assisted rotational resonance (DARR) mixing times on uniform (U)-13C,15N AS fibrils to 
demonstrate the sequential backbone connectivity for residues 89 to 95.  
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Figure 4.3. Chemical shift assignments of WT AS fibrils.  
(A) Strip plot from the 3D NCACX, NCOCX, CAN(CO)CX and CON(CA)CX spectra of U-13C, 15N AS 
fibrils showing the sequential backbone connectivity for residues 89 to 95. All spectra were acquired at 
600 MHz (1H frequency) and 13.3 kHz MAS rate. (B) Overlay of 13C-13C 2D spectra expansions with 50 
ms (black) and 250 ms (red) DARR mixing of U-13C, 15N AS fibrils. Intra-residue (black labels) and inter-
residue correlations (gray labels) were used to confirm assignments. (C) Expansion of a 13C-13C 2D with 
250 ms DARR mixing time on U-15N AS fibrils with 2-[13C] glycerol. Black peak labels indicate 
additional correlations that could be assigned with sparsely labeled samples. Spectra (B) and (C) were 
acquired at 900 MHz 1H frequency and 13.3 kHz MAS rate.  
 
A backbone walk with these 3D experiments was conducted for residues 44 to 96 (Figure 
4.4), leading to a high degree of assignment confidence for the majority of fibril core signals 
(residues 38 to 96, Table 4.2). To complement the 3D spectra, where peak intensities varied by a 
factor of 5 or more among residue types, we performed higher sensitivity 2D experiments with 
longer mixing times (e.g., 250 ms) to confirm inter-residue correlations (Figures 4.3B and 4.3C). 
In addition to the U-13C, 15N-labeled samples, sparse 13C isotopic labeling patterns were also 
utilized to acquire higher quality spectra45,46. The samples included: (a) U-15N AS fibrils with 1,3-
[13C] glycerol and (b) U-15N AS fibrils with 2-[13C] glycerol. In these samples, most of the one-
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bond 13C-13C J-couplings were removed, which increased the sensitivity and allowed the 
detection of additional residues. Data acquired on these samples enabled the detection of 15 
additional residues using CP-dipolar experiments, such as residue 33 or 106, as shown by the 
13C-13C 2D correlation experiment with DARR mixing in Figure 4.3C. Further 3D spectra, in 
which we employed SPC-53 mixing47 for targeted polarization transfers with maximal sensitivity, 
confirmed the number of unique signal patterns by residue type for the U-13C, 15N labeled 
samples (Figure 4.5A). 3D experiments were also acquired on the sparsely labeled samples as 
described in Figures 4.5B and 4.5C, as well as the ZF-TEDOR (Z-filtered transferred-echo 
double-resonance) experiment48 to assist in the chemical shift assignments of Lys sidechain 
signals, Gly-Ala residue pairs and Thr N-CB correlations outside the core. Finally, spectra 
collected at 900 MHz 1H frequency (Figure 4.3B) offered superior resolution49 to confirm and 
complete the assignments.  
	   	   	  
   75 
 
Figure 4.4. Sequential backbone walk used for the assignment of AS fibril chemical shifts.  
 
Strip plots showing the sequential backbone walk for residues 96 to 75, 74 to 63 and 55 to 44. Acquired 
spectra include: 3D NCACX (55 h measurement time, 50 ms 13C-13C DARR mixing time), NCOCX (74 
h, 50 ms), CAN(CO)CX (102 h, 50 ms) and CON(CA)CX (41 h, 10 ms) spectra on U-13C,15N AS fibrils. 
All spectra were acquired at 600 MHz (1H frequency) and 13.3 kHz MAS rate. 
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Together, this extensive set of NMR data (Table 4.3) facilitated assignments of 91% of 
15N and 13C resonances (95% of the backbone and 86% of the side chains) of the detected 
residues between 38 and 96 (Table 4.2). Additionally, using dipolar based experiments, we were 
also able to assign residues in small stretches outside the core, such as E105 to A107 or G111 to 
I112, and residues present only in the N- or C- terminus, such as T or Y. This suggests the 
presence of locally structured regions in both termini. 
Figure 4.5. Additional experiments to complete the chemical shifts. 
(A) Strip plots of the NCACB with 2.4 ms SPC53 mixing at 10.0 kHz MAS rate. (B) CANCO plane of the 
U-15N AS fibrils with 2-[13C] glycerol (top) and U-15N AS fibrils with 1,3-[13C] glycerol (bottom), 
showing the complementary labeling pattern to confirm sequential assignments. (C) Planes of the 
NCACX (250 and 500 ms DARR) on the 2-[13C]-glycerol sample, showing some of the new residues 
detected (top) and correlations to neighbor residues (bottom). All spectra were acquired at 600 MHz (1H 
frequency) and 13.3 kHz MAS rate (unless indicated).  	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Table 4.2. 13C and 15N chemical shift assignments of wild-type AS fibrils (with 36% water by mass) 
(BMRB 16939).  
 
Residue 15N 13C’ 13CA 13CB 13CG 13CD 13CE 13CZ 15NZ 
T22** 112.0 - 58.5 71.4 20.3     
K23** 120.4 - - - - - -  - 
A30 - - 51.9 -      
G31 114.1 174.3 45.2       
K32 122.1 175.0 56.5 - - - 42.0  - 
T33 106.1 - 60.8 69.4 23.2     
E35 126.1 - 53.7 33.7 36.1 183.2    
G36 110.4 172.3 48.8       
V37 121.9 - 60.0 35.7 21.2/20.1     
Y39 119.4 175.2 53.6 36.2 130.1 133.1 118.8 157.9  
V40 126.0 - 59.7 35.5 21.9     
G41 115.5 174.1 48.2       
S42 111.8 171.3 58.4 67.6      
K43 122.5 173.1 54.8 38.0 26.0 31.1 41.9  29.5 
T44 113.7 175.4 59.5 71.4 22.3     
K45 122.7 173.7 56.2 36.8 27.2 30.7 42.2  33.9 
E46 126.4 175.0 53.9 32.3 35.2 182.8    
G47 115.6 172.7 48.4       
V48 118.6 174.7 59.5 37.7 20.7/24.0     
V49 126.7 174.7 61.3 34.2 20.5/22.7     
H50 125.8 - 52.7 - 127.1 - -   
G51 - - 47.9       
V52 123.6 174.8 61.2 33.3 20.8     
A53 132.7 175.9 49.8 20.8      
T54 121.2 173.2 61.5 71.5 21.6     
V55 126.6 174.6 61.1 35.0 20.9/22.4     
K58 - 176.6 55.6 35.6 25.9 30.1 42.0  34.1 
T59 122.4 174.3 67.2 67.2 22.6     
K60 120.5 - 54.8 - - - -  - 
Q62 - 175.6 - - - -    
V63 122.3 174.7 60.5 34.2 20.6/21.3     
T64 126.7 172.7 62.2 69.6 21.7     
N65 125.2 172.7 51.7 42.8 175.2    115.3 
V66 127.2 178.3 60.6 32.9 -     
G67 111.0 172.5 46.5       
G68 102.5 172.3 43.3       
A69 126.4 175.4 50.2 23.3      
V70 120.7 174.6 60.0 35.8 21.3     
V71 126.3 176.5 61.0 35.3 20.9/22.0     
T72 115.2 175.5 59.5 69.5 22.0     
G73 109.2 173.4 44.0       
V74 124.3 175.1 61.4 34.9 19.6/21.0     
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Table 4.2 (cont.) 
 
T75 127.8 172.1 61.7 70.4 21.4     
A76 130.4 174.3 49.7 21.3      
V77 124.0 172.9 60.5 35.8 20.4/21.3     
A78 130.1 176.6 49.8 24.9      
Q79 120.2 176.6 52.4 33.0 33.0 177.6   111.3 
K80 123.0 176.0 60.3 32.5 26.7 31.4 42.3  33.8 
T81 113.2 173.7 60.9 72.3 22.5     
V82 126.2 174.6 61.4 34.0 20.5/22.8     
E83 126.4 175.1 53.7 32.3 35.0 183.0    
G84 112.4 173.6 45.0       
A85 130.9 179.5 53.2 18.5      
G86 111.5 173.6 46.7       
S87 115.5 173.5 58.7 64.8      
I88 121.4 175.6 60.0 40.4 17.6/27.4 13.5    
A89 129.3 177.0 54.8 18.7      
A90 123.1 174.7 51.2 21.0      
A91 127.5 175.6 49.6 23.1      
T92 125.6 174.7 60.9 69.8 21.8     
G93 114.7 170.0 47.3       
F94 126.4 173.8 54.4 45.7 137.8 132.6 129.4 -  
V95 127.9 171.4 61.1 34.8 20.4/22.0     
K96 133.0 173.0 54.9 - - - -  - 
K97 130.3 - 54.1 - - - -  - 
E105 - 174.2 - - -     
G106 102.3 171.8 44.3       
A107 125.0 175.3 52.0 19.6      
G111 112.3 - 46.9       
I112** 123.3 179.5 59.3 42.1 18.1/27.1 15.2    
A - 182.7 53.8 20.4      
A - 175.7 50.4 18.4      
A - 177.7 52.7 19.4      
A (2 residues)* - 178.0 52.8 19.4      
A 126.9 - 51.8 16.0      
A 127.5 - 50.0 25.8      
A 129.6 - 51.0 22.2      
A 129.8 - 49.5 23.0      
D/N - 179.5 54.7 41.2 180.2     
D/N - 178.5 53.5 39.3 177.3     
D/N - - 54.8 42.7 177.4     
E/Q (3 res.)* - 177.0 56.8 30.4 36.4 183.3    
E/Q - 176.1 56.1 29.7 34.0 180.6    
E/Q - 177.0 56.8 30.4 34.8 178.8    
E/Q - - 54.1 33.4 36.0 182.9    
G 109.9 174.3 45.7       
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Table 4.2 (cont.) 
 
G 96.4 - 45.0       
G 98.6 - 45.2       
G 105.1 - 44.1       
G 119.2 - 48.3       
K (2 residues)* - 176.6 56.7 33.1 24.7 29.2 42.6   
L - 177.8 55.5 42.6 29.2 24.7    
P - 177.1 63.1 31.8 27.6 50.6    
P 133.2 - 58.1 36.9 51.0     
P - - 61.7 - 50.7     
S 121.7 56.4 - 65.6      
V 119.4 36.2 - 60.2      
V 119.5 34.5 - 61.3      
V - 176.2 62.5 32.9 21.4/20.7     
Y 105.4 - 174.9 57.0 138.9 - -   
Y/F - - 52.6 39.6 - - -   
Y/F - 123.5 61.0 - - - -   
  
 (*) The number of residues was calculated based on the integration of the peak intensity for overlapped 
peaks based on the integral of other well resolved peaks of the same amino acid type. 
(**)Variations in the chemical shifts suggest different conformations for this region of the sequence. 
 	   Highly confident resonance assignments directly yield substantial structural information. 
Empirical prediction of the backbone torsion angles Φ and Ψ from residues 30 to 110 of AS 
fibrils was obtained by using the 13C (CA, CB and CO) and 15N chemical shift assignments and 
the TALOS+ program50. Figure 4.6 shows a plot of (A) the dihedral angles and (B) the predicted 
order parameters (S2) reported by TALOS+. TALOS+ provides a prediction of the secondary 
structure that demonstrates the presence of a repeated motif in the core of AS fibrils from 
residues 38 to 66 and 68 to 96 (Figure 4.6D). Taken together, these secondary chemical shift 
analysis results indicate a repeated motif including a long β-strand (of ~12 residues, L38 to V49) 
and two short β-strands (of ~4 residues each, V52-V55 and V63-V66) separated by a loop of 
several residues; the motif repeats with a 12-residue β-strands (G68-Q79) followed by two short 
β-strands (T81-G84 and A90-K96). These results demonstrate differences in the secondary 
structure that do not agree with a proposed fold of AS27-31. Additionally, our results show that the 
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three single point mutation sites, including A30 and E46, which had not been detected in 
previous NMR studies27, are located in structured regions of the fibrils. 
Table 4.3. 3D datasets acquired in order to obtain the 13C,15N chemical shift assignments for wild-
type AS fibrils.  
 
The total amount of protein was calculated based on the integrated intensity of a 13C 1D DP experiment, 
relative to an external standard adamantane sample of known mass.	  
 
Labeling scheme Experiment Mixing 
scheme 
Mixing 
time 
(ms) 
Total time 
(h) 
Protein 
amount  
(mg) 
NCACX DARR 50 74 ~ 12 
NCOCX DARR 50 74 ~ 12 
NCOCX DARR 250 134 ~ 12 
CAN(CO)CX DARR 50 102 ~ 12 
CON(CA)CX DARR 50 41 ~ 12 
NCACX SPC53 2.6 84 ~ 22 
NCOCX DARR 50 118 ~ 12 
U-13C,15N 
CANCO - - 82 ~ 12 
NCACX DARR 250 77 ~ 12 
NCACX DARR 500 115 ~ 12 
NCOCX DARR 250 77 ~ 12 
U-13C,15N with 2-13C 
glycerol 
CANCO - - 58 ~ 12 
CANCO - - 43 ~ 13 U-13C,15N with 1,3-13C  
glycerol NCOCX DARR 250 134 ~ 13 
 
 
Chemical shifts also report directly on sidechain conformation preferences, most notably 
for Val methyl groups51. Whereas previous studies27 of AS did not report distinguishable 
differences among the Val methyl assignments, the present report demonstrates distinctive 
chemical shifts for many Val methyl groups. The likely conformations of V48, V49 and V82 is p 
(χ 1 ~ +60o), of V55, V74 and V95 is t (χ 1 ~ +180o), and of V71 and V77 is m (χ1 ~ -60o). 
Although these are not high-resolution dihedral restraints, the chemical shifts are consistent with 
the presence of well-ordered sidechains. In contrast, the observation of a single methyl frequency 
each for V40, V52 and V70 indicates a lack of strong conformational preference. We attribute 
these variations to sidechain packing (or lack thereof) in the fibril core. 
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Figure 4.6. Secondary structure of AS fibrils.  
 
(A) TALOS+ predicted backbone dihedral angles φ (squares) and ψ (circles) as a function of residue 
number. Error bars are based on the 10 best TALOS+ database matches. (B) TALOS+ predicted order 
parameters S2. (C) Relative peak heights from the cross peaks of the 3D CANCO spectrum of U-13C,15N 
AS fibrils (numbered according to the carbonyl residue). Residues labeled as (#) correspond to residues 
with overlapped peaks in the CANCO experiment. Error bars correspond to the noise level. (D) 
Representation of the secondary structure of AS fibrils based on TALOS+ analysis (arrows indicate β-
strands; curved lines are turn or loop regions; dashed lines indicated no prediction).  
 
4.5.2 Conformational dynamics of the fibril backbone 
Giasson et al. demonstrated that residues 71 to 82 are necessary for AS fibril assembly52; 
and therefore it is not surprising that these rigid residues yield some of the strongest solid-state 
NMR signals. We confirmed this in a site-specific manner by performing a 3D CANCO 
experiment and by normalizing the cross-peak intensities (Figure 4.6C) to the strongest signal 
(V77CA-V77N-A76C). The intensities in the CANCO report qualitatively on dynamic properties 
of the fibril, with the majority of cross peaks uniquely resolved. An advantage of the CANCO 
experiment, relative to NCACX or NCOCX experiments involving DARR mixing, is that peak 
intensities depend in the CANCO primarily upon the (T2 and T1ρ) relaxation rates of the spins on 
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which polarization resides during the chemical shift evolution and CP periods. In NCACX (or 
NCOCX) experiments, the peak intensities depend to a greater extent on the residue type, due to 
large variations in numbers of sidechain 13C sites and chemical shift patterns. All but a few 
residues from T64 to K96 have ~50% or greater intensity on this scale. The newly identified β-
strand from L38 to V49 has a much weaker signature, and peripheral regions (residues less than 
38 and greater than 96) are not observed in this experimentally demanding dipolar 3D 
experiment. 
 
Figure 4.7. Selected site-specific measurements of the AS fibril core dynamics.  
 
(A) 1HN-15N and (B) 1HA-13CA dipolar order parameters and trajectories. (C) 1HN R1ρ (s-1) relaxation 
rates for selected residues. Best-fitting simulations (solid lines) of the experimental trajectories were 
obtained by using SPINEVOLUTION43. Backbone order parameters (<S>=dexpIS/DrigIS) are included with 
the trajectories and were obtained by fitting the experimental trajectories to determine the dipolar 
coupling between the nuclear spins I and S (dexpIS). Equilibrium bond length for the 1HN-15N and 1HA-
13CA were assumed to be 1.04 Å and 1.12 Å, respectively, to compute the dipolar coupling in the rigid-
lattice (drigIS). Standard errors are derived from the MINUIT fitting. 
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Figure 4.8. Conformational dynamics measurements of AS fibrils based on the one-bond dipolar 
couplings and 1HN R1 relaxation trajectories.  
 
One-bond dipolar couplings were measured by using two different 3D 15N-13CA experiments that 
reintroduce the dipolar coupling in the third dimension. 3D pulse sequence scheme used to measure the 
(A) 1HN-15N and (B) 1HA-13CA one-bond dipolar couplings using the recoupling pulse sequence R1817 
(Ref. 53). (C) Expansion of a representative 2D 15N-13CA plane from a 3D 15N-13C R1817 experiment with 
dipolar evolution period set to 0 in U-15N AS fibrils with 2-13C glycerol and 100 kHz B1 field. Additional 
representative (D) 1HN-15N and (E) 1HA-13CA dipolar trajectories for selected residues of AS fibrils. (F) 
Representative 1HN R1ρ relaxation trajectories for selected residues from a NCA 2D plane54 on U-15N AS 
fibrils with 2-13C glycerol. 1H spin-lock field was set to ~57 kHz. Fitting simulations correspond to single 
exponentials. Standard errors are derived from the fitting. Data were acquired at 500 MHz (1H frequency) 
and 11.1 kHz MAS rate.	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As previously demonstrated for the Y145Stop prion protein54, such variations in intensity 
can arise despite a lack of large-scale backbone motions. For AS, we investigated this hypothesis 
further by measuring site-resolved 1H-15N and 1H-13CA dipolar couplings, where the time-
averaged coupling approximates the order parameter  (<S>), using the recoupling pulse sequence 
R1817 (Ref. 42). The 1HN-15N (Figure 4.7A) and 1HA-13CA (Figure 4.6B) dipolar trajectories for 
representative residues provide direct measurements that elaborate upon, but agree well with, the 
TALOS+ predictions (Figure 4.6B). For example, S42, A89 and F94 all have near rigid-lattice 
limit dipolar couplings for both backbone sites (<S> greater than 0.94). T59 has only a very 
slight increase in motion (<S> ~ 0.92 on average), despite being within a loop, and G67 likewise 
shows no significant averaging despite a distinct backbone conformation. On the other hand, S87 
displays an average <S> value of 0.88±0.02, consistent with the TALOS+ value for S2 of ~0.75.   
Although these small variations in average coupling (~10%) are experimentally 
significant, they fail to account for the large differences in peak intensities in the 3D spectra, 
which can range up to a factor of 10 for individual cross-peaks. Therefore, we next considered 
the rotating frame relaxation rates as a potential source of signal intensity variation, by 
measuring site-resolved 1HN R1ρ values (Figure 4.7C). Under the conditions examined, the 
majority of core residues have relaxation rates less than 90 s-1, and the rates coincide well with 
the peak intensities observed in the CANCO spectrum; for example, V77 has a small measured 
relaxation rate (V77, 70±4 s-1), similar to other residues that were not previously assigned such as 
Y39 or S42 (Y39, 63±10 s-1; S42, 75±5 s-1). In contrast, several residues with depressed signal 
intensities have higher rates (A53, 115±15 s-1; T59, 122±10 s-1; G73, 118±15 s-1). Therefore, the 
dispersion in relaxation rates appears to be responsible for the large variations in spectral 
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intensities previously reported for other systems54. We postulate that these increased rates may be 
due to small amplitudes, microsecond-to-millisecond timescale motions. 
 
Figure 4.9. Detection of the mobile regions of AS fibrils.  
 
Comparison of (A) 13C-13C 2D with initial CP to detect rigid regions (750 MHz), (B) IPAP (in-phase anti-
phase) CACO and CTUC COSY with initial CP44,45 to detect rigid and mobile regions (500 MHz) and (C) 
IPAP CACO and CTUC COSY with initial DP (direct polarization), low power decoupling and variable-
temperature (VT) gas temperature set to 30 °C to detect mobile regions (600 MHz). (D) Expansion of the 
Ala region from the CP-CC 2D (left), CP-CTUC COSY (center) and DP-CTUC COSY (right) spectra. 
Black labels show residues not detected in the multidimensional dipolar-based experiments, and gray 
labels show residues assigned with multidimensional dipolar-based experiments. AS sequence (gray 
residues in the termini with the local structure are underlined with a solid line and residue types present 
only in one side of the termini are underlined with a dashed line).  
 
For faster and/or larger amplitude motions, dipolar methods failed to detect the signals at 
all, in particular for residues in the terminal domains. Therefore we implemented J-based transfer 
experiments (Figure 4.9). The constant-time uniform-sign cross-peak (CTUC) correlation 
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spectroscopy (COSY) and the CACO IPAP (in-phase anti-phase)55,56 experiments resolved 
regions of the spectra that were not resolved or observed at all in dipolar spectra (Figures 4.9A 
and 4.9B). We attempted to perform the COSY experiment with an initial INEPT 1H-13C 
transfer57, but found the sensitivity to be inadequate. Therefore, we modified the J-based 
experiments to include 13C direct polarization (DP), instead of 1H-13C cross polarization (CP), 
and low power 1H SPINAL decoupling (60 kHz), which served as a 13C T2 filter to dephase the 
most rigid regions, resulting in much stronger relative peak intensities for the mobile residues 
(Figure 4.9C). These results are in agreement with the differences in intensity in the CP-dipolar 
experiments (Figure 4.6C), as evidenced by the presence of mobile residues such as T64, S87 
and I88 (Figure 4.9). Additional residues not previously detected in the CP-dipolar based 
experiments, and therefore more dynamic, were also detected. These residues included several 
Ala with random coil chemical shifts, as well as Val, Glu/Gln, Asp/Asn, Gly and Lys, suggesting 
that both the C- and the N- termini have locally structured regions but are more dynamic than the 
core (Figure 4.9D). 
 
4.5.3 Structural perturbations found in the fibrillar core upon mutation of two single point 
mutants located in the β-strand regions  
In addition to the multiplication of the WT AS allele11,12, three single point mutations 
(A30P, E46K and A53T) in the AS gene have been identified in familial early-onset PD8-10. Our 
results demonstrate that residues E46 and A53 are both located in the middle of rigid β-strands in 
the WT fibrils, while A30 is located in a loop region (Figure 4.5D). To further support these 
results, we prepared fibrils of the three single-point mutants (A30P, E46K and A53T) following 
the same procedure of fibril preparation and hydration as for the WT fibrils, and acquired 13C-13C 
2D spectra under identical conditions. Multidimensional experiments, equivalent to the subset 
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acquired for the U-13C,15N WT at 600 MHz 1H frequency, were also acquired to obtain de novo 
chemical shift assignments for the three mutants (Tables 4.4-4.6). These experiments indicate 
substantial alteration to the structure upon mutation, with major perturbations (|Δδ|avg~ 0.3-2.0 
ppm) upon E46K mutation and minor perturbations (|Δδ|avg~ 0.1-0.9 ppm) upon A53T mutation, 
as shown in the CC2D expansion of the Thr, Ala or Gly regions (Figure 4.10). Almost no 
perturbation was detected for A30P (|Δδ|avg< 0.2 ppm; Figure 4.10), which is located in a loop 
region. Regardless of these structural changes, a comparison of electron micrographs (EM) of the 
WT versus the three AS mutant fibrils demonstrates no major changes to the fibril morphology 
upon mutation (Figure 4.11).  
 
 
Figure 4.10. Structural perturbation caused by three early-onset PD mutants. 
 
Comparison of 13C-13C 2D spectral expansions (50 ms DARR mixing, 600 MHz 1H frequency and 13.3 
kHz MAS rate) for the WT AS fibrils and the three early-onset PD mutants (A30P, E46K and A53T): (A) 
Thr CA-CG2, (B) Ala CA-CB and (C) Gly CO-CA. Chemical shift perturbations for the mutants versus 
the WT for selected residues in each area are plotted in the left. Chemical shift assignments of the mutants 
were obtained with de novo sequential backbone walk using 3D experiments as conducted for the WT. 
Error bars correspond to the chemical shift variations from one WT batch to another. 
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Figure 4.11. Comparison of the electron micrographs of (A) wild-type AS fibrils versus the early-
onset PD mutants: (B) A30P, (C) E46K and (D) A53T. 
 
Table 4.4. Partial 13C and 15N chemical shift assignments of A30P AS fibrils (with 36% water by 
mass) (BMRB 17648).  
 
Residue 15N 13C’ 13CA 13CB 13CG 15NZ 
T64 126.6 172.6 62.2 69.8 21.8  
N65 125.2 172.6 51.8 42.9 175.1 115.0 
V66 127.4 177.8 60.7 33.2 21.2/20.0  
G67 111.2 172.7 46.5    
G68 102.8 172.4 43.3    
A69 126.4 175.4 50.3 23.4   
T75 127.7 172.1 61.7 70.5 21.4  
A76 130.3 174.4 49.7 21.4   
V77 123.8 172.9 60.5 35.9 20.4/21.3  
A78 130.0 176.4 49.9 25.0   
A91 127.5 175.6 49.6 23.1   
T92 125.5 174.7 61.0 70.0 21.8  
G93 114.7 170.1 47.4    	  
Table 4.5. Partial 13C and 15N chemical shift assignments of E46K AS fibrils (with 36% water by 
mass) (BMRB 17654). 
Residue 15N 13C’ 13CA 13CB 13CG 15NZ 
T64 122.9 173.8 62.6 71.3 21.3  
N65 128.6 172.9 52.8 42.5 175.3 - 
V66 124.4 174.1 59.7 36.1 20.3/19.4  
G67 111.6 172.3 44.7    
G68 109.6 170.8 44.7    
A69 124.5 174.9 49.7 25.0   
T75 124.7 171.8 61.6 71.3 20.4  
A76 129.6 175.8 49.6 23.2   
V77 120.7 172.9 59.9 35.6 22.5/20.4  
A78 130.3 175.7 50.2 23.4   
A91 125.2 175.8 49.7 23.3   
T92 121.8 174.8 61.5 71.5 21.6  
G93 115.0 170.3 47.2    	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Table 4.6. Partial 13C and 15N chemical shift assignments of A53T AS fibrils (with 36% water by 
mass) (BMRB 17649).	  	  
Residue 15N 13C’ 13CA 13CB 13CG 15NZ 
T64 126.8 173.0 62.5 69.6 21.7  
N65 125.5 172.9 52.0 43.7 174.9 - 
V66 127.5 178.0 60.9 33.7 21.6  
G67 111.6 172.6 46.9    
G68 103.4 172.6 43.7    
A69 126.8 175.6 50.6 23.7   
T75 128.0 172.2 62.1 70.6 21.6  
A76 130.6 174.4 50.1 21.5   
V77 124.1 173.0 60.9 36.1 20.6/21.5  
A78 130.3 176.3 50.2 25.0   
A91 127.6 175.7 49.9 23.3   
T92 125.7 174.8 61.3 70.3 22.0  
G93 115.1 170.2 47.8    
 
4.6 Discussion 
4.6.1 Structured regions of AS fibrils include the early-onset PD mutation sites 
Although it has been known for decades that LBs are the characteristic hallmark of PD2, 
it was not discovered until 1997 that the main protein component of LBs is fibrillar AS3. AS 
fibrils have motivated numerous structural studies6,7,15,27-31,58,59. Despite the considerable effort, the 
structural characterization of AS fibrils at atomic level is still incomplete. MAS solid-state NMR, 
a technique uniquely positioned to achieve information on amyloid fibrils at an atomic-level, 
requires first and foremost the determination of confident chemical shift assignments. Previous 
solid-state NMR studies of AS fibrils made substantial progress in this regard27-31. Here we have 
advanced these studies with new combinations of solid-state NMR experiments, improved 
sample preparation and sparse labeling schemes, permitting the detection and assignment of 
numerous residues not previously observed by solid-state NMR. Nearly identical chemical shifts 
were obtained for the regions previously detected with dried or fully hydrated fibrils29, with some 
local variations such as residues 86 to 88 (Ref. 29) or residues 64 to 67. Our results extend 
significantly upon previous studies, with the detection of a total of 106 residues versus 62 (Ref. 
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27) or 59 (Ref. 28). In addition, we have assigned 91% of the 15N and 13C resonances of the 
detected residues between 38 to 96 residues where others reported ~58% (Ref. 27) or ~48% (Ref. 
28). These experiments demonstrate that the three early-onset PD mutation sites are structured, 
with a β-sheet core that extends from residues 38 and 96 and local random coil regions in the 
termini, a finding in agreement with previous electron paramagnetic resonance (EPR) studies of 
the Langen group where they detected distances distributions of <15 Å between the nitroxide 
spin labels from residues ~34 to ~101 (Ref. 46). Additionally, our results demonstrate that E46 is 
located in one of the two longest β-strands of the fibril. This disagrees with previous studies that 
assumed it was located in a loop region, because signals were not detected for E46 or 
neighboring residues27,31. A53 is located in one of the four short β–strands, and A30 in a loop 
region near the N-terminus. Signals that correspond to residues 30 to 39 were not assigned by 
previous solid-state NMR studies27,31. A comparison of our chemical shifts to those from Heise et 
al.27 strongly suggests a difference in morphology, possibly as a result of different fibrillation 
conditions44. 
4.6.2 Secondary structure of AS fibrils includes a repeated β-strand motif  
Our results demonstrate the presence of additional structured regions in the fibrillar core 
of WT AS, which have led to significant differences in the secondary structure from those 
previously proposed27,31. Vilar et al.31 proposed a possible structural model of AS fibrils based on 
electron microscopy (EM) experiments and relatively limited solid-state NMR data of a fragment 
of AS. On the basis of hydrogen/deuterium (H/D) exchange NMR experiments, the authors 
reported the presence of five protected regions that they presumed to be five distinct β-sheet 
strands. In general, amyloid fibrils present segments in the fibrils core that are well protected 
from H/D exchanges, regardless of local secondary structure. Other, less protected segments may 
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be β-strand, but less stable and well more exposed to solvent. Thus, H/D exchange cannot be 
used to draw definitive structural conclusions. Our results demonstrate the presence of 
differences in the secondary structure versus previous studies, based on a significantly more 
extensive investigation with solid-state NMR and complete chemical shift assignments. The 
secondary structure includes a repeated motif that is composed of a long β-strand followed by 
two short β-strands located from residues 38 to 66 and again from 68 to 96 (Figure 4.6D). The 
length of the long β-strand (~5 nm, 12 residues) is compatible with our electron micrographs 
(Figure 4.2B), with the fibril width reported by Vilar et al. and also directly observed by EM in 
LBs from PD patients.6,7,60  
4.6.3 Conformational dynamics measurements reveal the rigid regions of AS fibrils   
The detection of a total of 106 residues in the sequence that accounts for the residues 
located in the core and residue types located only in the N-terminus (Thr, Val) or the C-terminus 
(Pro, Asp, Asn, Tyr), demonstrates the presence of partial structure in both the N- and the C-
termini. Previous investigations of the mobile regions of AS fibrils27 encountered problems 
caused by the presence of AS monomer that the authors identified by comparison to the 
assignments of AS monomer in solution. We have overcome this problem by washing the fibril 
samples. In our study, type-specific residue assignments, most notably for unambiguous cases 
such as Ala or Asp/Asn, demonstrate substantial differences (>0.5 ppm) from solution NMR of 
the unfolded state (BMRB 16300). Additionally, we detected the mobile regions using J-based 
experiments that agree with the residues located outside the core and the residues detected with 
the dipolar based experiments using samples with sparse labeling schemes and a 3D NCACB 
experiment with SPC53 mixing. Our investigations indicate the presence of conformational 
dynamics along the AS fibrillar core and demonstrate that the residues described by Giasson et 
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al. to be necessary for AS fibril assembly52 are among the strongest solid-state NMR signals and 
therefore are located in the more rigid regions of the fibril. 
4.6.4 The early-onset PD mutants that fibrillate faster than the wild-type have distinctive fibrillar 
forms  
Significant additional insight from our study includes the localization of the early onset 
mutation sites (A30P, E46K and A53T)8-10 to structured regions of WT fibrils. These results 
suggest a major effect on the fibril structure upon E46K or A53T mutation, both of which are 
located in β–sheet regions and therefore expected to cause more structural perturbation than 
A30P. The solution NMR structure of AS in mixed detergent micelles demonstrates that this 
region may serve as a key conformational switch61. Investigations of phospholipid binding 
revealed differences in the binding affinity of the mutants compared to the WT that could 
suggest increased vulnerability to self-aggregation62. Thus the mutation sites may be directly 
involved in dictating fibrillation. Additionally, our results demonstrate effects of E46 and A53 
mutation on the final fibrillar state. In E46K, a negatively charged amino acid, which is located 
in the middle of a long β–strand, is mutated to a positively charged amino acid that creates a 
major perturbation of the structure of AS fibrils. In A53T, an Ala located in one of the short β–
strands is mutated into a Thr, which generates a minor perturbation to the final fibrillar structure. 
The A30P mutation does not have a significant impact on the fibril structure that we have 
attributed to A30 being located in a random coil. These results indicate that the two mutants that 
have faster fibrillation rates (E46K and A53T) compared to the WT protein also have distinctive 
final fibrillar states compared to WT, while A30P has a slower fibrillation rate but a fibril 
structure similar to that of the WT. 
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4.7 Accession Numbers 
 Chemical shift assignments have been deposited to the BioMagResBank  (BMRB) for 
release upon publication (BMRB entry numbers 16939 for WT, 17648 for A30P, 17654 for 
E46K and 17649 for A53T). 
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CHAPTER 5 
Structural intermediates during α-synuclein fibrillogenesis on phospholipid 
vesicles 
5.1 Notes and Acknowledgements 
 This chapter is adapted with kind permission from the Journal of the American Chemical 
Society, Structural intermediates during α-synuclein fibrillogenesis on phospholipid vesicles, 
134, 5090-5099, 2012, authors: Gemma Comellas, Luisel R. Lemkau, Donghua H. Zhou, Julia 
M. George and Chad M. Rienstra. Copyright 2012 American Chemical Society. The work was 
supported by the National Institutes of Health (R01-GM073770) and utilized equipment 
procured with support of S10RR025037 from the National Center For Research Resources. 
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5.2 Abstract 
 α-Synuclein (AS) fibrils are the main protein component of Lewy bodies, the 
pathological hallmark of Parkinson’s disease and other related disorders. AS forms helices that 
bind phospholipid membranes with high affinity, but no atomic level data for AS aggregation in 
the presence of lipids is yet available. Here, we present direct evidence of a conversion from α-
helical conformation to β-sheet fibrils in the presence of anionic phospholipid vesicles and direct 
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conversion to β-sheet fibrils in their absence. We have trapped intermediate states throughout the 
fibril formation pathways to examine the structural changes using solid-state NMR spectroscopy 
and electron microscopy (EM). The comparison between mature AS fibrils formed in aqueous 
buffer and those derived in the presence of anionic phospholipids demonstrates no major changes 
in the overall fibril fold. However, a site-specific comparison of these fibrillar states 
demonstrates major perturbations in the N-terminal domain with a partial disruption of the long 
β-strand located in the 40s and small perturbations in residues located in the “non-β amyloid 
component” (NAC) domain. Combining all these results, we propose a model for AS 
fibrillogenesis in the presence of phospholipid vesicles. 
5.3 Introduction 
 α-Synuclein (AS) is a 14-kDa protein that is unstructured in solution yet forms fibrils that 
are the primary proteinaceous constituent of Lewy bodies, the pathological hallmark of 
Parkinson’s disease (PD)1. Three single point mutations (A30P, E46K, and A53T)2-4, as well as 
duplication and triplication of the AS allele5,6, are associated with familial PD. Despite these 
substantial associations of AS with disease, the understanding of its folding and misfolding 
pathways is far from complete. Initial in vitro studies demonstrated that AS binds anionic 
phospholipids with an increase in α-helical secondary structure7,8. Solution NMR studies of AS 
bound to sodium dodecyl sulfate (SDS) micelles demonstrated that AS residues 3-37 and 45-92 
bind via a helical conformation, while the C-terminus remains unstructured9,10. Recent studies 
have also reported on binding modes ranging from the free disordered cytosolic form to the 
anionic phospholipid-bound state11 and a structure of AS bound to phospholipid vesicles using 
site-directed spin labeling EPR12.  
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 The strong interaction of AS with anionic phospholipids has been shown to promote AS 
aggregation13-17. Smith et al. investigated the transition from α-helical to β-sheet and proposed 
the formation of an intermediate during fibril formation18. Bodner et al. proposed an increased 
population of a partially disrupted α-helix in the presence of the early-onset PD mutants that may 
affect the interaction with the membrane bilayer and AS fibrillation19. Recent investigations have 
indicated that AS might form α-helical tetramers that prevent the formation of fibrils20. 
Additionally, changes in the membrane have been detected in the presence of AS protofibrils21, 
with increased effects in the presence of the three mutants22. It has also been proposed that the 
formation of ion channels by AS may destabilize the ionic homeostasis of neurons and cause 
neuronal cell death23-25. Despite all these studies, atomic level structural insights into the 
aggregation of AS in the presence of lipids are lacking.  
 Magic-angle spinning (MAS) solid-state nuclear magnetic resonance (NMR) is uniquely 
able to characterize the structural changes of noncrystalline macromolecules, such as 
bacteriorhodopsin in the light-driven proton pumping cycle26, rhodopsin phosphoactivation27,28, 
and the site-specific investigation of protein folding29,30. Previous studies have demonstrated 
structural analysis of a metastable β-amyloid intermediate in a lyophilized state.31 Additionally, 
several groups, including ours, have conducted solid-state NMR studies to investigate the fibrils 
of AS prepared in aqueous buffer32-36. Thus, the application of solid-state NMR is well-suited to 
provide atomic-resolution structural information of the AS conversion from α-helical to β-sheet 
fibrils in the presence of physiologically relevant phospholipids. Here, we apply this approach to 
AS fibrils prepared by incubation in the presence of phospholipid vesicles. 
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5.4 Materials and Methods 
5.4.1 Sample Preparation 
 1-Palmitoyl 2-oleoyl-sn-glycerol-3-phosphatidylcholine (POPC) and 1-palmitoyl-2-
oleoyl-sn-glycerol-3-phosphate (sodium salt) (POPA) were mixed in chloroform at a 3:1 molar 
ratio and dried under a stream of N2. The dry lipids were resuspended in 50 mM sodium 
phosphate buffer (pH 7.4) with 0.02% NaN3 and subjected to cycles of freeze-thawing to form 
vesicles. U-13C, 15N-labeled AS was expressed and purified as previously described37. AS 
solutions were prepared at 1 mM concentration in phosphate buffer and passed through a 0.2 µm 
filter immediately prior to use. AS was added to the lipid solution to reach a lipid-to-protein ratio 
of 50:1 and an AS concentration of 0.5 mM. The mixture was immediately incubated at 37 °C 
with shaking (200 rpm) for the defined time of 1, 2, 3, 6, or 11 days under nitrogen atmosphere. 
At the conclusion of the incubation period, the samples were ultracentrifuged at 110000 g for 1 h 
at 4 °C. Two additional zero time point samples (noted as “0 days incubation”) were prepared 
and ultracentrifuged immediately after adding the AS to the lipid vesicles (and lyophilized 
directly in the case of the lipid-free sample). In all cases, the pellet from the ultracentrifugation 
was lyophilized, packed into a MAS rotor and rehydrated, as recently described for fibrils 
formed in aqueous buffer35. Additionally, we measured the approximate lipid-to-protein ratios 
present in the solid-state NMR rotors based on the integration of the direct-polarization (DP) 13C 
and 31P 1D spectra versus standard compounds, as described in Table 5.1. 
5.4.2 Solid-State NMR Spectroscopy 
 MAS solid-state NMR experiments were performed using (1) a 11.7 Tesla (500 MHz 1H 
frequency) Varian VNMRS spectrometer (Walnut Creek, CA, and Loveland, CO) equipped with 
a 3.2 mm Varian Balun 1H-13C-15N MAS probe; (2) a 14.1 Tesla (600 MHz, 1H frequency) 
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Varian Infinity Plus spectrometer with a 3.2 mm HXY narrow bore tuned to double resonance 
mode for 1H and 13C frequencies or triple resonance mode for the 1H, 31P and 13C frequencies; and 
(3) a 17.6 Tesla (750 MHz, 1H frequency) Varian VNMRS spectrometer equipped with a 3.2 mm 
Varian BioMAS 1H-13C-15N probe (Varian is now part of Agilent Technologies, Santa Clara, CA, 
and Loveland, CO). All experiments utilized tangent ramped cross-polarization (CP)38. SPINAL-
64 1H decoupling was applied during acquisition and evolution periods with a field strength of ~ 
75 kHz39,40. DARR mixing was used for 13C13C polarization transfer41. Chemical shifts were 
referenced externally with adamantane (assuming the downfield peak at 40.48 ppm)42. 
Table 5.1. Evaluation of lipid-to-protein ratios for the samples packed in solid-state NMR rotors as 
a function of the incubation time 
 
* Lipid-to-protein ratios of solid-state NMR samples were calculated based on the selected integral 
intensity of a 13C 1D DP experiment (protein) and 31P 1D DP experiment (lipids), relative to external 
standards of known mass.  
 
Incubation time (days) Lipids-to-protein ratio* 
0 
1 
2 
3 
6 
11 
100 ± 11 
95 ± 10 
70 ± 7 
48 ± 5 
50 ± 6 
49 ± 4 
 
 The majority of 13C13C 2D correlation spectra were acquired at 600 MHz 1H frequency 
and 13.3 kHz MAS. Spectra were acquired with 50 ms of DARR mixing41, 25.6 ms of 
acquisition, and 1280 rows of TPPI phase encoded t1 evolution (dw=12.5 µs). Spectra were 
processed with 50 Hz (F1) and 50 Hz (F2) net Lorenzian-to-Gaussian line broadening for all the 
incubation times, except for some data sets of lower sensitivity, which were processed with 75 
Hz (F1) and 75 Hz (F2) net Lorenzian-to-Gaussian line broadening. 13C13C 2D correlation 
spectra of the 11-day-incubated sample and mature fibrils formed in aqueous buffer were 
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acquired on a 750 MHz 1H frequency and 12.5 kHz MAS. Spectra were acquired with 50 ms 
DARR mixing41, 25.6 ms of acquisition, and 768 rows of States-TPPI phase encoded t1 evolution 
(dw=20.0 µs). Spectra were processed with 30 Hz (F1) and 30 Hz (F2) net Lorenzian-to-
Gaussian line broadening. All spectra, unless indicated otherwise, were acquired at a variable 
temperature (VT) of ca. -6 °C, which corresponded to an actual sample temperature of ca. -3 °C, 
as determined by an ethylene glycol calibration43. This is slightly above the phase transition of 
the lipids in these samples, resulting in optimal resolution and relaxation properties44. 1H 1D 
spectra at VT temperatures from -20 to 10 °C, which correspond to an actual sample temperature 
from ca. -17 °C to ~ 13 °C, were acquired to confirm the POPC:POPA (3:1) phospholipid phase 
transition (Figure 5.1). In the gel phase, 1H linewidths decrease and signal intensity increases as 
the temperature increases. Upon raising temperature through the phase transition and entering the 
liquid crystal phase, the 1H linewidths decrease dramatically.  
 
Figure 5.1. 1H 1D spectra of U-13C, 15N labeled AS, incubated with phospholipids for 11 days.  
(A) Spectrum acquired at a VT temperature of 10 °C (actual sample temperature of ~ 13 °C) with the 1H 
resonance assignments from Holte et al53. (B) Spectra acquired at VT temperatures of -20 °C, -10 °C, 0 
°C and 10 °C (actual sample temperature from ca. -17, ca. -7, ~ 3 and ~ 13 °C) to determine the 
POPC:POPA (3:1) phospholipid phase transition.  
 
 2D 1H spin diffusion 1H-13C experiments9,10 were acquired at 600 MHz 1H frequency, 
13.3 kHz MAS, utilizing several 1H-1H mixing times to assess the polarization transfer 
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dynamics. Spectra were acquired with 20.5 ms of acquisition and 256 rows of TPPI phase 
encoded t1 evolution (dw=10.0 µs) and processed with 100 Hz (F1) and 15 Hz (F2) net 
Lorenzian-to-Gaussian line broadening. 1H spin diffusion 1H-13C spectra were performed with 
the VT gas adjusted to 10 °C, which corresponds to an actual sample temperature of ~ 13 °C, 
significantly above the lipid phase transition, to enable an efficient T2 filter for lipid acyl chain 
1H signals. 
5.4.3 Data Processing and Analysis 
 All spectra were processed with NMRPipe, with back linear prediction and polynomial 
baseline correction in the direct dimension. Zero-filling and Lorentzian-to-Gaussian apodization 
and/or cosine bells were applied for each dimension before Fourier transformation. Peak picking 
and assignments were performed in Sparky45. For quantitative analysis of 2-D spin-diffusion 
spectra, 1H cross sections were extracted from the 2-D spectra for the 13C frequencies ranging 
from 50 to 70 ppm. Peak intensities were plotted as a function of the square root of the 1H-1H 
mixing time (τmix) and corrected for T1 relaxation during the mixing time by multiplication with 
exp(τmix / T1). 
5.4.4 Electron Micrographs 
 Samples for electron microscopy were ultracentrifuged and the supernatant and pellets 
were separated. At this point, both the pellets and supernatant were resuspended in buffer and 
Karnovsky’s fixative was added. Samples were applied to Formvar carbon-coated grids (300 
mesh), negatively stained with 2% ammonium molybdate (w/v) and viewed with a Hitachi H600 
transmission electron microscope (TEM), operating at 75 kV. To ensure uniform vesicles for the 
microscopy measurements, after evaporating the chloroform from the phospholipids mixture, 
these were dissolved in buffer and drawn into a Hamilton (Reno, NV) 1 mL gastight syringe. The 
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syringe was placed in an Avanti Polar Lipids Mini-Extruder and the lipid solution was passed 
through a 0.20 μm Millipore (Billerica, MA) polycarbonate filter 21 times. The newly formed 
vesicles were collected in the syringe that did not contain the original suspension. 
5.5 Results and Discussion 
5.5.1 Characterization of the α-synuclein fibril formation time course in the presence of anionic 
phospholipids 
 
Figure 5.2. Transition from α-helix to β-sheet evidenced by the changes in chemical shifts of AS 
incubated in the presence of phospholipid.  
 
(A) Expanded regions of 13C13C 2D spectra of AS incubated in the presence of phospholipid for: 0, 1, 2, 3, 
6 and 11 days. All contours were drawn at ~ 6 σ. Full 13C13C 2D spectra of samples incubated for (B) 0, 
(C) 1 and (D) 11 days. Expanded regions shown in part A are highlighted in grey. 
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In order to structurally characterize the AS fibril formation time course and monitor the 
transition from a highly α-helical to a β-sheet conformation in the presence of anionic 
phospholipids, six samples were prepared as described in the Materials and Methods section. 
These samples were incubated at 37 °C for defined time periods (0, 1, 2, 3, 6, and 11 days) and 
2D 13C13C NMR spectra were acquired for each sample under identical instrumental conditions. 
A comparison of these spectra, emphasizing the Ala, Thr, and Val spectral regions corresponding 
to the N-terminal (residues 1-60) and NAC (residues 61-98) domains (Figure 5.2A), illustrates 
that early in the time course AS is predominantly α-helical (state 1), based on secondary 
chemical shifts resolved by amino acid type. Ala, Thr and Val residues —all of which are 
prevalent throughout the N-terminal and NAC domains of AS— show exclusively α-helical 
patterns of shifts, consistent with EPR studies12,46,47. After 1 day of incubation, the conversion to 
β-sheet is evident from the change in chemical shifts of the same spin systems (Figure 5.2). 
Further conversion is evident after 3 days of incubation and accompanied by an increase in 
spectral resolution, an indication of a more homogeneous structure. This structural maturation 
continues at the 6 day time point, and after 11 days the peak linewidths and most of the spectral 
fingerprints converge to a state that is predominantly consistent with those of mature fibrils 
prepared by in vitro incubation in aqueous buffer without lipids35. 
These results support the following model of AS fibrillogenesis. The N-terminus and 
NAC domain of AS bind to vesicles with an α-helical conformation (state 1), based on the 
detection of specific residue types only present in this region of the sequence, such as Thr or Val 
(Figure 5.2A, 0 days). Next, AS nucleates and converts into a distinct β-sheet secondary 
structure (Figure 5.2A, 1 day). Specifically, the 13C13C 2D spectrum of the 1 day sample (state 2) 
shows patterns of peak intensities that cannot be accounted for by a superposition of the initial 
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and final states. For example, the Thr CB-CG2, Val CB-CG, and Ala CA-CB regions (Figure 
5.2A) show minimal methyl chemical shift dispersion in state 2; the methyls are all within a 
range of ~ 1 ppm. As the sample matures into a well-ordered fibril with long-range order (Figure 
5.2A, ~ 3-11 days), packing interactions among side chains lead to a greater dispersion of methyl 
shifts, in a manner reminiscent of the distinctive methyl shifts of V50 in the HP35 villin 
headpiece subdomain, which were attributable to tertiary contacts with a ring current effect29,48. 
Side chain packing leads to greater dispersion of methyl 13C shifts, which is what is observed in 
the mature fibrillar state here.  
To ensure that the structural changes only occur during the incubation, not during the 
course of the NMR measurements, we removed excess monomeric AS at the time of trapping 
each sample and collected most solid-state NMR data sets at a sample temperature of ca. -3 oC, 
in comparison to an incubation temperature of 37 oC.  For confirmation, we evaluated the initial 
and final blocks of the 13C13C 2D spectra, which were collected in ~ 3-4 h intervals (Figure 5.3) 
for a total of ~ 50 h. The spectra showed no changes over this time period. We also re-examined 
the 0, 1, and 11 day samples following several months of storage (at -20 oC, except for periods of 
NMR data collection). In the case of the 0 hour incubated sample (state 1), we observed changes 
in the chemical shifts towards state 2 (Figure 5.3B); in contrast, the sample incubated for 1 day 
(state 2) presented unaltered chemical shift patterns for multiple months after the initial data 
collection, corroborating the trapping of this state (Figure 5.3C). These results suggest that the 
conversion of state 2 to mature fibrils might require overcoming a higher energy barrier and/or 
the presence of additional monomer present in the solution to complete the conversion toward 
more mature states. 
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Figure 5.3. Trapped intermediates are stable during prolonger acquisition of solid-state NMR 
spectra.  
 
U-13C, 15N labeled AS incubated in the presence of phospholipids for 0, 1, 2, 3, 6 and 11 days. 13C13C 
2D spectra of each sample was acquired over 54 h. (A) Initial (red) and final (blue) 13.5 h blocks overlaid 
for each time point show that the trapped intermediates were stable during the acquisition of the spectra. 
Spectra were processed with 75 Hz (F1) and 75 Hz (F2) net Lorenzian-to-Gaussian line broadening. 
Overlay of the carbonyl and aliphatic spectral regions (with expansions of the Val, Ala and Thr regions) 
of two 13C13C 2D spectra of U-13C, 15N labeled AS incubated in the presence of phospholipids for 0 (B) 
and 1 days (C). Spectra of the freshly prepared samples are shown in red (with 50 h of total acquisition) 
and spectra of the same samples 3 months (stored at -20 oC) after preparation are shown in black (30 
hours of acquisition time). Expanded regions shown in Figures (B) and (C) are highlighted in grey in the 
full spectra displayed in parts (B) and (C). 
 
 To further investigate AS fibril formation, incubation of AS in the absence of 
phospholipids was conducted at three different incubation times, 0 h, 1 day, and 3 weeks, to 
obtain mature fibrils. In contrast to the initial α-helical state observed in the presence of 
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phospholipids, the 13C-13C 2D spectra of the 0 h incubated sample demonstrates the presence of 
initial β-sheet states (Figure 5.4A). This result is also supported by the electron micrographs 
(Figure 5.5C) with the observation of a few initial oligomer species. Further conversion is 
evidenced after 1 day, as shown by the changes in chemical shifts in the 13C-13C 2D spectra 
(Figure 5.4B). The chemical shifts of this state do not overlap with the initial state or the mature 
fibrils, suggesting the presence of a new state and not a mixture of the initial and final states. 
These findings are in agreement with the changes in morphology observed by EM (Figure 5.5C, 
0 and 1 days), from a few small oligomers initially to many particles with well-defined spherical 
morphology, similar to the intermediate state detected for β-amyloid31. Once mature fibrils are 
formed (Figure 5.5C), linewidths and chemical shift patterns similar to those of the fibrils formed 
in the presence of phospholipid vesicles are observed (Figure 5.4C).  
 
Figure 5.4. Full 13C13C 2D spectra of samples incubated in the absence of phospholipids for (A) 0 
days, (B) 1 day and (C) 3 weeks. All contours were drawn at ~ 6 σ . 
 
 Further comparison of the two fibrillation pathways was performed by comparing the 
electron micrographs at different incubation times in the presence and absence of phospholipids, 
as well as a control experiment with only phospholipids (Figure 5.5). Once AS is added to the 
phospholipid vesicles, perturbation of the phospholipid vesicles is apparent (Figures 5.5, A, B, 0 
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days incubation). After 3 days of incubation, initial linear structures elongating from the vesicles 
are detected in the presence of AS in comparison to the vesicle controls. These results agree with 
the solid-state NMR spectra (Figure 5.2) that exhibit fingerprints of the AS fibril core. Well-
defined fibrillar morphologies can be observed after 6 days of incubation, and a significant 
number of fibrillar species are detected after 11 days (Figure 5.5).  
 
Figure 5.5. Electron micrographic comparison of samples incubated for 0, 1, 2, 3, 6 and 11 days: 
(A) phospholipid controls, (B) AS in the presence of phospholipids and (C) AS in the absence of 
phospholipids. 
 
5.5.2 Structural perturbations found in the N-terminus of fibrils formed in the presence of 
phospholipid vesicles 
An overlay of 13C13C 2D spectra acquired on mature fibrils formed in the absence (blue) 
and presence of phospholipids (red) (Figure 5.6A) shows very good overall agreement, 
indicating that both fibrils have overall a similar fold. Further, similar morphology of the fibrils 
is observed with negative staining TEM, shown in Figure 5.6C, D.  
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Figure 5.6. Comparison of AS fibrils formed in aqueous buffer and in the presence of 
phospholipids.  
 
(A) Overlay of 13C13C 2D spectra (50 ms DARR mixing) of AS fibrils formed in aqueous buffer (blue) 
and in the presence of phospholipids (red). Spectra were collected at 750 MHz (1H frequency). (B) 
Comparison of expanded regions marked in grey showing the shifting of some peaks in certain regions 
for the 13C13C 2D spectra. Residues labeled in bold represent shifting and new peaks are marked with 
arrows. Electron micrographs of AS fibrils formed (C) in aqueous buffer and (D) in the presence of 
phospholipids after 11 days of incubation. Arrows indicate AS fibrils in both images for comparison.  
 
We next performed a complete study of the mature fibril samples, to site-specifically 
compare those incubated in the presence of lipids to those incubated in aqueous buffer. De novo 
chemical shift assignments of the backbone and side chains for the fibrils formed in the presence 
of phospholipid vesicles were obtained (Table 5.2). A sequential backbone walk was conducted 
using multidimensional solid-state NMR experiments, as shown in Figure 5.7A for residues 83-
86. A site-specific comparison of the chemical shifts demonstrates major and minor 
perturbations in the structure. The weighted average chemical shifts for the 13CA and 15NH, given 
by |Δδ | avg (ppm) = {[Δδ2CA + Δδ2NH /(5/2)]/2}1/2,  is shown in Figure 5.7B as a function of residue 
number. These site-specific measurements demonstrate major perturbations (|Δδ|avg ~ 0.2–4.0 
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ppm) in the N-termini and minor perturbations (|Δδ|avg ~ 0.2–0.7 ppm) in residues located in the 
NAC domain. These results are in agreement with the overlaid expansions of the 13C13C 2D 
correlation spectra shown in Figure 5.6B, with shifting of peaks that correspond to residues in 
the N-termini such as S42, T44, or V48.  
Figure 5.7. Secondary structure comparison between AS fibrils formed in aqueous buffer and in 
the presence of phospholipids.  
 
(A) Strip plot from the 3D NCACX, NCOCX and CANCO spectra of U-13C, 15N AS fibrils in the 
presence of phospholipids showing the sequential backbone connectivity for residues 83 to 86. (B) 
Weighted average chemical shift perturbations (|Δδ|avg) for the AS fibrils prepared in the presence of 
phospholipids versus the fibrils prepared in aqueous buffer. Error bars correspond to the chemical shift 
variations from one batch to another of the fibrils prepared in aqueous buffer, as shown in Comellas et al. 
(C) TALOS+ predicted backbone dihedral angles φ and ψ as a function of residue number. Error bars are 
based on the 10 best TALOS+ database matches. (D) Representation of the TALOS+ predicted secondary 
structure of AS fibrils prepared in the presence of phospholipids (top) and in aqueous buffer (bottom) 
(arrows indicate β-strands; curved lines are turn or loop regions; dashed lines indicate no prediction). 
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Table 5.2. 13C and 15N chemical shift assignments of wild-type AS fibrils formed in the 
presence of phospholipids  
 
Residue 15N 13C’ 13CA 13CB 13CG 13CD 13CE 13CZ 15NZ 
G41 115.0 169.6 47.5       
S42 108.6 171.3 58.5 67.4      
K43 - 171.9 - - - - -  - 
T44 121.9 175.4 58.3 71.8 22.6     
K45 123.4 173.8 55.9 - 27.0 - -  - 
E46 126.0 175.1 53.8 34.5 34.5 183.0    
G47 113.1 173.7 49.2       
V48 117.4 174.3 59.3 37.9 20.6/23.7     
V49 127.3 175.1 61.1 34.1 20.6     
H50 126.0 - - - - - -   
V52 - 174.4 61.3 34.0 21.2     
A53 131.0 175.8 49.6 21.4      
T54 121.1 173.0 61.6 71.3 21.1     
V55 126.9 174.9 61.3 34.3 21.3/22.5     
E57 - 175.3 - - - -    
K58 123.3 176.6 54.0 - - - -  - 
T59 121.9 175.2 67.2 67.2 22.4     
Q62 - 176.0 - - - -    
V63 121.9 175.2 61.5 34.7 21.5     
T64 126.8 172.6 62.2 69.2 21.7     
N65 124.8 172.6 51.6 42.9 175.1    115.7 
V66 126.9 178.0 60.7 35.5 20.8/21.8     
G67 110.7 172.5 46.3       
G68 103.2 172.4 43.0       
A69 127.1 175.7 49.8 23.1      
V70 121.2 174.6 60.1 35.8 21.3     
V71 126.5 176.6 60.9 35.4 20.8/21.7     
T72 114.7 175.4 59.7 69.6 21.7     
G73 107.9 173.7 43.8       
V74 124.6 175.3 61.0 35.0 19.5/21.1     
T75 128.1 172.3 61.4 70.3 21.3     
A76 130.1 174.3 49.6 21.2      
V77 123.9 172.9 60.6 35.9 20.6/21.2     
A78 130.3 176.1 49.8 25.0      
Q79 120.8 176.6 52.3 33.0 33.0 177.5   111.9 
K80 123.0 175.8 60.8 33.0 26.9 - 42.2  - 
T81 113.2 173.8 60.8 72.1 22.3     
V82 126.3 174.8 61.1 34.3 21.2/22.2     
E83 126.0 175.2 53.6 33.9 33.9 -    
G84 113.1 173.7 44.7       
A85 130.2 179.7 53.2 18.2      
G86 112.0 173.9 46.4       
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Table 5.2 (cont.) 
 
S87 116.4 173.5 58.7 64.5      
I88 121.7 175.6 60.0 40.5 17.5/27.4 13.6    
A89 129.2 176.9 54.8 18.8      
A90 123.5 174.8 51.2 21.1      
A91 127.9 175.6 49.5 23.0      
T92 125.5 174.6 60.9 69.7 21.8     
G93 115.3 170.0 47.3       
F94 126.5 174.1 54.3 45.1 - - - -  
V95 127.8 171.3 61.0 34.9 20.5/22.2     
K96 133.0 173.2 54.7 - - - -  - 
K97 130.2 175.2 53.8 - - - -  - 
D98 124.3 - 55.0 - -     
A - - 54.0 20.4      
A - - 50.6 18.4      
A - - 52.7 19.4      
A 117.1 - 53.8 17.8      
D/N - - 54.5 41.3 -     
D/N - - 53.6 39.4 -     
D/N 124.3 177.2 54.7 42.9 -     
E/Q (2 residues)* - - 56.8 30.5 36.4 -    
E/Q - - 55.8 29.7 34.0 -    
K  - 176.5 56.7 33.23 25.0 29.2 42.3   
L - - 55.3 42.3 29.2 25.0    
P - - 63.3 32.4 27.5 50.8    
S - 56.4 - 66.7      
V - - 62.8 33.1 21.2/20.7     
 
 
Additionally, the presence of additional structured regions (indicated by arrows in Figure 
5.6B), some with helical chemical shifts or residue types only present in the N-termini, supports 
the idea that the N-terminal domain anchors AS to the lipid bilayer and promotes the formation 
of β-sheet structures in registry throughout the NAC domain19. To test this hypothesis more 
robustly, we conducted 2D 1H-13C experiments with 1H-1H spin diffusion of the sample incubated 
for 0 days (state 1) and 1 day (state 2). Figure 5.8B shows a representative plane for 256 ms 
mixing time; the protein to CH2 lipids and protein to water cross-peaks can be clearly observed at 
the 1H chemical shifts of ~ 1.3 and 4.8 ppm, respectively. Cross-peak intensity for the 13C 
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chemical shifts from 50 to 70 ppm (corresponding primarily to protein signals; this was 
confirmed by DQ filtering experiments) was plotted as a function of mixing time (Figure 5.8A). 
The lipid acyl chain to AS correlations build up much more slowly than those from the water 
signals, consistent with an α-helical state (state 1) bound to the surface of the lipid bilayer. 
Signal patterns are consistent with those amino acid types most prominent in the N-terminal 
domain, and thus these results support the model in which AS is anchored on the surface of the 
lipid bilayer at the initial stages, as represented in Figure 5.9A. However, after 1 day of 
incubation, state 2 shows a similar buildup for the water and the lipid acyl curves (Figure 5.8C), 
suggesting the proximity of AS to the lipid acyl groups, in a manner expected when the protein is 
at least partially embedded in the lipid bilayer (Figure 5.9A). 
 
Figure 5.8. 1H spin diffusion from lipid CH2 chains and water to AS in the presence of 
phospholipids.  
 
1H spin diffusion build-up curves for lipid CH2 chains (red) and water (blue) to AS for samples incubated 
with phospholipids for (A) 0, (C) 1, (D) 2 and (E) 11 days and (B) selected 2D 1H-13C spectrum with a T2 
filter of 1.2 ms and 1H-1H spin diffusion of 256 ms for samples incubated 11 days. Selected cross-peaks 
for the correlations between the acyl chains and water to the protein are marked in red and blue, 
respectively. Data for the build-up curves were corrected for the 1H T1 relaxation. Error bars represent the 
error associated with the integration by NMRpipe of the 2D spectra. 
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Figure 5.9. Schematic representation of the proposed mechanisms for AS fibril formation, (A) in 
the presence and (B) in the absence of phospholipids.  
 
(C) Schematic representation of the different domains of AS and predicted secondary structures of AS 
bound to phospholipids (top, Jao et al. Proc. Natl. Acad. Sci. 2008) and AS fibrils prepared in aqueous 
buffer (bottom, Comellas et al. J. Mol. Biol. 2011). Arrows indicate β-strands; curved lines are turn or 
loop regions; dashed lines indicate no prediction. Essential residues for AS fibrillation (Giasson et al. J. 
Biol. Chem. 2001) are labeled in the residue numbers. 
 
In the absence of phospholipids, the initial state is less accessible to water, as shown by a 
comparison of the water-to-protein correlation trajectories for the two initial states trapped in the 
presence (Figures 5.8 A,C) and absence of phospholipids (Figures 5.10 A,B).  These differences 
further support the presence of different morphologies, as observed in the electron micrographs. 
On the basis of these results, we propose the formation of a hydrophobic core with β-sheet 
secondary structure in the absence of phospholipid vesicles (state 1, without phospholipids) that 
contrasts with the N-termini binding of AS with an α-helical secondary structure with the 
headgroups of phospholipids (state 1, with phospholipids), as represented in Figure 5.9. As AS 
(in the absence of phospholipids) converts to state 2, accessibility to water increases (Figure 
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5.10B). This result is consistent with the stabilization of additional hydrophilic residues in this 
state 2, which is a well-defined sphere in the electron micrographs (Figures 5.5C and 5.9B).  
 
 
Figure 5.10. 1H spin diffusion build-up curves from water to AS for the samples incubated without 
phospholipids for (A) 0 days, (B) 1 day and (c) 3 weeks.  
 
Data for the build-up curves were corrected for the 1H T1 relaxation. Error bars represent the error 
associated with the integration of the spectra by NMRpipe.  
 
In the presence of phospholipids, after further incubation (2 days) the AS is less strongly 
associated with the acyl chains, as evidenced by a slower buildup curve for the lipid-to-protein 
correlation than the water-to-protein correlation (Figure 5.8D). Furthermore, at this point there 
are significant chemical shift changes observed in the 13C13C 2D spectra. After 3 days, the 
electron micrographs show substantial perturbations in the phospholipid vesicles (Figure 5.5B), 
coinciding with the chemical shift pattern indicative of fibrils. Further comparison of the mature 
fibril buildup curves (Figure 5.8E) shows a similar trend for water and the lipids, in addition to a 
slower buildup than mature fibrils formed in aqueous media (Figure 5.10C). We propose that this 
similarity in the buildup curves results from the fibrils being immersed in a network of vesicles 
with substantially perturbed morphology resulting from the fibril formation. 
To further investigate the structural changes in the two final fibrillar states, an empirical 
prediction of the backbone torsion angles was obtained using the 13C (CA, CB and CO) and 15N 
chemical shift assignments and the TALOS+ program49 (Figure 5.7C). TALOS+ predicts the 
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secondary structure (Figure 5.7D) and demonstrates a similar repeated motif in the core of the 
fibrils as for those formed in aqueous buffer35, but with disruption of the longest β-strand from 
the N-termini, where we detect the largest perturbations in the chemical shifts.  
5.5.3 Conformational dynamics of fibrils formed in the presence of phospholipid vesicles 
Our recent investigations of AS fibrils prepared in aqueous buffer35 demonstrated the 
presence of conformational dynamics along the core of the fibrils and showed that the most rigid 
residues included the residues from T64 to K96. This region included residues 71 to 82 that were 
described by Giasson et al.50 to be essential for AS fibril assembly. Considering the structural 
perturbations observed in the N-termini for this fibrillar state versus the fibrils formed in aqueous 
solution, we investigate further whether there were changes in the conformational dynamics 
versus the fibrils formed in aqueous buffer.  
Figure 5.11. Conformational dynamics of AS fibrils formed in the presence of phospholipids.  
(A) Overlay of DP CTUC COSY spectra (4.5 ms) of AS fibrils formed in aqueous buffer (blue) and in the 
presence of phospholipids (red). Residues with perturbations are marked with arrows. (B) TALOS+ 
predicted order parameters S2. (C) Relative peak heights from the cross-peak intensity of the 3D CANCO 
spectrum (numbered according to the carbonyl residue). Residues labeled as (#) correspond to residues 
overlapped in the CANCO experiment. Error bars correspond to the noise level. (D) Representation of the 
TALOS+ predicted secondary structure of AS fibrils prepared in the presence of phospholipids (arrows 
indicate β-strands; curved lines are turn or loop regions; dashed lines indicate no prediction). 
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In a site-specific qualitative manner, we confirmed no major conformational differences 
by performing a 3D CANCO experiment and normalizing the intensities to the strongest signal 
(A90CA-A90N-A89C). Almost all peaks between T64 and K96 had ~ 50% or greater intensity 
on this scale (Figure 5.11C). Therefore, the N-terminus of the fibrils formed in the presence of 
phospholipids is still a weaker signature than the residues located in the NAC domain, as 
previously shown for the fibrils formed in aqueous buffer. Additionally, these fibrils also present 
an overall similar predicted S2 by TALOS+ (Figure 5.11B). To complement these results, direct 
polarization constant cross-peak correlation spectra (DP CTUC COSY)35 were acquired on the 
fibrils formed in the presence and absence of anionic phospholipids (Figure 5.11A) to probe a 
similar structure for the dynamic regions. Overall, our results demonstrate high structural 
similarity between the dynamic regions of the fibrils, indicating only small perturbations (Figure 
5.11). 
5.5.4 Molecular basis of the α-synuclein fibril formation in the presence of anionic 
phospholipids 
Our results demonstrate that the N-terminus and NAC domains of AS bind at the surface 
of the phospholipid vesicles with an α-helical conformation (state 1). After 1 day of incubation, 
we detected state 2 that interacts with the acyl side chains of the phospholipids, which indicates 
embedding of AS in the phospholipid vesicles. After nucleation and formation of the initial β-
sheet species, the sample matured into well-ordered fibrils, as shown by the chemical shift 
fingerprints shown in Figure 5.2. After 3 days of incubation, we observed the presence of well-
resolved peaks that agreed with those of mature fibrils, such as V74, A76, or A78, that are within 
the residues demonstrated by Giasson et al. to be necessary for AS fibril assembly50. Additional 
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peaks that did not change upon longer incubation times are also detected, such as A90 or A91, 
that are among the most rigid residues in the core of AS fibrils. All these residues are located in 
β-sheet regions of mature AS fibrils; this suggests that these are already well-packed by 
intermolecular contacts at this stage of fibril formation. As the fibrils mature, we detect changes 
in the observed correlations of some additional peaks, such as T59 or A85, that are located in 
loop regions of the mature fibrils. These changes could be attributed to a reduction of signal-to-
noise, as T59 has weaker signal intensity in the mature fibrils than V74 or A78. However, A85 
has a similar intensity as V74 in the mature fibrils. Therefore, this suggests that these contacts 
might be stabilized at a later stage of fibril formation.  
5.6 Conclusions 
 In summary, we have captured different states on the pathway of AS structural transition 
from predominantly α-helical conformation to β-sheet fibrils, as indicated by the secondary 
chemical shifts and supported by the morphology changes in the electron micrographs. We have 
compared them to the fibrillation pathway in the absence of lipids. We have also demonstrated a 
similar fold and morphology between fibrils formed in the presence of phospholipid vesicles and 
in aqueous buffer, with major perturbations in the N-terminus and minor perturbations in the 
NAC domain. Our investigations demonstrate that AS binds at the surface of phospholipids with 
an α-helical secondary structure (state 1) and then converts to state 2 with a mostly β-sheet 
secondary structure and a close interaction with lipids. After 3 days of incubation, the nascent 
fibrils (sometimes also referred to as protofilaments) exhibit well-resolved peaks in the solid-
state NMR spectra with key chemical shift signatures that agree with the mature fibrils. As 
fibrillation proceeds, further changes in chemical shifts corresponding to residues located in loop 
   121 
regions are observed, which indicates further stabilization of these regions at a later stage, likely 
due to quaternary assembly of protofilaments. 
 These results provide information at an atomic level on the pathway of conversion from 
the α-helical to β-sheet fibrillar states of AS in the presence of vesicles. By performing de novo 
chemical shift assignments of this fibrillar state, we have demonstrated major perturbations 
(|Δδ|avg ~ 0.2–4.0 ppm) in the N-terminus with partial disruption of the long β-strand located in 
the 40s and small perturbation (|Δδ|avg ~ 0.2–0.7 ppm) in residues located in the NAC domain. 
Despite these structural perturbations, conformational dynamics measurements of this fibrillar 
state show a much weaker signature for the β-strand located in the 40s, compared to the residues 
between T64 and K96. Similar results were observed for the fibrils formed in aqueous buffer35. 
Significantly, we detect the residues with stronger signature to already have the final structure, 
based on their chemical shifts, after only 3 days of fibrillation. 
These investigations will serve as basis for further studies toward understanding how AS 
fibrils lead to the formation of Lewy bodies51, the transmission of aggregates from neuron-to-
neuron52, or the possible disruption of ionic homeostasis of neurons by fibrillar AS in disease23-25. 
Additionally, our results also demonstrate the feasibility and potential of solid-state NMR for the 
investigation of protein misfolding pathways and disease-associated amyloid fibril formation in 
the presence of phospholipids.  
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CHAPTER 6 
Towards the tertiary and quaternary structures of α-synuclein fibrils:  Evidence 
for a water inaccessible core with symmetric packing  
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6.2 Abstract 
 α-Synuclein (AS) fibrils are the main component of Lewy Bodies (LB’s), the 
pathological hallmark of Parkinson’s disease and other neurodegenerative diseases. AS fibrils 
have received intense attention from the scientific community and previous studies have 
proposed the possible arrangement in a β-serpentine fold. However, up to now no high-
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resolution structure has yet been published. Here, we present unambiguous long-range restraints 
(in the amino-acid sequence) observed with the h15Nhh13C and h13Chh13C spectra on 
homogeneous U-15N, 13C labeled samples that disagree with the previously proposed fold. 
Additionally, we examined the fibrils by scanning transmission electron microscopy (STEM) to 
measure the mass-per-length (MPL). The MPL predicts the axial stacking of the monomer 
perpendicular to the fibril axis and shows a 1.12±0.10 subunits per 0.47 nm for AS, which 
provides an important restraint for selecting among the possible family folds. In addition, we also 
present water-to-protein correlation experiments on AS fibrils to elucidate the residues that are 
less water accessible and more likely located in protected parts of the fibril core. Taking together 
all of these results, we propose possible arrangements of the fibrils that demonstrate the presence 
of a water inaccessible core with symmetric packing and comment on ongoing research efforts to 
elucidate the 3D arrangement of AS fibrils. 
6.3 Introduction 
 Parkinson’s disease (PD) is pathologically characterized by the presence of Lewy Bodies 
(LBs), which are insoluble intracytoplasmic aggregates present in neurons. Although the LBs 
were discovered in the early 1900’s1, it was not until 1997 that Spillantini et al.2 discovered that 
the main protein component of LB was fibrillar AS. Additionally, three single point mutations in 
the AS gene3-5 and multiplication of the AS allele6,7 were also correlated to early-onset PD. Since 
then, there has been significant effort by the scientific community on structural studies of AS 
fibrils. Conway et al. demonstrated that AS can form in vitro fibrils with similar morphology to 
the fibrils found in LBs8. Exogenous AS fibrils have been shown to in vivo seed the formation of 
inclusion with analogous morphologies to the LBs9. Recent studies have also suggested that AS 
might indeed propagate the pathology through neuron-to-neuron transmission of aggregates. All 
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these discoveries have brought AS to the center of the PD investigations10. However, how this 
protein leads to the formation of these insoluble aggregates is not yet understood. 
 Early structural investigations of AS demonstrated the presence of a structured core with 
β-sheet secondary structure with an amyloid-like cross-β structure11,12. Initial studies by Fourier 
Transform Infrared (FTIR) spectroscopy suggested a parallel in register arrangement8,13. 
Subsequent FTIR studies detected the presence of antiparallel in register β-sheets that was 
attributed to possible hairpins without ruling out the possibility of the parallel in register β-
strands13. These investigations were followed by EPR studies that demonstrated a central core of 
~70 residues, in agreement with protein K digestion studies12, and suggested a possible parallel 
in register arrangement due to broadening of the signals caused by spin-spin interactions14.  
 AS fibrils are not soluble and do not form diffraction quality crystals, therefore common 
techniques such as solution nuclear magnetic resonance (NMR) or X-ray diffraction cannot be 
used to obtain an atomic-resolution structure. Magic-angle spinning (MAS) solid-state NMR is 
uniquely positioned to achieve such a goal and many solid-state groups, including ours, have 
already conducted structural investigations of the fibrils15-20. Vilar et al. proposed a low-
resolution fold of the fibrils based on previous EPR studies, electron microscopy (EM) and 
relatively limited solid-state NMR data (without distance restraints). On the basis of their 
hydrogen/deuterium (H/D) exchange NMR experiments, they presumed the presence of five β-
sheet strands17. However, as demonstrated by our recent investigations with extensive solid-state 
NMR datasets19, some of the areas that are exposed to the H/D exchange are located in β-sheet 
strands that are more dynamic than other regions, while some loop areas are more protected from 
the H/D exchange and are less dynamic. Therefore, our recent results disagree with that proposed 
model. More recent solid-state NMR investigations of AS fibrils have also shown correlations 
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between the Cα and Cβ of the same residue in different strands, for S42 and S87, using very 
long mixing times18. These results support previous EPR results that suggest the parallel in 
register of AS fibrils. However, it does not yet provide a detailed description of the fibrils 
packing. 
 In amyloid fibrils, β-sheet strands are arranged in parallel or anti-parallel in register in 
order to form the cross-β structure that is directed by the hydrogen bonding between the different 
β-sheet strands. For very short peptides, fibrils would consist of single molecules bound by 
hydrogen bonds to each other along the fibril axis21. However, more complex arrangements arise 
for larger systems of prion domains like Urep2, Sup35, HET-s, Sup35NM or Rnq122-25, or the 
assembly of distinctive monomers perpendicular to the fibril axis in systems like β-amyloid 26-29 
or amylin fibrils30. As previously demonstrated by the HET-s Prion protein31, solving the tertiary 
structure is highly simplified from having the mass-per-length (MPL) ratio. The MPL 
corresponds to the measure of the number of molecules per length of the unit cell along the fibril 
axis, which provides an important constraint for the molecular structure considering that the 
spacing between β-sheet strands is always 0.47 ± 0.01 nm. The MPL ratio can be experimentally 
measured with dark-field scanning transmission electron microscopy (STEM) or tilted beam–
transmission electron microscopy, as previously demonstrated for other amyloid fibrils such as 
β-amyloid25-29, Ure2p22, HET-s24 and Sup35 (Ref. 23). Here, we present the determination of the 
MPL for wild-type (WT) AS fibrils using STEM. Our results demonstrate that the arrangement 
of the AS fibril core is consistent with the arrangement of one molecule per length of the unit cell 
along the fibril axis. Additionally, solid-state NMR experiments on U-15N,13C AS fibrils were 
collected to obtain unambiguous long-range contacts in the amino-acid sequence. Using the 
h15Nhh13C and h13Chh13C spectra, we have demonstrated unambiguous distance restraints that 
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disagree with a possible β-serpentine fold. The detection of single resonances per residue 
demonstrates the symmetric packing of the fibrils repeated along the fibril axis. Additionally, we 
have combined these experiments with water-to-protein correlations to demonstrate water 
inaccessibility to certain regions of the fibrils core using 1H spin diffusion experiments32, as 
previously conducted for other cases33,34. These results support our newly proposed models, and 
disagree with a possible β-serpentine fold. Ongoing work includes the use of mixed and diluted 
samples to obtain unambiguously intra- and inter-molecular restraints. To do so, biosynthetic 
preparation of samples using U-13C-depleted glucose and U-15N-depleted ammonium chloride is 
currently being conducted.  
 These results will constitute the basis for obtaining a detailed description of the AS fibril 
tertiary and quaternary structures. These structures are considered to be significant as they will 
assist in future structural studies and in drug development for PD for the reduction or elimination 
of AS aggregates, as well as in biomarker design for early diagnosis, monitoring disease 
progression and effectiveness of new drugs in vivo.  
6.4 Materials and methods 
6.4.1 AS expression and purification 
 WT AS was expressed, purified and used to prepare fresh AS fibrils, as previously 
described35. Different labeling schemes were used or are in preparation for the present study: (i) 
natural abundance, (ii) Uniform (U)-13C, 15N, (iii) U-13C, 15N: U-12C, 14N (1:3) and U-13C, 14N: 
U-12C, 15N (1:1). The last sample is currently being prepared by using 13C depleted D-glucose for 
the preparation of the U-12C, 15N sample and 15N depleted–ammonium sulfate for the preparation 
of the U-13C, 14N sample in order to minimize the contribution of the 13C and 15N isotopes, 
respectively. 
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6.4.2 Preparation of the fibrils for solid-state NMR 
 After ultracentrifugation, the pellets containing the WT AS fibrils were washed with 
water, dried under N2 gas and rehydrated, as recently described19. 
6.4.3 Preparation of the fibrils for TEM and STEM  
 After ultracentrifugation, the pellet was resuspended in 20 mM HEPES buffer (pH 7.4, 
0.02 % sodium azide and 0.1 mM EDTA) and ultracentrifuged. This cycle was repeated several 
times and the final solution was sonicated (600 volts, 5 Amps.) three times using 1 min. pulses.  
6.4.4 Transmission electron microscopy 
 Negatively stained AS samples for transmission electron microscopy (TEM) were 
prepared by resuspending the fibrils in 20 mM HEPES buffer (pH 7.4, 0.02 % sodium azide and 
0.1 mM EDTA), Karnovsky’s fixative was added and a drop was placed over Parafilm. A 
formvar carbon coated grid (300 mesh) was positioned face down on the drop for 15 min to 
absorb the fibrils. The grid was then placed for 2.5 min in a drop of 0.2 % ammonium molybdate 
(w/v) for negative staining, wicked in a drop of water and allowed to dry. Electron micrographs 
were recorded in a Hitachie H600 Transmission Electron Microscope, operating at 75 kV. 
6.4.5 Scanning transmission electron microscopy 
 AS samples for STEM were prepared using the wet film approach with freeze-dried 
specimens according to the standard methodology of the Brookhaven STEM facility 
(www.biology.bnl.gov/stem/stem.html), which is described as follows. 2.3 mm titanium grids 
were coated with thick holey carbon film that supported a thin carbon film. The thin carbon film 
was prepared by ultra-high vacuum evaporation onto a freshly cleaved crystal of rock salt and 
floated on a dish of clean water to avoid unspecific absorption of material. Grids were then 
positioned face down on the floating thin carbon films and picked such as the thin carbon film 
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retained a droplet of water. This water was exchanged by washing by injection buffer containing 
2 µL of tobacco mosaic virus (TMV) as quantitative internal control at a concentration of 100 
µg/mL, incubated for 1 min and washed four times. Three different grids were prepared by 
adding 2 µL of AS fibrils at the concentrations of 120 µg/mL, 300 µg/mL and 1200 µg/mL in 20 
mM HEPES buffer, respectively, incubated for 1 min and washed ten times with the buffer and 
water. After the final wash, the grid was pinched between two pieces of paper filters and 
immediately plunged into liquid nitrogen slush. The grids were then transferred under liquid 
nitrogen to an ion-pumped freeze dryer with an efficient cold trap, freeze-dried overnight by 
gradually warming to -80°C and transferred under vacuum to the STEM. Dark-field micrographs 
were recorded on a custom-built Phillips STEM, operating at 40 kV, with a probe focused at 0.25 
nm and a sample temperature of -150°C. 
 6.4.6 Mass-per-length measurement and analysis of the STEM images 
 Dark-field STEM micrographs with 512 x 512 points and a dwell of 30 µs per pixel were 
analyzed using the PCMass software available from the Brookhaven STEM resource 
(http://www.bnl.gov/biology/stem/Data_Analysis.asp)36. The MPL measurements were 
conducted using boxes of 30 nm length and the appropriate widths for TMV determined by the 
21root model and 55amyloid fitting functions, respectively, from PCMass31. The resulting data 
was normalized to the known MPL of TMV (131.4 kDa/nm). Histograms of the AS fibrils MPL 
measurement were calculated with 1-kDa/nm bins and the main peak was fitted to a Gaussian 
distribution using the Marquardt-Levenberg algorithm, as implemented in Sigma Plot (Systat 
Software).  
6.4.7 Solid-state NMR spectroscopy 
 MAS solid-state NMR experiments were performed using a 11.7 T (500 MHz) Wide 
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Bore VNMRS spectrometer (Varian NMR) equipped with a 3.2-mm Varian BalunTM probe, a 
14.1-T (600 MHz) Narrow Bore Varian Infinity Plus spectrometer with a 3.2-mm T3 Varian 
tuned to double resonance mode for 1H and 13C frequencies and a 17.6-T (750 MHz) Wide Bore 
VNMR spectrometer with a Varian 3.2-mm Balun™ 1H–13C–15N probe. Varian is now part of 
Agilent Technologies (Santa Clara, CA and Loveland, CO). All experiments were performed at a 
variable-temperature (VT) gas adjusted at 10 °C, which corresponds to an actual sample 
temperature of ~13 °C based on ethylene glycol calibration37. All experiments utilized tangent 
ramp cross-polarization (CP)38. SPINAL-64 1H decoupling was applied during acquisition and 
evolution periods with a field strength of ~75 kHz39,40. Polarization transfer between 13C and 13C 
was performed using DARR41. Chemical shifts were referenced externally with adamantane 
(assuming the downfield peak of 40.48 ppm)42. 
 6.4.8 NMR data processing 
 All spectra were processed with NMRPipe with back linear prediction and polynomial 
baseline correction in the direct dimension. Zero filling and Lorentzian-to-Gaussian apodization 
and/or cosine bells were applied for each dimension before Fourier transformation. Peak picking, 
assignments and peak height measurements were performed in Sparky43. 
6.5 Results and discussion 
6.5.1. Symmetric packing of the AS fibrils core   
 As shown in Figure 6.1A, the resonance assignments displayed in the 13C13C two-
dimensional (2D) spectrum (based on our recently published assignments19) demonstrate single 
resonances for each residue site for AS fibrils. This result reveals the symmetric arrangement of 
AS in the fibrils, as previously described for HET-s31, which represents an important constraint 
to consider for the possible tertiary and quaternary arrangements of the fibrils.  
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Figure 6.1. Symmetric packing of AS, as demonstrated by the single set of solid-state NMR 
resonances, and repetition of the amino-acid types within the core.  
 
(A) 13C13C 2D MAS solid-state NMR spectrum of AS fibrils acquired at 750 MHz 1H frequency, 12.5 
kHz MAS and 50 ms DARR mixing. Labeled by residue number and atom according to the 13C 
frequencies, based on Comellas et al.19. (B) Plot of the number of residue types founds in the AS fibrils 
core (residues 38-97), based on Comellas et al.19. 
 
6.5.2. Determination of long-range unambiguous distances for AS fibrils  
 Long-range unambiguous restraints constitute one of the most important sources of 
information towards investigating the fibrils’ fold. However, determination of long-range 
distances for AS fibrils has been demonstrated to be significantly challenging. Not only are AS 
fibrils significantly larger than all the previous amyloid structures solved by solid-state NMR 
(and described in Chapter 1)21,31,44-47, but they also have significant conformational dynamics (as 
demonstrated in Chapter 4) and repetition in the amino-acid sequence (Figure 6.1B) that has 
made previous identification of unambiguous long range distances very difficult. After several 
attempts to obtain long range distances by different solid-state NMR methods, we decided to 
implement a previously published pulse sequence that would allow rapid through space (1H,1H) 
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polarization transfers to detect non-trivial proton-proton contacts by minimizing the relaxation 
losses48. This experiment was based on the idea that proteins have high abundance proton-proton 
distances in close contact that can be essential for protein folding.  
 We implemented this pulse sequence as h13Chh13C and h15Nhh13C experiments, where 
the (1H,1H) zero-quantum (0Q) longitudinal transfer step was enclosed by a set of two short (t
NH
 
or t
CH, tCH) heteronuclear CP segments that ensure polarization transfer within NH or CHx groups 
only48. As demonstrated in Figure 6.2A, the h13Chh13C version of this experiment tested on GB1 
provides unique proton-proton contacts with minimal degeneracy for their assignments. For 
instance, the experiment provides unique unambiguous restraints (considering ~0.2 ppm 
uncertainty) between different β-strands for GB1 (Figure 6.2B). These results contrast with the 
restraints that would be obtained from the commonly employed DARR mixing41 based 
experiment (Figure 6.2C). In this case a significant number of restraints between neighboring 
residues result from the 1H CW irradiation to fulfill a rotary-resonance condition and transfer the 
polarization from 13C’s to other 13C’s. This experiment requires long mixing times to observe 
long-range distances and makes the unambiguous assignment of long ranges distances more 
challenging. Based on the GB1 results, we could use this experiment to permit detection of some 
unambiguous long-range restraints for AS fibrils. However, one important consideration 
resulting from the GB1 spectral analysis is that several intermolecular restraints were observed. 
Therefore, in addition to the homogeneous labeling scheme, other labeling schemes will be 
necessary to unambiguously identify if these are intermolecular or intra-molecular restraints for 
AS.  
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Figure 6.2. Unambiguous identification of long-range restraints between different β-strands for 
GB1.  
 
(A) Overlay of a 13C13C 2D (25 ms DARR mixing, red) and h13Chh13C 2D (150 µs 1H-1H mixing, blue) 
MAS solid-state NMR spectra of GB1. Residues are labeled residues by number and atom according to 
the 13C frequencies published by Franks et al.49. Grey labels correspond to intra-residue correlations and 
black labels correspond to some unique long-range restraints from the h13Chh13C. (B) Some of the unique 
unambiguous restraints between different β-strands detected in the h13Chh13C experiment for GB1 are 
displayed on the pdb structure 2QMT50. (C) Overlay of a 13C13C 2D (25 ms DARR mixing, red) and 
13C13C 2D (500 ms, blue) MAS solid-state NMR spectra. All spectra were acquired at 750 MHz 1H 
frequency and 12.5 kHz MAS. 
  
 The acquisition of the h13Chh13C and h15Nhh13C experiments (Figure 6.3 A,B) provided 
unique unambiguous long-range correlations on the homogeneous U-13C,15N AS fibrils. These 
include restraints like I88 to K43, K80 to G47 and A48 to A78 among other restraints as 
displayed in Figure 6.3C that would not agree with the proposed β-serpentine arrangement. 
Distance restraints, such as A69 to G93, could support the presence of a possible hairpin, as 
suggested by EPR14, between the β-strands in the 70s and 80s-90s. Several additional ambiguous 
restraints (considering a 0.2 ppm uncertainty19) were also detected and would include possible 
correlations that would be consistent with possible arrangements of AS supporting these 
unambiguous long-range restraints. 
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Figure 6.3. Determination of unambiguous long-range restraints between different β-strands of AS 
fibrils.  
 
(A) h13Chh13C 2D MAS solid-state NMR spectrum of AS fibrils acquired at 500 MHz 1H frequency, 11.1 
kHz MAS and 180 µs 1H-1H mixing. (B) h15Nhh13C 2D MAS solid-state NMR spectrum of AS fibrils 
acquired at 750 MHz 1H frequency, 12.5 kHz MAS and 320 µs 1H-1H mixing. Labels based on the 
residue number and atom according to the 13C frequencies by Comellas et al.19. Bold labels correspond to 
unambiguous long-range distances. (C) AS core sequence. Red-labeled residues correspond the β-strand 
regions and lines to the unambiguous long-range restraints. 
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 Based on these correlations, reanalysis of previous datasets were conducted and it was 
found that some of the weak correlations agree with the unambiguous long-range correlations. 
For example, the 13C13C 2D experiment with 250 ms DARR mixing acquired at high field and 
displayed in Figure 6.4 shows the G47 to A78 correlation. Significant correlations to the 
neighbors are detected in this experiment, as already demonstrated for the protein GB1. For AS 
several correlations were detected specially in the area around residues A85 to A91 that 
combined with the TALOS+ results (Chapter 4) support the presence of a tight loop between the 
two β-strands in the 80-84 and 91-97 (Figure 6.5A). Several correlations are also observed for 
the residues between A78 to K80 that are also located in a loop region. In addition, we acquired 
the h13Chh13C experiment on A30P AS fibrils for which we have recently demonstrated adopts 
the same structure as the WT51. However, the quality of the datasets for this mutant has always 
been somewhat superior, probably due to stabilization on the N-termini. In this case, we detected 
the same unambiguous distances, but we further confirmed the K43 to I88 correlation by not 
only detecting the correlations to the K43CD and K43CE, but also to the K43CG site.  
 All of these unambiguous restraints suggest the proximity of the β-strands located in the 
80s-90s somewhat close to the 40s, which would not agree with an intramolecular restraint 
present in a β-serpentine fold (Figure 6.5F). Although one could envision the possibility of being 
an intermolecular restraint for this fold, the β-strands displayed in orange and yellow would be 
found in different environments. As a result, we would not obtain a single peak per residue, as 
demonstrated in Figure 6.1A. Taken all these results together, several other possible 
arrangements are proposed in Figure 6.5 B-E that would satisfy these long-range restraints and 
the symmetry requirements leading to a single set of chemical shifts. Considering the challenges 
that we encountered towards obtaining these unambiguous restraints, we decided to pursue 
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further structural investigations using dark-field STEM in order to combine them with the solid-
state NMR restraints.  
 
Figure 6.4. Additional measurements support the unambiguous long-range restraints between 
different β-strands for AS fibrils. 
 
13C13C 2D MAS solid-state NMR spectrum of AS fibrils acquired at 900 MHz 1H frequency, 12.5 kHz 
MAS and 250 ms DARR mixing. Labels based on the residue number and atom according to the 13C 
frequencies by Comellas et al.19. Bold labels correspond to an unambiguous long-range distance. Dashed 
lines in orange shown support the assignment of the long-range distance and blue shown the correlations 
in the loop regions. 
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Figure 6.5. Secondary structure of AS fibrils and possible models based on the unambiguous long-
range restraints and disagreement with the β-serpentine arrangement.  
 
(A) Secondary structure of AS fibrils based on Comellas et al.19 Arrows indicate β-strands; curved lines 
are turn or loop regions; dashed lines indicate no prediction. (B-F) Possible models of the AS fibril 
arrangements. Green lines correspond to long-range restraints that satisfy possible intra-molecular 
correlations. Blue lines correspond to long-range restraints that satisfy possible inter-molecular 
correlations. Red lines correspond to long-range restraints that would not satisfy possible intra-molecular 
correlations.  
 
6.5.3. Mass-per-length measurement of AS fibrils  
 Using bright-field negatively stained TEM images (Figure 1A), we measured the fibril 
width that corresponds to 4.6 ± 0.4 nm. Our previous investigations using MAS solid-state 
NMR19 demonstrated that the core of AS fibrils presents short and long β-sheet strands of ~4-6 
and ~12 residues, which would correspond to ~1.4-2.1 and 4.2 nm, respectively. Considering the 
uncertainty of the TEM images and the contributions from the flexible regions, the longest strand 
would be in agreement with the width measurements.  
 Investigations of the monomer arrangement in the fibrils were conducted by the MPL 
measurement. As displayed in Figure 6.6C, this measurement can distinguish the possible 
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arrangement of the fibrils in a β-serpentine or other arrangements with one molecule per length 
of the unit cell along the fibril axis, versus a β-solenoid, domain swap or other similar 
arrangements. As described in the Materials and Methods section, AS fibrils were prepared for 
the STEM images and datasets were acquired and analyzed. Our results show the distribution of 
more than one peak, which were fitted to single Gaussian functions (Figure 6.6D). Based on the 
measurement of the MPL for several other systems following exactly the same sample 
preparation method, the peak with lowest ratio usually corresponds to the single fibril, as 
demonstrated for Urep222, Yeast prion23 and HET-s24. This was further confirmed by the width 
measurement along the fibrils axis, as previously conducted for HET-s24. Considering the mass 
of a subunit of AS (14.4 kDa) and this result, this would lead to 1.12 ± 0.10 subunits per 0.47 nm 
(Figure 6.6C, Table 6.1) that supports the models with one molecule per length of the unit cell 
along the fibril axis (B,D,F) and not models C or E.  
 In order to perform the MPL measurement, the sample preparation was optimized to 
minimize the salt concentration by washing our fibrils with HEPES buffer. To ensure that the 
fibril structure was not changed upon the preparation for STEM samples, we evaluated the 
chemical shifts of U-13C, 15N AS fibrils prior to and after the washing step (Figure 6.6E). First, a 
solid-state NMR spectrum was acquired on the sample prepared as previously described19 
(Figure 6.6F, spectrum in red). After acquiring this first spectrum, the rotor was unpacked and 
the fibrils were washed with 20 mM HEPES buffer several times, as described in the Material 
and Methods section for the STEM samples (6.4.3). The sample was then dried and packed into 
the NMR rotor and re-hydrated, as previously described19. A 13C13C 2D spectrum was collected 
on this sample to demonstrate that no perturbation in the structure was caused upon its 
preparation for STEM and their chemical shifts were compared (Figure 6.6E). Therefore, the 
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MPL can be directly correlated to the solid-state NMR results, as the structures are 
indistinguishable based on our solid-state NMR analysis. 
 
Figure 6.6. Mass-per-length (MPL) measurement of AS fibrils.  
 
Bright-field of negatively stained samples and (B) dark-field unstained STEM. Single-headed arrows 
indicate examples of fibrils. Double-headed arrows indicate tobacco mosaic virus (TMV) rods. (C) 
Representation of the possible arrangements of AS fibrils depending on the MPL. (D) Histogram of the 
distributions of the STEM MPL measurement of unstained, freeze-dried, specimens of AS fibrils. 
Gaussian distributions were fitted to the histogram; black arrows indicate the position of each peak. (E) 
Chemical shift comparison of the fibrils as prepared for solid-state NMR and after washing with HEPES 
buffer for electron microscopy. (F) Expansions of overlaid 13C13C 2D’s of U-13C, 15N AS fibrils as 
previously prepared for solid-state NMR (red) and fibrils washed with HEPES buffer as the samples for 
electron microscopy (blue). Spectra were acquired at 600 MHz 1H frequency, 13.3 kHz MAS and 50 ms 
DARR mixing. 
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Table 6.1. MPL measurement of unstained AS fibrils by STEM. Standard deviations were 
calculated from the width of the Gaussian fits 
 
MPL (kDa/nm) * Relative amount of 
observed species 
Subunits/0.47 nm (for multiple fibrils, 
measured density was divided by number 
of single fibrils) 
34.45 ± 2.95 (singlet) 
61.29 ± 3.04 (doublet) 
87% 
13% 
1.12 ± 0.10 
1.00 ± 0.10 
 
 
6.5.4 Unambiguous determination of the inter- and intra-molecular restraints 
 To further investigate the arrangement of the fibrils, different labeling schemes were 
considered to distinguish between intra- and inter-molecular restraints. By labeling AS fibrils as 
U-13C, 15N: U-12C, 14N (1:3) (Figure 6.7A), only intra-residue constraints would be detected due 
to the dilution of U-13C, 15N monomer with natural abundance material. While labeling them as 
U-13C, 14N: U-12C, 15N (1:1) (Figure 6.7B) would only provide inter-residue constraints due to 
the mixed labeling scheme.  
 
 
Figure 6.7. Representation of the expected restraints for homogeneous versus (A) diluted and (B) 
mixed samples. 
 
The labeling schemes include (A) U-13C, 14N: U-12C,15N (1:1) and (B) U-13C, 15N: U-12C, 14N (1:3) 
 
 Initial investigations were conducted with mixed labeled samples. However, ambiguous 
results were obtained as a consequence of (i) residues detected in the termini due to use of [2-
glycerol]-13C and [1,3-glycerol]-13C labeling schemes for the 13C labeling and (ii) possible 
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contributions from the natural abundance 13C and 15N isotopes. In order to overcome these 
challenges, ongoing research that I am currently conducting includes the sample preparation 
using 15N-depleted NH4Cl, instead of natural abundance NH4Cl, that would remove the ~0.37% 
natural abundance of 15N isotope and 13C-depleted D-glucose to overcome the ~1.11% 
contribution of the 13C isotope. We expect that the application of the h15Nhh13C and h13Chh13C 
experiments on the mixed and diluted samples, respectively, will provide further information on 
the arrangements of the fibrils, as we will be able to unambiguously determine if these long-
range correlations are inter- or intra-molecular restraints. 
6.5.5 AS fibrils have a water inaccessible core  
 Additional investigations of the AS arrangement was conducted by using water-to-protein 
solid-state NMR correlation experiments in order to obtain site-specific information about the 
regions that are exposed to water. Using (1h)13C13C 2D correlation experiments32,33,52, the 1H 
magnetization from water was selected by a T2 filter, and then transferred to the 1H spins of the 
protein via 1H spin diffusion, during the tH-Hmixing period. After this mixing period, the 1H 
magnetization was transferred to the 13C spins of the protein using cross-polarization. To do so, 
the 1H spin-spin relaxation constant (T2 ~ 1.5 ms, Figure 6.8A) of the water molecules was 
measured to set the T2 filter. The 1H-1H spin-diffusion mixing times were selected based on 1D 
hC spectra trajectory as a function of the square-root of the 1H spin-diffusion mixing time 
(Figure 6.8C). Additionally, a 1H spin diffusion HC 2D control spectrum was acquired and 
revealed that the only source of 1H spin diffusion was water; therefore, no polarization coming 
from the 1H spins of mobile regions of the fibrils was detected (Figure 6.8B).  
 Based on the spin diffusion trajectory, two different 1H-1H mixing times were selected (5 
and 10 ms) to conduct the 2D (1h)13C13C  experiments with a 50 ms DARR mixing time. The 
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resolved cross-peaks from both experiments were integrated and the ratios of the integrals from 
the 2D (1h)13C13C and a 2D 13C13C  experiment were measured, providing site-specific 
information on the residues that in a water inaccessible core (Figure 6.8E, residues marked in 
orange). These experiments demonstrate the regions that are more protected within the core of 
the fibrils, which are in agreement with the residues whose chemical shift assignments were 
demonstrated to not be affected between fully hydrated and dried fibrils53. These correspond to 
the residues that were recently demonstrated to be the ones that stabilize sooner during the fibril 
formation in the presence of phospholipid vesicles54. Additionally, these residues are located 
inside the core of the fibrils in the two proposed models that satisfy the long-range unambiguous 
restraints and MPL (Figure 7.6 C and E).  
 
Figure 6.8. Water accessibility of AS fibrils based on 1H spin diffusion experiments. 
 
Ratios of the integrals for the resolved peaks in the 2D (1h)13C13C (with T2 filter to select the 1H 
polarization from water and 1H-1H mixing versus the peaks in the 2D 13C-13C experiment on U-13C, 15N 
WT AS fibrils using (A) 5 ms 1H-1H mixing and (B) 10 ms 1H-1H mixing. Error bars are the absolute 
uncertainty of the intensity ratios based on the square root of the sum of squares of the noise levels of the 
13C peaks in the 2D spectra multiplied by the ratio.  
 
6.6 Conclusions 
 Unambiguous long-range restraints (in the amino-acid sequence) were detected on 
homogeneous U-15N, 13C labeled AS fibrils samples using the h15Nhh13C and h13Chh13C 
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experiments, which disagreed with the previously proposed β-serpentine model. Considering 
these restraints and the recently described secondary structure of the fibrils, several possible 
models were proposed for the tertiary arrangements of the fibrils. Solid-state NMR was 
combined with STEM to measure the MPL of the fibrils that corresponds to 34.45±2.95 (for 
singlets), which is equivalent to 1.12±0.10 subunits per 0.47 nm for AS. This result demonstrates 
the arrangement of one molecule per length of the unit cell along the fibril axis that imposes a 
stringent constraint to the AS fold and the proposed models. In addition, water-to-protein 
correlation experiments were acquired on AS fibrils to elucidate the residues that are less water 
accessible and located in protected parts of the fibril core. Taking together all of these results, we 
propose possible arrangements of the fibrils that satisfy all of these results and support the 
presence of a water inaccessible core with symmetric packing. Ongoing research efforts will help 
to further elucidate the 3D arrangement of AS fibrils.  
 These results will serve as basis for future structural investigations of PD that will assist 
in the development of brain imaging biomarkers for diagnostics and evaluation of disease 
progression. The design of biomarkers for PD has become the center of many investigations, as 
evidenced by the Parkinson’s Progression Markers Initiative (PPMI) or the Parkinson’s Disease 
Biomarkers Identification Network (PD-BIN). As described by Montine55, the clinical potential 
of AS biomarkers in early diagnosis of PD and other neurodegenerative diseases might guide 
future clinical trials and the assessment of the disease progression. This has already demonstrated 
by the successful achievements obtained with β-amyloid in Alzheimer’s disease56-58, with the 
design of radioligands that bind selectively to β-amyloid for the in vivo assessment of the 
severity of the disease and/or effectiveness of drug that aims to reduce amyloid plaques. 
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However, further high-resolution structural information of the AS structure is necessary in order 
to site-specifically design radioligands for this protein system. 
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CHAPTER 7 
Towards de novo  3D structure determination of large proteins using solid-state 
NMR restraints 
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7.2 Abstract 
 Magic-angle spinning (MAS) solid-state NMR is the only technique currently available 
to obtain high-resolution structures of amyloid fibrils or membrane proteins in the presence of 
physiologically relevant lipids. Significant advances in the last decade have made possible the 
determination of 3D high-resolution structures of peptides and protein with this technique (see 
Chapter 1). However, significant challenges are still encountered when solving the structures of 
large proteins. This study investigates the incorporation, for the first time, of solid-state NMR 
chemical shifts and structural restraints into a new CS-Rosetta protocol to facilitate the structure 
determination of large proteins. Our results demonstrate, even in the absence of complete 
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restraint datasets, significant improvement in the models obtained by CS-Rosetta, specifically 
with the incorporation of high-resolution TEDOR 15N-13C distance restraints. 
7.3 Introduction and initial tests 
Solid-state NMR has emerged as a novel technique in structural biology, capable of 
solving structures of amyloid fibrils, as well as membrane proteins or large protein complexes in 
the presence of physiologically relevant lipids. The study of these systems requires overcoming 
the challenges imposed by a high degree in chemical shift degeneracy that compromises the 
determination of unambiguous distance restraints. Therefore, in order to solve 3D structures of 
these systems, advancements in the computational approaches for the structure determination 
methods will be necessary. Here we present the incorporation of solid-state NMR chemical shifts 
(CS) and other structural restraints into the program Chemical-Shift Rosetta (CS-Rosetta)1 in 
collaboration with the group of Prof. David Baker, who developed this program.  
CS-Rosetta is a robust protocol that employs isotropic CS, in combination with additional 
datasets for complex systems2, to obtain de novo protein structures from solution NMR datasets. 
CS-Rosetta utilizes SPARTA-based selection3 of protein fragments from the protein structures 
database in conjunction with Monte Carlo assembly and relaxation procedures, for pre-filtering 
of the fragment selection process. Within this methodology, the ambiguous restraints can be 
included in the re-scoring step, subsequently filtering Rosetta models for those that satisfy the 
NMR data. Incorporating the high-precision data available from solid-state NMR into the pre-
filtering step will restrain the fragments available to Rosetta during the fragment replacement 
procedure, with the possibility of also including the data during the assembly and relaxation step. 
The incorporation of these datasets is expected to drastically cut computational time and open the 
possibility to address significantly larger systems than CS-Rosetta is currently configured.  
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Figure 7.1.  CS-Rosetta protocol for de novo 3D structure determination using solid-state NMR   
(A) Schematic representation of the newly developed solid-state NMR CS-Rosetta protocol. (B) [2-
glycerol] 13C, U-15N GB1 13C13C 2D spectra with 300 ms DARR mixing time with ambiguous 
correlations due to the peaks overlap. (C) Plots of rescored Rosetta all-atom energy versus 13CA RSMD 
relative to the GB1 structure reported in Franks et al by using the ambiguous restraints from the 100ms 
and the 300ms mixing time 13C13C 2D, respectively. 
 
Previous investigations of large proteins by solution NMR have demonstrated as 
significant improvement in the convergence of CS-Rosetta through the utilization of ambiguous 
NMR distances4. Therefore, we anticipate that the incorporation of solid-state NMR restraints in 
CS-Rosetta will also considerably improve its convergence. Initial tests were pursued using 
ambiguous solid-state NMR distance restraints from the microcrystalline protein GB1 for the 
fragments selection and scoring function within CS-Rosetta. Ambiguous restraints were obtained 
from 13C13C 2Ds spectra with 100 ms, 300 ms and 500 ms DARR mixing time5 acquired at 750 
MHz 1H frequency from [2-glycerol]-13C, U-15N and [1,3-glycerol]-13C, U-15N samples. The 
spectrum shown in Figure 7.1B (300 ms DARR mixing) highlights the 13CA-13CA region of the 
[2-glycerol]-13C sample, an area of high-ambiguity at longer mixing times due to the relative lack 
of CS dispersion of the 13CA carbons. The application of this methodology yielded full atom 
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models with small RMSDs compared to experimentally determined X-ray or NMR structures, 
even without using the CS. This is displayed in the plot of Figure 7.1C for the re-scored Rosetta 
full-atom energies of all models with respect to their 13CA RMSD values relative to the GB1 
published structure6.  
Additionally, we also tested the incorporation of high-resolution solid-state NMR 
restraints, in the form of ZF-TEDOR 15N-13C distances7 (that we will refer as 15N-13C TEDOR 
distances). We tested this procedure by comparing the results obtained by only using the CS and 
with the incorporation of both restraints (15N-13C TEDOR distances and CS) at the same time. As 
displayed in Figure 7.2B, significant improvement was obtained with the incorporation of both 
restraints, CS and 15N-13C TEDOR distances, when compared to the regular protocol that 
included only CS.  
 
Figure 7.2. (A) Crmsd for the computed models of GB1 using TEDOR 15N-13C distances, Chemical 
shifts (CS) and both restraints simultaneously versus the structure solved by Franks et al. using 
solid-state NMR restraints and simulated annealing6. Comparison of the histograms for the 
structural models obtained (B) without and (C) with the TEDOR 15N-13C distances restraints. 
 
 
Based on the successful results of these initial tests, we decided to apply 13C13C, 15N-13C 
TEDOR distances and Chemical Shift Tensors (CST) to several proteins (ubiquitin, RrR43, 
   155 
StR65, CcR55, HR4394C, ER553, HR41 and DsbA) that ranged from 75 to 189 residues, as 
shown in Figure 7.3. As the number of ambiguous restraints increases, approximately as the 
square of the total number of residues, the challenges for solving these 3D structures 
significantly increase. These 9 proteins, whose structures are already known by X-ray 
crystallography and CS by solution NMR, constituted an excellent set to develop and test the 
methodology for 3D protein structure determination of large proteins using solid-state NMR 
restraints and CS-Rosetta.  
 
Figure 7.3. Selected proteins for the project and ordered by protein size (number of residues) 
 
GB1 (β1 immunoglobulin binding domain of protein G), UBQ (ubiquitin), RrR43*, StR65*, CcR55*, 
HR4394C*, ER553*, HR41* and DsbA. *Proteins from the NESG consortium (http://www.nesg.org/). 
 
7.4 Materials and Methods 
 
7.4.1 Simulation of the restraints 
 Simulation of 13C13C distances (experimentally obtained from 13C13C 2D spectra with 
DARR mixing), 15N-13C TEDOR distances (experimentally obtained from pseudo-3D TEDOR 
15N-13C spectra) and CSTs (experimentally obtained from a pseudo-3D 15N-13CA spectrum) were 
obtained by using the deposited PDB structures of the selected proteins. The selected PDBs 
included: 2kQ4.pdb for GB1, 2JZZ.odb for UBQ, 2K0M.pdb for RrR43, 2JN8.pdb for StR65, 
2JQN.pdb for CcR55, 2KK0.pdb for HR4394C, 2K1S.pdb for ER553, 2K07.pdb for HR41 and 
1A2J.pdb for DsbA. 
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7.4.1.1 13C-13C distances 
Via scripts written in house, all 13C atoms within the distances and errors described in 
Figure 7.4A (selected based on the distance and error values previously described by Franks et 
al.6) were measured. These measurements included all the possible distances without taking into 
account the labeling scheme or ambiguous restrains due to spectral degeneracy. This is an 
important consideration for large proteins, especially if one does not use multidimensional 
experiments due to problems with sample sensitivity.  
 
Figure 7.4. Schematic representation of the methodology used for the simulation of (A) 13C13C 
distances and (B) 15N-13C TEDOR distances from 2D spectra. 
 
After simulating the distances, the output lists were converted into frequencies lists using 
the CS, which were used to create lists of ambiguous and unambiguous distances (by accounting 
for a 0.15 ppm uncertainness). Solution NMR CS’s were used in cases where no solid-state 
NMR datasets were available. In this process, the labeling schemes were also considered: (a) 
Uniform (U)-13C, 15N; (b) [2-glycerol]-13C, U-15N and (c) [1,3-glycerol]-13C, U-15N, as 
summarized in Figure 7.4A.  
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7.4.1.2 15N -13C TEDOR distances 
For the 15N-13C TEDOR distances, a similar procedure to the 13C13C distances was 
followed. However, the ambiguous and unambiguous restraints were considered as separate lists, 
as the fitting of overlapped peaks would be less precise (see Figure 7.4B). The isotopic labeling 
schemes (b) and (c) described for the 13C13C distances, were also considered for the 15N-13C 
TEDOR distances. However, distance measurements and error values were selected based on 
previous results by Nieuwkoop et al.8, as displayed in Figure 7.4B. 
7.4.1.3 Chemical shift tensors  
The three components δn (n = 1,2,3) of the CSTs were simulated for each 13CA atom. To 
do so, the 20 amino acids chemical shielding surfaces from ab initio calculations from the 
Oldfield group (http://feh.scs.uiuc.edu/amino_acid.php) were used in combination with the 
backbone angles (φ, ϕ) derived with the program TALOS+ and the solid-state NMR CSs (or 
solution NMR, in case no solid-state NMR data was available). BMRB entries for the CSs were: 
15652 for RrR43, 15089 for StR65, 15281 for CcR55, 16348 for HR4394C, 15683 for ER553, 
6546 for HR41, 16327 for DsbA. Ab initio calculations provided the shielding surfaces 
references relative to the bare nucleus. Using the experimental datasets for GB1, we referenced 
these datasets relative to DSS using regression analysis for each residue type, as previously 
conducted by Wylie et al.9.  
The list of the 15N and 13CA solid-state NMR CSs (or solution NMR in case where no 
solid-state NMR data was available) for each protein was used to simulate the 15N13CA 2D plane 
of a pseudo-3D experiment, which was then used to select the unambiguous CSTs. At the same 
time the different isotopic labeling schemes were considered: (a) [2-glycerol]- 13C,U-15N and (b) 
[1,3-glycerol]-13C, U-15N, as summarized in Figure 7.5. 
   158 
 
Figure 7.5. Schematic representation of the methodology used for the simulation of CST restraints. 
 
7.4.2 Experimental restraints 
 Three of the nine selected proteins (GB1, CcR55, and DsbA) where chosen to collect the 
experimental datasets. These corresponded to a small, a mid size and a large protein among the 
selected systems. Experimental datasets included 13C13C restraints from DARR mixing, 15N-13C 
TEDOR 2D spectra to obtain build-up curves and CSTs obtained from a 3D pseudo-experiment 
based on a 15N13CA 2D plane.  
7.4.2.1 13C-13C distances   
13C-13C 2D spectra with different DARR mixing times (short, medium and long) and 
different labeling schemes: (a) U-13C, 15N, (b) [2-glycerol]-13C, U-15N and (c) [1,3-glycerol]-13C, 
U-15N were acquired for the selected systems and were processed with NMRPipe10. Comparison 
of 13C-13C 2D spectra of U-13C, 15N (A) GB1, (B) CcR55 and (C) DsbA are shown in Figure 7.6. 
Although spectra overlay is expected to increase as protein size increases, we attribute problems 
in the crystallization of CcR55 that lead to decreased spectral resolution and made further data 
acquisition difficult.  
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Figure 7.6. Comparison of 13C13C 2D spectra for (A) GB1, (B) CcR55 and (C) DsbA. 
 
All spectra were acquired at 750 MHz 1H frequency with DARR mixing (25 ms for A and C, 50 ms for 
B). Part A was adapated from Sperling et al11 
 
All peaks for the GB1 and DsbA spectra were picked with the program Sparky12 and lists 
of frequencies with the integrated peak volumes for the corresponding 13C13C correlations were 
extracted. As summarized in figure 7.7, using the solid-state NMR CS, we created a list of 
ambiguous and unambiguous distances by considering the labeling scheme of the corresponding 
sample: (a) U-13C, 15N, (b) [2-glycerol]-13C, U-15N and (c) [1,3-glycerol]-13C, U-15N. As 
previously described by Franks et al.6, peak intensities for the unambiguous restraints in each 
spectra were sorted into strong, medium and weak categories by resolved cross-peaks with 
known (~100%) labeling patterns and distances. Both ambiguous and unambiguous distance 
restraints were used for the calculations. 
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Figure 7.7. Methodology used for the analysis of the 13C13C distance restraints. 
 
7.4.2.2 15N-13C TEDOR distances 
 15N-13C TEDOR build-up curves for GB1 were published by Nieuwkoop et al.8 were 
further reanalyzed to consider the ambiguous and unambiguous distance restraints resulting from 
this experiment. To do so, the distance restraint lists resulting from the build-up curve fitting 
were considered. Using the solid-state NMR CS of GB1, we created a list of ambiguous and 
unambiguous distances by considering at the same time the isotopic labeling scheme: (a) [2-
glycerol]-13C, U-15N or (b) [1,3-glycerol]-13C, U-15N, similarly to the analysis conducted for the 
13C13C 2D analysis. 
 For DsbA, 15N-13C TEDOR 2D spectra (with mixing times from 1.44 to 14.4 ms) had 
been collected to conduct the solid-state chemical shift assignments13. Further analysis of these 
spectra was necessary to obtain the distance restraints, as previously conducted for GB18. This 
analysis can be summarized as follows. Peak intensities for each mixing time were extracted 
using the nlinLS package. Simulated trajectories were generated using SPINEVOLUTION14 to 
model the spin dynamics of ZF-TEDOR for each of the n 15N sites coupled to a single 13C 
resonance. Using in-house FORTRAN code that called MINUIT minimization libraries15 and 
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SPINEVOLUTION, parameters were determined by minimizing the global difference between 
the simulated and experimental trajectories.  
7.4.2.3 Chemical shift tensors  
 The GB1 CST were published by Wylie et al.9 and used for the CS-Rosetta calculations. 
Initial analysis of the DsbA CST was conducted following the same methodology as for GB19. 
Measurement of the peak intensities in each 15N-13CA 2D plane and extraction of the trajectories 
of the ROCSA time domain was conducted by using the autoFit.tcl package in NMRPipe10.  
7.4.3 CS-Rosetta fragments selection protocol 
 The original selection protocol of CS-Rosetta16 was modified to (i) exclude proteins that 
were homologous to the selected targets from the fragment picking processes and (ii) to use 
fragments of the length of 3 to 15 amino acids. Additionally the fragment selection protocol was 
used as (a) the CS score, as in CS-Rosetta1, and (b) CS and distance restraints with additional 
scoring terms for the distance restraints. 
7.4.4 CS-Rosetta simulation details  
 Three parallel Rosetta simulations were run for these initial datasets with (a) only CS 
during fragment selection, (b) CS and distance restraints during fragment selection and (c) CS 
and distance restraints during fragment selection and distance restraints during the simulation. 
Only in case (c) restraints were used as part of the energy function and scored during the 
simulation with a linear penalty potential derived from a flat bottom function, described as 
follows: 
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7.5 Initial results and discussion 
 Initial results were obtained with a benchmark of 19 globular proteins (GB3, hpr, 
tm1442, calbindin, GmR137, mrr16, TR80, Din1, sen15, LkR15, RrR43, ER553, ARF1, ccr19. 
T4lys, BcR103A, DsbA, Acap and Alg13), for which 15N-13C TEDOR distances were used 
assuming that all peaks could be individually resolved and fitted. These tests were conducted in 
order to do an initial screening of “ideal” 15N-13C TEDOR distances on the Rosetta simulations 
over a range of protein sizes (from 56 to 201) to provide a gradual increase of the difficulty level. 
7.5.1 15N-13C TEDOR distances help picking better fragments for CS-Rosetta 
 Evaluation of the incorporation of 15N-13C TEDOR distances in the fragment selection 
step was conducted by comparing the crmsd distances between fragments and the respective 
region in the native structure, as shown in Figure 7.8. Each point of the plot corresponds to a 
single sequence position in one of the 19 targets for which fragments were selected with only 
using CS versus the fragments selected using CS and 15N-13C TEDOR restraints. These results 
demonstrate an overall significant improvement in the fragment selection from adding 15N-13C 
TEDOR restraints.  
 
Figure 7.8. Comparison of the cmrsd distances measured between fragments and the native 
structure by using CS and 15N-13C TEDOR restraints for the fragment selection versus only CS 
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7.5.2 Improvement from 15N-13C TEDOR distances to the modeling with CS-Rosetta 
 To evaluate the incorporation of 15N-13C TEDOR distances in modeling with CS-Rosetta, 
comparison of the cmrsd distances between the native structure and 10/00 models selected by the 
lowest energy criteria was pursued, as shown in Table 7.1 and Figure 7.9. For 7 (GB1, hpr, 
tm1442, calbindin, GmR137, mrr16 and TR8o) out of the 19 cases, it was possible to generate 
properly scored models below 3 Å. In several cases, the use of 15N-13C TEDOR distances for 
modeling yielded to an improvement of 1 Å or superior.  
Table 7.1. Comparison of the cmrsd distances measured between the native structure and 10/00 
models selected by the lowest energy criteria by using (i) CS, (ii) CS and 15N-13C TEDOR distances 
for the fragment selection and (iii) CS and 15N-13C TEDOR distances for the fragment selection and 
15N-13C TEDOR distances for modeling 
 
Cmrd distances versus the native structure for  
Protein Models 
obtained with 
CS for 
fragment 
selection  
Models obtained 
with CS and 15N-13C 
TEDOR distances 
for fragment 
selection  
Models obtained with CS 
and 15N-13C TEDOR 
distances for fragment 
selection and 15N-13C 
TEDOR distances during 
the modeling  
 
Difference 
between 
Crmsds 
GB3 
Hpr 
tm1442 
Calbindin 
GmR137 
mrr16 
TR80 
Din1  
sen15 
LkR15 
RrR43 
ER553 
ARF1 
ccr19 
T4lys 
BcR103A 
DsbA 
ACap 
Alg13 
1.19 
3.22 
2.40 
3.42 
2.54 
3.53 
4.41 
3.49 
5.23 
6.29 
8.02 
9.23 
14.77 
9.25 
12.12 
10.01 
19.18 
10.50 
17.69 
1.00 
2.27 
2.38 
2.96 
2.56 
2.83 
3.03 
3.62 
4.24 
4.89 
6.12 
6.47 
9.58 
6.69 
10.13 
11.89 
17.77 
8.36 
16.74 
1.08 
1.66 
2.28 
2.32 
2.41 
2.41 
2.84 
3.33 
4.03 
4.05 
5.37 
6.46 
7.81 
7.87 
9.10 
9.20 
9.79 
11.14 
14.85 
0.11 
1.55 
0.12 
1.10 
0.13 
1.13 
1.57 
0.17 
1.20 
2.24 
2.65 
2.77 
6.96 
1.38 
3.01 
0.82 
9.38 
-0.64 
2.85 
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Figure 7.9. Comparison of the Cmrsd distances measured between the native structure and by the 
10/00 models selected with the lowest energy criteria. 
 
CS and 15N-13C TEDOR restraints were used for the fragment selection versus only CS for fragment 
selection (left). These results were compared to CS and 15N-13C TEDOR restraints for fragment selection 
with 15N-13C TEDOR restraints during modeling versus only CS for fragment selection (right). Errors 
estimators were calculated by 100 fold bootstrap procedure. 
 
Table 7.2. Final results from rescored models: cmrsd distances between the native structure and the 
20 lowest energy models. 
 
Cmrd distances for  
Protein 
Models obtained with CS for the 
fragment selection versus the 
native structure 
Models obtained with CS and 15N-13C 
TEDOR restraints for fragment 
selection and 15N-13C TEDOR restraints 
during the modeling versus the native 
structure 
GB3 
Hpr 
GmR137 
Calbindin 
tm1442 
mrr16 
TR80 
0.840 
1.701 
1.996 
2.309 
2.312 
2.441 
3.032 
0.253 
0.668 
0.337 
0.511 
0.688 
0.538 
1.330 
0.927 
1.063 
1.905 
1.809 
1.777 
2.151 
1.876 
0.264 
0.229 
0.313 
0.379 
0.204 
0.525 
0.516 
 
 
7.5.3 Final scoring of the models with CS-Rosetta  
 It has already been reported1,17 that rescoring the calculated models versus the 
experimental CS helps picking a better solution. For the seven best targets, we selected the 500 
best scoring structures according to the Rosetta energy criteria and the theoretical CS spectrum 
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was calculated with Sparta program3. This spectrum was then compared to the “hypothetical” 
experimental spectrum. Finally, models were ordered by a linear combination: Rosetta + 100 x 
CS desviation, as shown in Table 7.2. 
7.6 Conclusions and outlook 
 Our initial results demonstrate significant improvement in the models resulting from the 
incorporation of solid-state NMR restraints in this new CS-Rosetta protocol versus the original 
version. Additional calculations are currently being performed with the new simulated restraints 
and experimental datasets that will provide a better evaluation on the effect of the solid-state 
NMR experimental datasets on the new CS-Rosetta protocol. In order to obtain further 
improvement in the de novo 3D structural investigations of large proteins, we believe that the 
simultaneous incorporation of different kinds of solid-state restraints might provide additional 
advances.  
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CHAPTER 8 
Conclusions and outlook 
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8.2 Conclusions 
My dissertation thesis produced work towards providing atomic resolution biophysical 
insights into the pathogenic role of α-synuclein (AS) in Parkinson’s disease (PD). PD is the most 
common movement disorder that affects approximately 1-2% of the population over age 651 and 
is characterized by the presence of Lewy bodies (LBs) in dopaminergic neurons2. LBs are 
intracytoplasmic aggregates composed largely of fibrillar AS3. AS binds to anionic 
phospholipids with an α-helical secondary structure4 and promotes AS fibrillation at certain lipid 
to AS concentrations5,6. While most cases of PD are sporadic, three distinct mutations (A30P, 
E46K, A53T) in the AS gene7-9 and multiplication of the wild-type (WT) AS allele10,11 have been 
identified in familial early-onset PD. Together, these findings implicate AS misfolding in both 
sporadic and familial PD, but why and how these structural changes occur in the protein are not 
yet understood. Little is known about the AS fibrillar structures, since fibrils are insoluble and do 
not crystallize, which impedes the traditional biophysical methods of solution NMR and X-ray 
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diffraction. Magic-angle spinning (MAS) solid-state nuclear magnetic resonance (NMR) 
spectroscopy provides site-specific structural information of amyloidogenic fibrils. 
During my dissertation work, I have developed12-14 and combined state-of-the-art solid-
state NMR experiments with (scanning) transmission electron microscopy ((S)TEM) to obtain an 
atomic level structure of the fibrils and the mechanism of their formation. I have investigated the 
details of the structure and conformational dynamics of AS fibrils and employed advanced 
multidimensional solid-state NMR methods. These results show that the core of the fibrils 
extends with a repeated secondary structure motif (Figure 8.1)15, contradicting the previously 
proposed fold of AS fibrils obtained with limited solid-state NMR data16. These results also 
demonstrate that the three mutation sites (A30P, E46K, A53T) are located in structured regions 
of the fibrils (Figure 8.1)15. Furthermore, we have shown that upon mutation, the structure 
suffers major and minor perturbations by E46K and A53T, respectively,15,17 while the structure is 
unaltered by A30P (Figure 8.1)15,18.  
To evaluate the specific fold, I have also measured the mass-per-length of the fibrils 
using STEM that we have used together with the solid-state NMR restraints as a molecular 
structural constraint to investigate the fold of the fibrils19. Finally, I have also investigated fibril 
formation by capturing the transition from α-helical to β-sheet at the atomic level using solid-
state NMR and characterized the changes in the phospholipid vesicles, where dopamine is stored 
in the dopaminergic neurons, upon the fibril’s formation20. For the first time, these results 
provide information at an atomic-level about the pathway of conversion from the α-helical to β-
sheet fibrillar state of AS in the presence of phospholipid vesicles. 
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Figure 8.1. Schematic representation of the AS fibrils secondary structure, location of the early-
onset PD mutation sites and effect of the early-onset PD mutants. 
 
Taken together, these investigations will serve as basis for the understanding of how AS 
fibrils lead to the formation of LBs, the pathological hallmark of PD, or the transmission of 
aggregates from neuron-to-neuron involved in the propagation of the disease21. Although 
available drugs can relieve many of the disease symptoms, no known treatment has been shown 
to stop or reverse the disease. The availability of structural information will aid in the design of 
biomarkers to identify neuronal dysfunction (e.g., antibodies specific to the pathogenic states). 
Therefore, the fundamental understanding of the causes will help in the future diagnosis and 
rational drug design of PD. 
8.3 Outlook 
8.3.1 Tertiary and quaternary structures of AS fibrils and structural perturbation by the early-
onset PD mutants 
 Although the secondary structure and the fold of AS fibrils are now described in great 
detail15,19, no high-resolution 3D structure of the fibrils is yet available. To do so, long-range 
distances will be necessary and initial results have been presented in chapter 6. Additional efforts 
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have been conducted in the group towards applying paramagnetic relaxation enhancement (PRE) 
experiments to AS fibrils, which had already been applied to GB122. Based on the secondary 
structure of the fibrils, we selected four initial mutants that would be located in regions that one 
would expect minimum perturbation to the structure based on their secondary structure and 
conformational dynamics15, as displayed in Figure 8.2. These mutants are currently being 
investigated in the group. 
 
 
Figure 8.2. Selected residues for the incorporation of the PRE labels. 
 
(a) TALOS+ predicted order parameters S2. (b) Relative peak heights from the cross peaks of the 3D 
CANCO spectrum of U-13C,15N AS fibrils (numbered according to the carbonyl residue). Residues labeled 
as (#) correspond to residues with overlapped peaks in the CANCO experiment. Error bars correspond to 
the noise level. (c) Representation of the secondary structure of AS fibrils based on TALOS+ analysis 
(arrows indicate β-strands; curved lines are turn or loop regions; dashed lines indicated no prediction) 
with the mutation sites marked in red.  
 
Once long-range distances are measured, these will be used, in combination with other 
restraints we have measured using (i) U-15N.13C, (ii) U-15N,[2-13C] glycerol and (iii) U-15N,[1,3-
13C] glycerol labeling schemes (data not shown here) and new computational methods, to resolve 
a 3D high-resolution structure of AS fibrils. Once the tertiary structure of the fibrils is obtained, 
solid-state NMR restraints could be combined with electron microscopy to obtain the quaternary 
structure of the fibrils.  
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 Not only would this represent the largest high-resolution structure of an amyloid solved 
up to now, but also the basis for future investigations in PD investigations. These would range 
from elucidating the structural changes caused by the early-onset PD mutants to the binding site 
of brain imaging markers for the early diagnostic of PD as well as the design of possible 
therapies. 
8.3.2 Investigations of the fibrillation pathway of the AS early-onset Parkinson’s disease mutants 
in the presence of phospholipid vesicles 
Although most PD cases are sporadic, three single point mutations in the AS gene (A30P, 
E46K and A53T) have been correlated to familial early-onset PD7-9. From a kinetic point of 
view, A30P fibrillates slower than the WT in aqueous buffer23, while E46K and A53T fibrillate 
faster24,25. From a structural point of view the fibrils suffer perturbations upon E46K and A53T 
mutation versus the WT, and almost no perturbation in the presence of A30P15,17,18. However, 
our recent results demonstrate differences in the fibrillation pathway in the presence or absence 
of physiologically relevant phospholipids for the WT20.  
Previous biophysical studies have demonstrated decreased lipid affinity for the A30P 
mutation, similar affinity for A53T and increase for E46K versus the WT AS23,26,27. Therefore, 
one might envision differences in the fibrillation pathway between the WT and the mutants. 
Recent solution NMR investigations have demonstrated the presence of two binding modes: the 
SL1 binding mode (residues 3-25 bound as an α-helix) and the SL2 (residues 3-100 bound as an 
α-helix), as shown in Figure 8.328. Bodner et al proposed that the SL1 binding mode, which 
binds to the N-terminus of AS in the lipoprotein complex while the hydrophobic “non amyloid 
component” (NAC) region remains dynamically disordered, is prone to intermolecular 
interactions and progress toward disease-associated oligomers and fibrils. This is the region that 
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includes the essential residues for the fibrils formation20, which we have demonstrated to be the 
first ones positioned in the fibrils form for the WT. The increment of the SL1 binding mode 
might be correlated to the presence of the A30P, E46K, and A53T disease mutants of AS, which 
might explain the correlation of these mutants with the early-onset PD cases. Following a similar 
protocol to the investigations we have done for the fibrillation pathway for the WT20, the 
proposed disruption of the SL2 state upon mutation could be investigated by using solid-state 
NMR. 
 
Figure 8.3. Schematic depicting the proposed increased vulnerability of AS to self-association 
when engaged in the SL1 binding mode versus SL2. 
 
The A30P and A53T disease mutations are proposed to increase the relative population of SL1, for which 
a long unstructured stretch of N-terminal residues (including the hydrophobic NAC region) would be 
exposed. Image adapted from Bodner et al28. 
 
8.3.3 Structural comparison of the AS fibrils formed in vitro versus the Lewy bodies seeded 
fibrils  
The structure of AS fibrils, as many other amyloids, has been demonstrated to be 
dependent on the in vitro growth conditions29. Controlled fibrillation conditions have enabled us 
its investigation by different labeling schemes and to report the difference with the early-onset 
PD mutants15,17,18. However, the molecular structures obtained in vitro might differ from the 
structure found in LBs from PD patients. Amyloid fibrils formation is a nucleation-based 
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process. Therefore, amyloid structures propagate themselves in seeded growths. As previously 
demonstrated for β-amyloid (Aβ), brain tissues of deceased Alzheimer’s disease (AD) patients 
were used to seed the growth of synthetic Aβ1–40 fibrils and to prepare isotopically labeled 
samples for MAS solid-state NMR. These samples most likely reflect the structures that are 
present in AD brain for Aβ30.  
 
Figure 8.4. Schematic depicting the proposed methodology to prepare the AS fibrils seeded with 
LB from PD patients.  
 
Blue regions correspond to controls (dotted line boxes include experiments already completed) and 
orange regions include the preparation of LBs seeded AS fibrils. 
 
A similar methodology could be applied to AS fibrils, which would require the 
preparation of several controls and fibril generations as suggested in Figure 8.4. Initial controls 
have already been prepared to evaluate that AS fibrils propagate themselves the fibrils growth. 
Control 1 and 2 were obtained by incubating AS under “shaking” or “twisting” in order to lead to 
different fibrils forms, as demonstrated in Figure 8.5. Cross seeding of these controls, as 
described in Figure 8.4, would permit to demonstrate the propagations of the fibrils growth. 
Additionally, a blank control with brain extract from a non-PD patient could be used to 
CONTROL 1: 
WT AS fibrils 
“shaken not 
seeded” 
CONTROL 2: 
WT AS fibrils 
“twisted not 
seeded” 
Lewy bodies 
from PD 
patient A 
Lewy bodies 
from PD 
patient B 
AS fibrils 
generation “1A 
shaken” 
AS fibrils 
generation “1B 
shaken” 
AS fibrils 
generation “1 
shaken” 
AS fibrils 
generation “2A 
shaken” 
AS fibrils 
generation “2B 
shaken” 
AS fibrils 
generation “1 
twisted”  
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demonstrate that no fibrillation is induced by other factors (eg. Lipids) when comparing the 
kinetics and the final structure with the LB seeded samples. 
Isotopically labeled fibrils would be prepared by seeding with LBs from PD patients. In 
an ideal situation, two different samples (from different patients) would be used to seed natural 
abundance material from two different PD patients (A and B) with similar medical history, e.g. 
non-familial PD, to double check the proper propagation fibril growths (generations 1A and 1B). 
These samples would be used to evaluate the fibrils by EM and prepare the next generations (2A 
and 2B) with isotopically labeled material for solid-state NMR. 
 
 
Figure 8.5. Overlay of 13C-13C 2D spectra of AS fibrils incubated by shaking (blue) and 
titling the solution (red). 
 
Displayed regions include: carbonyl region (left), aliphatic region (central) and expansion of the 
Gly, Ala and Thr regions (right, from top to bottom). Spectra were collected with 50 ms DARR mixing at 
600 MHz 1H frequency and 13.3 kHz MAS. 
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